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Abstract
Joint injuries and associated diseases such as osteoarthritis place an immense socio-
economic burden on developed countries through consequences such as loss of work 
or costs associated with treatments. Whilst clinical strategies have been developed to 
treat joint defects, none have produced consistent positive results over a long-term. 
Alternate approaches have been explored in functional tissue engineering, with 
scaffold systems offering potential for healing of these osteochondral defects by 
inducing and guiding the desired tissue formation. In this thesis I aimed to develop 
scaffold systems and characterise assessment criteria for osteochondral tissue 
engineering. 
I first explored melt-extruded polycaprolactone scaffolds in vitro under static and 
perfusive flow conditions. Scaffold groups shared structural porosity and varied in 
design, with four different architectures presented. I demonstrated a difference 
between groups in terms of mechanical response and fluid flow through the 
scaffolds, and confirmed that these differences affected osteoblast response in a cell 
culture under osteogenic conditions. 
Secondly, I designed and constructed a hybrid zonal scaffold comprising a 3D-
printed alginate-hydroxyapatite paste cast into a gelatine methacrylamide or gelatine 
methacrylamide/hyaluronic acid methacrylate blended hydrogel. This scaffold 
system was cultured in vitro with human articular chondrocytes, testing whether the 
formation of a zone of calcified cartilage was promotable. I found that whilst 
chondrogenic markers were upregulated throughout the culture in the hyaluronic 
acid-containing groups, there was no concrete evidence of the formation of a 
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calcified region in this case. I postulated that with physical compression of the 
hydrogels during culture a greater effect may be seen in future work. 
Thirdly, I developed a criterion on which to assess photocrosslinkable hydrogel 
systems in terms of cytotoxicity and hence optimise mechanical properties. 
Photocrosslinking proceeds through radical polymerisation under ultraviolet light, 
both components of which are toxic. I hypothesised that when a hydrogel has a 
greater number of reactive functional groups, these will selectively interact with the 
photoinitiator molecules and reduce cytotoxicity of the system. This was found to be 
the case when tested on human articular chondrocytes. I also tested the influence of 
two different ultraviolet light dosages on chondrogenic differentiation in vitro and 
found that at the chosen dosages there were no apparent effects, however both of the 
dosages were comparably cytocompatible. 
Lastly, I tested gelatine methacrylamide, gellan gum and gellan gum methacrylate in 
various blends, using a relatively complex mechanical testing regimen to assess the 
tailorability of hydrogel viscoelasticity. Hydrogels were physically crosslinked 
(gellan gum) or chemically crosslinked (gelatine methacrylamide, gellan gum 
methacrylate) through photopolymerisation. I compared the viscoelastic properties of 
the hydrogels with those of native human cartilage explants and found that physically 
crosslinked hydrogels demonstrated the closest viscoelasticity however with a 
      ø           ê           ê       
yielded highest elastic modulus with somewhat lower viscoelastic properties. 
Modulation of the ratio of physical and chemical crosslinks may be used in future to 
tailor material viscoelasticity to that of numerous biological tissues. Further 
examination of viscoelasticity as a criterion would provide a deeper understanding of 
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the role of such mechanical properties in design of tissue engineering structures and 
its relevance in cartilage development. 
Overall, my work demonstrated design of two scaffold systems within bone and 
osteochondral contexts, along with two characterisation methods that may be used to 
further develop tissue engineering structures for osteochondral regeneration. 
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Chapter 1: Introduction
1.1 BACKGROUND
Osteoarthritis (OA) is a whole-joint disease, affecting hyaline cartilage, 
subchondral bone as well as the biomechanical and biochemical environment of the 
joint. It is the most common form of arthritis and a prominent cause of disability and 
morbidity, as well as a burden for the health system through costs associated with 
treatments and loss in work [1]. Although the causal factors of OA are not 
completely clear, it is known that the disease progresses as a result of both biological 
and mechanical factors which destabilise normal joint equilibrium, affecting the 
extracellular matrix (ECM) and the chondrocytes which reside in cartilage as well as 
adjacent structures such as the subchondral bone tissue, synovial joint lining and 
connective tissue elements [2]. 
Hyaline articular cartilage is responsible for providing a low-friction 
articulating surface between bones during movement as well as providing load 
transfer and force distribution [3]. Unlike bone, hyaline articular cartilage is a tissue 
lacking innervation or a blood supply and is hence largely hypoxic and reliant on 
diffusion through the subchondral bone and the synovial fluid for nutrient supply. 
The physiology of cartilage, along with the relatively low cell volume – 
chondrocytes are the only cell type found in cartilage and occupy around 5 % of the 
tissue volume [3] – mean that intrinsic repair of the tissue is very limited, especially 
when contrasted with the spontaneous healing capacity of bone. Hence in the case of 
injury, cartilage does not heal well, either growing a fibrocartilaginous tissue within 
the wound site or simply lacking any repair at all; in either case the physiological and 
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biochemical changes result in an alteration to the overall environment and eventually 
lead to the development of OA. 
Cartilage tissue engineering (TE) has focused on attempting to heal cartilage 
defects, and developing systems to combat the joint degradation which occurs in 
diseases such as OA. TE comprises a wide range of sciences, with a general 
approach of forming temporary biomaterial substitutes (scaffolds) which provide 
mechanical support and differentiative stimulation to injury sites in order to attempt 
the healing of injuries that are difficult or impossible to treat through conventional 
methods [4]. Alternately, TE provides a means through which costs associated with 
traditional treatments, such as the use of autograft for bone repair, can be decreased, 
and issues with complications such as donor site morbidity may be avoided. 
Osteochondral TE focuses on the use of mixed, heterogeneous or zonal 
constructs in an attempt to reconstruct elements of the subchondral bone and the 
overlaying articular cartilage. Whilst thermoplastic polymers are well suited to the 3 
dimensional (3D) printing technologies generally used for bone tissue engineering 
[5-8], hydrogels, highly hydrated polymer materials, form more suitable matrices for 
the development of cartilage [9-13]. 
However, prominent hurdles remain in current osteochondral TE technologies, 
and include: scaffolds failing to achieve required biomimetic mechanical properties – 
both in terms of load requirements in situ as well as forming an appropriate 
environment for osseo- or chondroinduction; complications with a trade-off between 
mechanical properties and cytocompatibility in hydrogel systems; implant-to-target 
site integration, including that of cartilage and subchondral bone; and size-limit of 
regeneration. The targeting of regeneration to a cartilage-only level through TE 
treatment of OA may contribute data pertaining to a final solution regarding full joint 
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repair; however this approach may be lacking in terms of providing insight on 
regeneration of the full thickness of cartilage, including the zone of calcified 
cartilage (ZCC) and the subchondral bone, all of which develop pathological issues. 
The study of chondrocytes in a combined osteochondral model may allow for the 
examination of material, biological and structural interactions that lead to the 
development of both bone and cartilage tissues and yield a preliminary foundation on 
which future full-joint regeneration approaches may be structured. 
In my thesis, I explored the influence of various design and production factors 
on scaffolds for bone and cartilage regeneration in an in vitro setting. First, I assessed 
the influence of bone scaffold architecture on fluid flow and cell growth in static and 
perfusion contexts. Secondly, in collaboration with colleagues from the Technical 
University of Dresden (TUD), I explored the formation of a ZCC to confirm the 
chondrogenic potential of hyaluronic acid in a hybrid osteochondral scaffold-gel 
system comprising a 3D-printed hydroxyapatite paste cast into a hydrogel. Thirdly, I 
assessed the protective effects of reactive functional groups on cells in 
photocrosslinkable hydrogels subject to ultraviolet (UV) radical polymerisation in 
the presence of a photoinitiator, and also assessed any permanent effects UV 
exposure may have on chondrocytes in a chondrogenic culture. Finally, I delved 
deeper into complex hydrogel viscoelastic material properties, assessing the 
tailorability of viscoelasticity of hydrogel blends and comparing their mechanical 
properties against explanted donor cartilage tissue. 
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1.2 PURPOSE OF RESEARCH 
The purpose of this research was to expand knowledge in the field of tissue and 
biomaterials engineering. More specifically, it was to expose some factors in tissue 
engineering that may not be commonly assessed or considered and bring them to 
light. The significance of aspects such as fluid flow within a scaffold, material 
viscoelasticity, polymer characterisation post-modification, cytotoxicity of 
photoinitiators and potential mechanisms of cytoprotection, are commonly known. 
However the elucidation of desirable attributes, the assessment of their relevance and 
establishment of methods on which to construct future scaffold design requires 
further investigation. This research presents various criteria on which to assess 
biomaterials and scaffolds which have not been previously explicitly described and 
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1.3 LITERATURE REVIEW 
1.3.1 Bone Physiology 
Bone is a structurally supportive, living tissue that is constantly renewed and 
regenerated by the body. It is made up of cancellous (or trabecular) and cortical 
phases. The cortical bone provides the majority of the strength and stability to the 
tissue, making up 80 % of the weight of the total bone mass in an adult skeleton [7]. 
The calcified matrix of bone contains three major cell types which produce 
(osteoblasts), maintain (osteocytes) and resorb (osteoclasts) the bone [8]. Cancellous 
bone is present at the ends of long bones, surrounded by a layer of cortical bone. The 
cancellous bone is composed of a network of filamentous rods and plates and acts to 
greatly reduce the overall weight of the organ as well as providing the necessary 
volume for bone marrow [7]. Functionally, bone provides a biomechanical leverage 
system for the muscles and connective tissues of the body, as well as protecting 
sensitive organs. Similarly to all organ systems in the body, bone is a hierarchical 
tissue, with numerous anatomical subsystems identifiable at various length scales 
[14]. The largest subunit of cortical bone is comprised of Haversian systems (or 
osteons). These cylindrical structures are axially oriented along the compressive 
stress plane and thus give the required mechanical properties of the tissue at this 
level: strong resistance to compression, coupled with a resistance to bending whilst 
maintaining elasticity. The osteocytes that are housed within these structures feature 
comprehensive networks of cellular processes through which relevant proteins 
modulate cell function. The extracellular matrix (ECM) of bone consists of two 
primary phases, a nonmineralised organic component comprised of collagen type I 
which renders the bone elastic and tough, and a mineralised inorganic reinforcing 
component comprised of 4 nm plate-like carbonated apatite mineralites 
(hydroxyapatite; HAP) giving stiffness and strength to the tissue [14]. The ECM also 
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contains over 200 noncollagenous matrix proteins [14]. Figure 1.1 illustrates the 
structure of the organ diagrammatically. 
Figure 1.1: Hierarchical organisation of bone over different length scales.
A) the cortical outer layer; b) the many cylindrical osteons (or Haversian systems); c) 
a range of cell membrane receptors specific to binding sites; and d) the 
nanoarchitecture of the surrounding extracellular matrix (ECM) [14]. Reproduced 
with permission from the publisher. 
Regeneration of bone tissue occurs through four stages, which are: 
inflammation, soft callus formation, hard callus formation, and remodelling. The 
time for complete resolution of these stages is dependent on the species and the level 
of trauma. Typically in a human the process takes 9-12 weeks. The initial swelling or 
haematoma features recruitment of mesenchymal stem cells (MSCs), or more 
specifically, Bone Marrow Stromal Cells (BMSCs). These cells proliferate at the site 
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of injury and differentiate into both osteoblasts and chondrocytes when exposed to 
appropriate stimuli. 
Although not much is known about the regulation of cell recruitment on a 
molecular level [15], it is known that the secretion of growth factors such as the 
family of Bone Morphogenetic Proteins (BMPs), members of the Transforming 
Growth Factor- (TGF-) superfamily, is key in the induction of this process, which 
is referred to as endochondral ossification. 
Whilst the regenerative capacity of bone is remarkable, with tissue responding 
well to biomechanical as well as biochemical stimuli [8], it may be significantly 
impeded under certain conditions such as in the presence of ‘critical-size’ defects. 
These defects are gaps in bone tissue of such size that spontaneous healing no longer 
occurs. They typically result from trauma caused by interventions such as removal of 
tumour tissue or accidents causing large, open or comminuted fractures. Clinically, 
these types of injuries are primarily treated through the transplantation of inductive 
bone tissue at the site of trauma. The ‘gold standard’ method for this is the autograft 
or autologous bone graft [16], which involves the harvest of a bone tissue sample 
from the patient’s iliac crest and implantation of this sample into the site of injury. 
Variations on this technique have been explored, such as the allograft, wherein same-
species donor tissue is transplanted into the patient, or the xenograft, which involves 
the use of an alternate-species donor [16]. All of these methods carry their own 
disadvantages, with even the gold standard suffering from drawbacks including 
secondary-site trauma, possibility of donor site morbidity, or limitations in 
harvestable volume. Bone tissue engineering strategies have been developed to 
remedy these issues, with the goal of the optimisation of biomaterial scaffolds that 
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provide necessary structural support and biological signalling whilst alleviating 
limitations seen in grafting techniques [5, 7, 8, 14, 17]. 
1.3.2 Cartilage Physiology 
Hyaline articular cartilage lines the ends of articulating bones. It is a multi-
phasic tissue with a limited capacity for regeneration – it is avascular and lacks a 
connection to the nervous system, with all nutrient transfer reliant on diffusion 
through the subchondral bone or the surrounding synovial fluid [18, 19]. Articular 
cartilage limits wear or degradation in diarthrodial joints whilst allowing for smooth 
joint movement through a high load bearing capacity coupled with low friction 
characteristics. Articular cartilage is primarily composed of sparsely distributed 
chondrocytes (~5 % volume) within a dense ECM [3, 20]. Zonal variance exists 
across the three phases of cartilage: superficial, middle and deep, and manifests in 
both chondrocytic phenotype and proteoglycan and collagen content [21]. In the 
superficial (or tangential) zone, chondrocytes appear flattened, with collagen fibres 
travelling parallel to the surface, providing the tissue with resistance to transverse 
expansion and shear. In the middle (or transitional) zone, chondrocytes bear a 
rounded morphology, whilst collagen II fibres cascade down to an angled orientation, 
forming a link between the surface and the deep areas of the tissue. Finally in the 
deep (or radial) zone, chondrocyte columnar stacking may be observed, with 
collagen fibre orientation being perpendicular to the surface. Figure 1.2 shows a 
cross-section of cartilage illustrating the chondrocytic variance and content of ECM 
components.  
 
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Figure 1.2: Zonal collagen fibril alignment in articular cartilage. 
Across the three zones, collagen type II fibre alignment may be seen to change from 
parallel to the surface to a mixed alignment and finally perpendicular to the surface 
in the deep zone. Proteoglycan content transitions from the lowest content (~15 %) in 
the superficial layer to a peak (~25 %) in the middle zone and a middle value in the 
deep zone (~20 %). Conversely, collagen content as a percentage of dry weight of the 
tissue decreases from a very high proportion (~85 %) in the superficial layer to a 
plateau in the deepest regions of the tissue (~67 %) [22]. Reproduced with 
permission from the publisher. 
Specifically, the ECM of cartilage is composed of water (70 %) and an organic 
component (30 %); no mineral constituents are present in the healthy tissue [23]. The 
organic component of ECM is comprised primarily of collagen type II, IX and XI, 
with collagen types IV and VI present in pericellular matrix (PCM) space (total 60 % 
collagen in ECM), proteoglycans (25 %), and other matrix proteins (15 %) [23]. 
Figure 1.3 illustrates the relationship between collagen type II, aggrecan, hyaluronic 
acid (HA), and the proteoglycans chondroitin sulphate (CS) and keratin sulphate 
(KS). 
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Figure 1.3: Relationship between collagen type II, aggrecan, hyaluronic acid 
and proteoglycans in articular cartilage. 
Hyaluronic acid (HA) forms complexes with the proteoglycans chondroitin sulphate 
(CS) and keratin sulphate (KS) through a link protein association. These interactions 
enhance the mechanical properties of the tissue and increase water retentive capacity 
by manipulating charge [22]. Reproduced with permission from the publisher. 
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1.3.3 Joint Pathologies and Treatments 
The avascular, alymphatic and aneural nature of cartilage is a limitation when 
attempting to regenerate the tissue, with injuries to cartilage typically degenerating 
further rather than spontaneously healing [21]. This degradation causes impairment 
of joint movement, disability, and significant pain to the individual, as well as 
resulting in economic burden through loss of work output and medical costs 
associated with treatments [21]. Injuries to the tissue are typically caused by 
unnatural loading, torsional loading, joint misalignment and foreign bodies within 
the joint [19, 21, 24, 25]. Joint injuries may also extend into the subchondral bone 
[11, 21, 26]. Similarly to injuries of the cartilage surface, osteochondral (OC) defects 
are commonly caused by trauma, however they also develop in individuals suffering 
from diseases such as osteochondritis dissecans, wherein the subchondral bone 
atrophies due to disturbed blood supply and flaps of cartilage may detach as a result 
[6, 27, 28]. 
Generally, all cartilage injuries may be classified as one of three types: 
osteochondral defects, chondral defects, or microfractures of the cartilage surface 
[21]. The Outerbridge classification system [21, 29, 30] is a clinically recognised 
cartilage injury grade scale that is as follows (also illustrated in Figure 1.4): 
 Grade 0: normal cartilage 
 Grade I: softened and swollen cartilage 
 Grade II: (most frequently observed clinically) a defect containing 
fissures that do not reach subchondral bone; defect diameter less than 15 
mm 
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 Grade III: same as grade III, only the defect reaches the subchondral 
bone, or has a diameter in excess of 15 mm 
 Grade IV: cartilage injuries resulting in exposure of subchondral bone 
It may be evident that Grade III and above are osteochondral injuries, whilst 
the lower Grades remain exclusively chondral in nature. Multiple clinical approaches 
exist for the repair of focal lesions (defects penetrating superficial cartilage yet 
maintaining a small diameter) and surface damage of articular cartilage, including 
studies involving progenitor cells [31], tissue adhesives [32], laser solder welding 
[33], osteochondral grafting [34], and autograft cell/tissue transfer via periosteal 
grafts [35]. These methods provide largely short-term relief of symptoms and are not 
ideal over the long-term due to various shortcomings, such as donor site morbidity 
and the degradation of the tissue despite treatment [6, 18, 36, 37]. Despite the 
distinction that may be made between cartilage and osteochondral injuries, any 
disturbance of the equilibrium of the joint may lead to cartilage degradation and 
overall joint pathology such as the development of osteoarthritis [2, 38]. 
Although osteochondral injury involves a higher degree of tissue damage, it 
may also potentially trigger subchondral bleeding and hence provide an alternate 
nutrient supply to the otherwise avascular region [21]. This allows an increased 
capacity for tissue regeneration at the injury site; however, again the resulting 
neotissue typically consists of fibrocartilage and leads to further joint complications 
and eventual onset of osteoarthritis [21, 39]. Similar outcomes have been reported 
from clinical bone marrow stimulating techniques such as microfracture or multiple 
drilling [10, 40]. 
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Figure 1.4: Outerbridge classification of cartilage injury. 
Various grades of cartilage injury are illustrated, with a) grade I: softened or swollen 
cartilage; b) grade II: a defect containing fissures that do not reach subchondral bone; 
defect diameter less than 15 mm; c) grade III: same as grade III, only the defect 
reaches the subchondral bone, or has a diameter in excess of 15 mm; and d) grade 
IV: cartilage injuries resulting in exposure of subchondral bone [29, 30, 41]. 
Reproduced with permission from the publisher. 
Osteoarthritis (OA) is the most common joint disorder, characterised by a 
degeneration of articular cartilage, intraarticular inflammation with synovitis, and 
subchondral bone changes [2]. It is predominantly observed in the aging population, 
with the majority of individuals over 65 having clinical and/or radiographic evidence 
of the condition [2]. A consensual definition of OA diseases has described the 
conditions as a result of biological and mechanical events that are involved in the 
destabilisation of standard homeostasis of cartilage tissue. Namely, this involves the 
disruption of the relationship between degradation and synthesis, affecting 
chondrocytes, extracellular matrix and subchondral bone. Whilst it is uncertain 
whether the disease manifests due to a single cause or a multitude of factors - 
genetic, developmental, metabolic and traumatic aspects have all been implicated in 
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the cause of the disorder. OA results in changes to biochemistry, biomechanics and 
morphology to both cells and matrix, which leads to the degradation of all tissues 
within the diarthrodial joint including the softening, ulceration, fibrillation and loss 
of articular cartilage, the eburnation and sclerosis of subchondral bone, and the 
development of osteophytes and subchondral cysts. Clinically observable cases of 
OA share symptoms, namely joint pain, limitation of movement, tenderness, 
effusion, crepitus and inflammation [42].  
Whilst many systemic and local factors have been identified as causal in the 
development of OA, no single model has been identified that is able to replicate the 
condition in a laboratory setting [2]. In regenerative medicine, the treatment of OA 
through the regeneration of damaged cartilage and bone is a large focus due to the 
comprehensive nature of the condition. However, as the mechanisms through which 
the disease manifests are not completely understood, the ultimate success of these 
approaches in treating OA is still unknown. For example, microfracture/subchondral 
drilling, despite resulting in a fibrocartilaginous layer, has been reported to decrease 
symptoms of existing osteoarthritis and furthermore promote healing of 
osteochondritis dissecans [43].  
Direct clinical treatment of cartilage injuries using methods such as 
mosaicplasty or autologous osteochondral grafting result in poor long-term tissue 
formation and suffer from difficulties in matching the shape of donor and target 
tissues [39, 44, 45]. Total joint replacement (or arthroplasty) exists as a final solution 
in current medicine, with this method consisting of a complete removal of the 
dysfunctional components and replacement with typically a polymeric acetabulum 
and stainless steel femoral nail [46]. Whilst unable to provide a complete recovery of 
function, the total joint replacement does provide patients with a stable and largely 
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functional joint. Implant loosening (in the case of total knee replacement) has been 
assessed since 1977 [47], and has been reported as the result of repetitive impact to 
the tibial component by the distal femur in hyperextension, as well as hyperflexion 
leading to extraction moments and subsequent implant failure. Additionally, 
placement of the implant in the joint has been found to largely influence failure, with 
numerous cases of this reported over the last 60 years [48-51]. The life of the implant 
varies, with implant type influencing outcome, but a general 10 – 25 year duration is 
observed overall [52-55]. Unlike total joint replacement, functional tissue 
engineering approaches involve the formation of replacement tissues or inductive 
and supportive scaffolds with the goal of avoiding commonly seen clinical 
complications, whilst providing the potential for complete biological regeneration of 
tissue and function [18, 21]. 
1.3.4 Functional Osteochondral Tissue Engineering 
The field of tissue engineering emerged from a combination of materials 
science, biology and engineering, and has since been established as an individual 
discipline. Overall, TE involves the use of a combination of biomaterials, cells and 
inductive stimuli in the treatment of injuries, defects or organs which are either 
unable to spontaneously heal.  The concept was originally defined by Robert Langer 
and Joseph P. Vacanti in their 1993 publication [4]. Various approaches are used 
within current TE practice and each chapter of this thesis will present a detailed 
background to contextualise its content. However, the basic concept of TE is as 
follows: a patient presents with an injury to a specific site; a biopsy is taken or a site 
is resected to obtain a sample of the relevant cells from the patient; the cells are 
expanded in vitro; the expanded population is seeded into a mechanically supportive 
structure (scaffold), or cultured in a 3 dimensional (3D) environment through another 
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method; the final construct is then transplanted into the patient, presenting a scaffold 
and a viable cell population (Figure 1.5). This system may of course vary, with cell-
free, scaffold-free, multi-phasic, ordered and disordered approaches all being 
explored throughout the field. 
 
Figure 1.5: The tissue engineering process illustrated schematically. 
The process follows a basic cycle, wherein tissue is harvested from the patient to 
allow for the isolation of cells and their subsequent expansion in culture. This cell 
population is then seeded into a construct for 3D culture, and after sufficient tissue 
growth is observed, the construct is implanted into the target site of the patient [56]. 
Reproduced with permission from the author. 
A range of different tissue engineering strategies for osteochondral 
regeneration have been explored in the past decade, with various scaffold material 
and inductive biological components used. Scaffold structural approaches feature 
either a bone layer scaffold, a cartilage layer scaffold, a combination of bone and 
cartilage scaffolds, or one scaffold across both layers [6]. Biological components 
may consist of nothing (purely material/surface based approach), no cells but various 
types of growth factors in bolus or controlled-release forms, chondrogenic cells, 
osteogenic cells, or combinations of any of these aspects [6]. In any case, the scaffold 
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is present within the defect for the purpose of enhancing proliferation and targeted 
differentiation of progenitor cells, as well as providing a temporary structural support 
network to allow regeneration to occur. Scaffold material properties are tailored to 
the target tissue type to further encourage induction of the desired tissue structures. 
Scaffold material components in recent osteochondral (OC) engineering research 
predominantly consist of thermoplastic aliphatic polymers such as poly-lactic acid 
(PLA), poly-glycolic acid (PGA), poly-lactic-co-glycolic acid (PLGA) or 
polycaprolactone (PCL) [57-67]. Ceramic structures and hydrogels are also 
frequently utilised [10, 68-70], with the majority consisting of composites of calcium 
phosphate or hydroxyapatite combined with various hydrogels. A summary of the 
advantages and disadvantages of each class of materials is shown in Table 1-1. 
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Table 1-1: Summary of materials used in osteochondral tissue engineering, 
including examples, advantages and disadvantages. 
Material Type Examples Advantages Disadvantages 
Thermoplastic 
 Polycaprolactone [5, 
71, 72] 
 Poly-lactic acid [35] 









 Degradation may 
lead to local pH 
decrease and 
associated issues 
 Limited bioactivity 
 No cell 
encapsulation 
Hydrogel 
 Gelatine [9, 75-77] 
 Alginate [76, 78-80] 
 Chitosan [81] 
 Gellan gum [82, 83] 
 Hyaluronic acid [35, 84]
 Bioactivity 
 Cell adherence 
 Suitability for 
mixing into 
composites 





 Calcium phosphate 
[85, 86] 














Whilst techniques consisting of cell transplants both with and without scaffolds 
have frequently appeared in cartilage tissue engineering, no purely cell- or biologic-
based approaches have been successful in the consistent formation of tissue with the 
structural and mechanical properties of native cartilage [81]. Progress in functional 
tissue engineering appears concurrently dependent on advances in biological 
understanding of the problems at hand along with that of biomaterial performance, 
with the microenvironment of the scaffold seeming pivotal in the success or failure 
of a construct [87]. Whilst the formation of hyaline-like tissue has been achieved in 
modern scaffold-based tissue engineering, the resulting cartilage has also been found 
to lack biomechanical characteristics observed in native tissues [88]. Hence although 
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components such as cells or cell stimulating factors are necessary to induce healing, 
the level to which these are introduced into a construct prior to implantation to yield 
greatest benefit, and the significance of the scaffold micro-structure and environment 
is yet to be optimised [88].  
Currently, prevalent cartilage tissue engineering techniques largely involve the 
in vitro culture of scaffolds with autologous chondrocytes, followed by implantation 
of these structures into defects [6]. Such approaches are limited by potential donor-
site morbidity, lack of harvestable tissue, time and cost. Cell-free systems offer a 
solution to this wherein a one-step procedure may minimise the aforementioned 
disadvantages. Drawbacks of a cell-free strategy primarily consist of limited cell 
migration and induction due to the nature of the implanted constructs. It should be 
noted however that when dealing with osteochondral injuries, migration of 
pluripotent BMSCs from the bone marrow may be stimulated [89, 90], and similarly 
evidence suggests that even in a purely cartilaginous environment, chondrocyte 
migration is a possibility [91]. It has been reported that migration of BMSCs into 
osteochondral scaffolds may hold a distinct advantage over chondrocyte implantation 
as BMSCs have been found to differentiate down both bone and cartilage pathways, 
resulting in better integration at the interface of the neotissues [92]. Despite this, 
research into cell-free strategies is less advanced than that of cell-containing 
scaffolds and the complications that are present with the technology are difficult to 
overcome. 
The differentiation of stromal cells within scaffolds into chondrocytes is 
primarily achieved through the use of growth factors such as the TGF- superfamily 
and allows the development of the appropriate phenotype along with the deposition 
of relevant ECM components [93]. Whilst bolus inclusions of growth factors were 
 20 Chapter 1: Introduction 
tested initially, more recent strategies involve the temporal and spatial regulation of 
growth factor release through encapsulation within biomaterials, such as in gels or 
microspheres, in an endeavour to further enhance tissue development [94].  
Tissue engineered cartilage systems have been used clinically in recent years, 
with a wide range of approaches explored. Whilst it appears that a one-step solution 
for patients and surgeons is the preferred approach, efficacy remains a limiting factor 
in these technologies, both in the short term and beyond two years [95]. Notable cell-
containing systems within this area include Cartilage Autograft Implantation System 
(CAIS; DePuy/Mitek, Raynham, MA, USA), CaReS® Cartilage Regeneration 
System (Arthro Kinetics, Bebenhausen, Germany), INSTRUCT (CellCoTec, 
Bilthoven, The Netherlands), CartiGro Autologous Chondrocyte Transplantation 
(ACT; CellGenix, Freiburg, Germany), Carticel® ACI and Matrix-assisted 
autologous chondrocyte implantation (Genzyme Biosurgery, Boston, MA, USA), 
NeoCart (Histogenics, Waltham, MA, USA), Aseed™ (Coloplast A/S, Humlebaek, 
Denmark), DeNovo® Natural Tissue (NT; ISTO Technologies, St. Louis, MO, 
USA), and BioCart II (ProChon Biotech Ltd., Waltham, MA, USA) [95]. Their 
current regulatory status and approach is summarised in Table 1-2. The clear 
multitude of companies offering various solutions for the regeneration of cartilage 
suggests that the field is still predominantly open and a comprehensive solution is yet 
to be found.  
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Table 1-2: Summary of a number of current cartilage/osteochondral repair 
products; approach and regulatory status 
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It is known that the structure must provide sufficient mechanical support at the 
target site so as to sufficiently shield any implanted or migrating cells from excessive 
damage, and to avoid the destruction of any ECM or neotissue. However, there must 
be stimulus of sufficient magnitude such that the remodelling of the matrix is 
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encouraged, and the cells are stimulated to differentiate down the appropriate 
pathway. There is thus a complex relationship between many factors, including cell-
material surface interactions, fluid flow through scaffold matrices, scaffold 
degradation rate, scaffold mechanical properties, and nutrient diffusion into the 
centre of the construct. It is not entirely clear what type of product will achieve 
desired outcomes in the clinic, as more complex cell-containing products must meet 
much more stringent regulatory conditions and proceed through longer clinical trials 
than simpler cell-free solutions, however, they do promise greater long-term 
durability. The development of regenerative solutions for cartilage is difficult in 
itself and the transition from laboratory to clinic is yet another hurdle in this complex 
problem. 
1.3.4.1 Additive Manufacturing 
Additive manufacture (AM), or as it has been described in the past: rapid 
prototyping (RP) or solid-freeform fabrication (SFF), allows the formation of 
scaffolds with tailored geometries consisting of mathematically calculable, 
designable and reproducible micro-architectures [24]. Whilst this provides 
advantages in terms of site-specific design, it also affords an additional level of 
customisability of the structural properties that result from manipulations of aspects 
such as scaffold architecture or porosity.  
A variety of AM techniques exist, most notably including inkjet printing [96], 
3D printing (3DP) [97], stereolithography [98, 99], laser direct writing [100, 101] 
and melt extrusion (including fused deposition modelling (FDM)) [24]. Most 
relevant to this thesis is the process of melt extrusion (ME), wherein a polymer is 
heated to a sufficient temperature so as to induce viscous flow and is then extruded 
out of the heated chamber by means of a screw or syringe driver.  
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The AM process involves the formation of structures through the deposition of 
material, as opposed to traditional manufacturing techniques such as milling where a 
final product is formed through the removal of material. This approach also offers 
advantages over traditional scaffold production techniques such as leaching [73, 
102], sintering [103, 104], foaming [102] and freeze-drying [84, 105], as it allows for 
the formation of soft or hard structures of high fidelity, the conservation of material, 
and for the tailorability of material deposition. By tailoring material flow rate and 
shear stress in a production method such as 3D printing, it becomes possible to print 
structures made of very sensitive materials, including hydrogel polymers containing 
living cells. Furthermore, printing of ordered structures allows for the design of 
specific fluid flow patterns and scaffold mechanical properties, especially when 
combined with finite element analysis (FEA) during design iteration. All of the 
aforementioned strategies of fabrication and TE involve a ‘top-down’ approach, 
which is the main focus of all strategies in this thesis [106]. 
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Figure 1.6: Top-down versus bottom-up approaches in tissue engineering. 
The top-down (traditional) approach involves the seeding of living components such 
as cells into a porous scaffold, the subsequent implantation of such a construct and 
the replacement of the scaffold material by native ECM. Conversely, the bottom-up 
approach involves the assembly of small cell-laden modules into larger structures, 
attempting to avoid shortcomings of the top-down approach such as poor diffusivity, 
inhomogeneous cell distribution or slow vascularisation [107]. Reproduced with 
permission from the publisher. 
However, a converse approach also exists, known as ‘bottom-up’, where tissue 
features are mimicked from the opposite direction (Figure 1.6). Namely, this 
approach involves the micro- or nano-scale production of components that may then 
be used as building blocks for larger structures. This may involve approaches such as 
direct cell-plotting into cell sheets, layering of cell sheets, or production of entire 
structures through self-assembly of microscopic components [106]. Comparatively, 
whilst the bottom-up approach forms a more biomimetic matrix at tissue level, the 
top-down approach is much more simple and easy to modify, allowing 
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developmental work to progress at a greater rate. In general, the AM field has a 
multitude of factors that can be further developed by exploring the possibilities of 
present technologies and pushing innovation where positive outcomes are met. 
1.3.4.2 Hydrogels 
Scaffolds for cartilage regeneration largely comprise hydrogel materials – 
highly hydrated (30 – 99 % water) polymer matrices – for the encapsulation and 
culture of cells for both in vitro and in vivo assessment [9, 21, 108]. Naturally-
derived hydrogels are well suited to the development of cartilage tissue as they 
provide a low-oxygen (hypoxic) environment that is comparable with that found in 
native cartilage [3]. They also provide a matrix of relevant density and hydration, 
providing nutrients through the diffusive methods that are available in situ [3]. Along 
with these features, the mechanical properties of hydrogels are largely tailorable, 
depending on polymer type, polymer content, combination of polymers, crosslinking 
method and crosslinking density [109]. 
A commonly used method for the crosslinking of hydrogels is that of 
photopolymerisation, wherein ultraviolet (UV) light is used to excite a photoinitiator 
molecule, which then enters a high-energy radical state and is able to interact with 
target reactive functional groups on a hydrogel macromer [110]. This form of radical 
polymerisation through permanent chemical crosslinking is, however, unlike a 
variety of similar methods that include crosslinking through the use of chemical 
initiator/accelerators (such as ammonium persulphate / 
etramethylethylenediamine (APS/TEMED)) mixed within the hydrogel precursor 
solution that immediately react upon mixing of components [109]. Whilst the 
crosslinking process itself is similar, these methods are limited in that the reaction 
occurs immediately after mixing of the precursor solutions and proceeds until all 
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active molecules are consumed. This may lead to the development of inhomogeneous 
structures and higher levels of cytotoxicity. Conversely, photocrosslinking allows the 
formation of a highly homogeneous network structure and limits radical interactions 
with cells largely to the duration of UV exposure [109].  
The presence of reactive functional vinyl groups on the monomer allows for 
effective crosslinking kinetics, and also may provide benefits in terms of protecting 
cells from radical damage. Reaction in photopolymerisation of hydrogels 
predominantly occurs through interaction with the vinyl group (which features a 
carbon-carbon double bond) [109, 111]. However, as reaction with the carbon-carbon 
bond is less specific than reaction with carbonyl (carbon-oxygen) groups that may be 
observed in ketone and aldehyde reactions, and may progress through either 
homolytic or heterolytic bond breakage, carbon-carbon reactions may interact with 
non-target molecules (such as those on cells) more readily than other crosslinking 
systems [111], and cause higher cytotoxicity. A higher number of functional groups 
on the polymer may thus yield cytoprotective effects; analysis of this theory is 
explored in Chapter 4. 
1.3.4.3 Viscoelasticity 
It is widely known that cartilage is a viscoelastic tissue, exhibiting features of 
strain-rate dependant modulus, creep and stress relaxation [112-116]. The concepts 
of fluid flow influencing cell response is also commonly explored in literature, 
frequently within bioreactor systems [69, 102, 113, 117]. Despite this, analysis of 
viscoelastic properties of hydrogels is not common [118], particularly when it 
concerns comparison of hydrogels and native tissue explants or elucidating to what 
level biomimetic viscoelasticity may be emulated with hydrogel constructs. The 
influence of covalent versus physical crosslinks have been explored most recently 
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however [119], indicating an increased proportion of physical crosslinks promotes 
viscoelastic hysteresis whilst a higher proportion of covalent crosslinks promotes a 
purely elastic response. Viscoelasticity of hydrogel blends is explored in Chapter 5. 
1.3.4.4 Mineral inclusions in osteochondral scaffolds 
Regeneration of osteochondral defects is difficult due largely to the dissimilar 
healing properties of bone and cartilage [120]. Many approaches for the treatment of 
such defects have been explored for TE, with the use of hydroxyapatite as a scaffold 
component resulting in positive outcomes for subchondral bone regeneration, with 
reported ingrowth into implants [70, 84, 121-123]. Work assessing the potential of 
hydrogel-ceramic hybrids has been recently explored, with a construct comprising 
alginate and hydroxyapatite cultured in vitro [124]. In this case a large homogeneous 
structure was able to stimulate the formation and development of a type of ZCC. 
Further, work by Fedorovich et al. [125] and Hollenstein et al. [126] demonstrated 
potential in the field, with layered scaffolds including a ZCC showing 
chondrogenesis and improved bone-hydrogel interfacing. Overall, this technology 
revolves around the inclusion of calcium within the ZCC, either in the form of 
calcium phosphate (CP) or hydroxyapatite (HAP) [28, 127-129]. Formation of zonal 
hydrogels with a hydroxyapatite layer is explored in Chapter 3. 
1.3.4.5 Bioreactor systems 
Bioreactor systems emerged in functional tissue engineering as a means of 
emulating the natural biological mechanical environment and hence providing a 
functionally relevant stimulus to cultured cells [21]. In bone tissue engineering, 
perfusion flow systems have been used with success, aiding the seeding of cells and 
their development [102, 130]. Both standard flow methods have been used as well as 
varied flow rates, wherein flow was periodically paused during culture [131-133]. In 
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the case of cartilage tissue engineering, physiologically relevant stimuli such as 
direct compression, hydrostatic pressure, shear or a combination of multiple loading 
regimes have been used, with positive results [21]. An increase in proteoglycan and 
collagen synthesis and ECM deposition has been reported with mechanical 
stimulation, along with improved nutrient transfer and waste removal affecting the 
cultured tissue. Further, bioreactors have shown promise in osteochondral tissue 
engineering, with positive outcomes resulting from the use of double chamber 
systems [10], as well as more simple bioreactor constructs [18, 57]. The effects of 
bioreactor culture in vitro provides both a means of stimulating greater phenotype 
expression as well as offering a method of isolating and examining innovations of 
concepts and designs through physiologically varied environments.  
1.3.5 Summary 
Examination of the physiology of bone and cartilage in the context of joint 
pathology indicates that healing these tissues remains a prominent issue affecting 
regenerative medicine, the economy and those suffering from pathologies such as 
osteoarthritis. Notably, current clinical methods of treating injuries to joint surfaces 
as well as full thickness defects are lacking, with no approach yielding tissue 
structures of sufficient mechanical or biological structure compared to that of native 
cartilage. However, as stimulation of regeneration as opposed to direct replacement 
is key in this field, the appropriate level of mechanical properties and chondrocyte 
maturity remains unclear. The use of scaffold technologies is an attractive concept 
yet further detail in fluid flow, scaffold architectural design, mechanical testing 
methodologies, effects of photoinitiator and combination of materials into hybrid 
structures are highly relevant to progress in the field and are presented within this 
thesis. 
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1.4 THESIS HYPOTHESES AND AIMS 
The overarching hypothesis of this thesis is that the development and 
characterisation of scaffold technologies and novel methods for analysis of 
constructs will afford positive outcomes for osteochondral tissue engineering and 
ultimately help further the progress into treatment of joint pathologies. 
1.4.1 Study hypotheses 
There were four specific study hypotheses tested herein, with work related to 
each of these forming a paper and a chapter in the thesis. The hypotheses are: 
1. Scaffold architecture will influence osteoblast response and fluid flow 
under static and perfusion in vitro culture conditions. 
2. Combination of 3D printed hydroxyapatite paste scaffolds and hydrogels 
will contribute to innovation in the development of hybrid scaffold 
technologies. 
3. Reactive functional groups in photocrosslinkable hydrogels interact 
preferentially with photoinitiator molecules and thus afford protective 
effects to cells under UV exposure. 
4. Combination of physical- and chemical- crosslinked hydrogels can lead to 
tailoring of viscoelasticity to biologically relevant levels. 
1.4.2 Effects of scaffold architecture of osteoblast response under static and 
perfusion bioreactor in vitro culture conditions 
The first study (Chapter 2) explored bone tissue engineering scaffolds melt-
extruded from polycaprolactone (PCL). Four different designs were made, where 
weight porosity (wt %) was maintained constant whilst pore size and shape were 
varied in design and hence printing. Weight porosity refers to taking the theoretical 
weight of a 0 % porosity polymer cylinder of relevant dimensions and then 
 30 Chapter 1: Introduction 
calculating what percentage of this comprised actual polymer in the printed scaffold. 
The scaffolds were characterised using mechanical fluid flow, computational fluid 
dynamics (CFD) fluid flow modelling, micro computed tomography (μCT) and 
mechanical testing (compressive elastic modulus, strength, strain at yield and strain 
at failure). An in vitro culture was then conducted within control and osteogenic 
conditions, with static (well plate) and perfusion bioreactor (custom made device) 
culture groups. The aim of this study was to assess the effect that architecture had on 
fluid flow (for example, wall shear stress), mechanical properties, and cell response 
within the various culture methods (assessing seeding efficiency, proliferation and 
osteogenic differentiation).  
1.4.3 Combination of 3D printed hydroxyapatite paste scaffold and hydrogel 
yields chondrogenesis and potentiates targeted calcification 
The second study (Chapter 3) of this thesis was conducted with the aim of 
assessing the relevance of a hybrid construct made of a paste scaffold with a 
hydrogel cast within it for osteochondral tissue engineering. The study formed part of 
a collaborative project between QUT and the Technical University of Dresden 
(TUD). Hydroxyapatite paste and alginate paste scaffolds were printed using a 3D 
printer to form the base of a control (alginate) and calcified (hydroxyapatite) zone of 
calcified cartilage. Functional hydrogels were synthesised and chondrocyte-
containing gels were formed with the scaffolds forming the base of the construct. A 
28 day cell culture under chondrogenic stimulation was performed to assess any 
cytotoxicity and any relevant differentiation from the scaffolds. 
1.4.4 Protective effects of reactive functional groups on chondrocytes in 
photocrosslinkable hydrogel systems 
This study (Chapter 4) was designed to assess protective effects that reactive 
functional groups of a monomer may have whilst a photopolymerisation reaction is 
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underway. It was hypothesised that with a greater number of reactive groups within a 
hydrogel, a greater proportion of photoinitiator would interact with the monomer 
instead of causing cell damage and death. Further, it was proposed that the effects of 
UV may have a lasting influence on chondrogenesis of cells. 
Firstly, hydrogels with various degrees of functionalisation (DOF) were 
synthesised and assessed quantitatively using proton nuclear magnetic resonance (1H 
NMR), after which the number of reactive groups relative to the number of 
photoinitiator groups was quantified as a molar ratio. Hydrogels were made using 
various concentrations of photoinitiator and UV dose and were assessed 
mechanically, after which a 24 hour culture was performed on chondrocyte-
containing hydrogels with two photoinitiator and two UV doses to test the initial 
hypothesis. Hydrogels were then made with chondrocytes at one photoinitiator dose 
and two UV doses and cultured for 14 days in chondrogenic conditions, to test 
whether the UV dose had an effect on viability, glycosaminoglycan (GAG) content, 
DNA content, mechanical properties, gene expression and presence of relevant 
proteins (immunofluorescence). 
This study formed a criterion on which DOF and photoinitiator concentration 
may be tailored in future hydrogel systems. 
1.4.5 Assessing biomimetic viscoelasticity of gelatine-methacrylamide and gellan 
gum-methacrylate hydrogel composites for cartilage tissue engineering 
The aim of this study (Chapter 5) was to assess the tailorability of viscoelastic 
properties within hydrogel blends, assess what is achievable and compare these 
values to those observed in native cartilage tissue explants. Hydrogels were 
functionalised and characterised using 1H NMR and rheology and a preliminary (7 
day) cell culture to ensure the blends were not cytotoxic. 
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Complex mechanical analysis was then performed, assessing the elastic, 
equilibrium, storage, and loss moduli, and the loss tangent. These tests were 
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2.1 INTRODUCTION
Bone tissue engineering is a research area with notable potential in the realm of 
repair and regeneration of bone injuries. The tissue engineering approach involves 
the use of biodegradable scaffold systems to structurally support a target site whilst 
host cells and/or transplanted cell populations are induced by bioactive materials, 
growth factors, or other stimulatory systems to regenerate bone [134-138]. 
Thermoplastic polymer scaffolds have featured prominently within this field as the 
materials are relatively simple to process and are chosen on the basis of 
biodegradability and biocompatibility whilst providing desired mechanical 
characteristics [139-141]. On the one hand, a considerable amount of research has 
been focused on the characterisation and optimisation of the mechanical [103], 
inductive [142] and osteoconductive [143] aspects of the scaffold constructs. On the 
other hand, a large proportion of work has focused on different cell and/or growth 
factor strategies to best achieve a desired differentiation and extracellular matrix 
(ECM) deposition at the target site [88, 144-146]. Optimisation of the 
microenvironment of biomaterial structures from a materials and engineering 
standpoint has been previously described as a pivotal aspect in the ultimate success 
of scaffold implants [87]. A multi-faceted approach, wherein mechanical efficacy 
and target-site suitability are analysed together with cell response to scaffold 
architecture, allows a more complete progression of knowledge in the applicability of 
scaffolds as tissue healing modalities. 
Work on scaffold architecture to date primarily addresses global aspects such 
as differences in both porosity and lay-down orientation across test groups (Figure
2.1; [147]), material variations [148], micro- or nanoarchitectures [149] or material 
densities [150]. However, the aforementioned studies vary multiple parameters 
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between groups, e.g. testing the influence of lay-down patterns without controlling 
porosity, which confounds the effects of each single parameter. 
 
Figure 2.1: Schematic of lay-down and offset in 3D-printed scaffolds. 
A) A single scaffold layer consisting of parallel filaments, viewed from the top; b) a 
90 ° lay-down, consisting of a second layer of parallel filaments globally rotated by 
90 ° about the Z-axis. C) An inter-layer offset of a factor of 0.5 filament-to-filament 
distance introduced in the 90 ° design. D) The first two layers of a 60 ° lay-down, 
illustrating a second layer of parallel filaments globally rotated by 60 ° about the Z-
axis; e) the third layer in the 60 ° sequence, completing the layer-tiling sequence for 
this angle. F) A 0.5 inter-layer offset introduced into a 60 ° lay-down design. 
In order to characterise the influence that certain aspects have on scaffold 
efficacy, adequate control over all scaffold parameters is necessary. In this study, we 
present a melt extruded (ME) thermoplastic polymer scaffold system within which 
we introduce architectural variations of inter-layer lay-down angle and offset whilst 
maintaining a constant porosity, scaffold material and extruded filament thickness (~ 
400 μm). We propose that the architectural modifications will affect scaffold 
mechanical characteristics as well as cellular response in an in vitro culture model 
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consisting of either static plate or custom-designed perfusion bioreactor culture 
methods. 
2.2 MATERIALS AND METHODS  
2.2.1 Scaffold Design and Fabrication 
MatLab (The MathWorks Inc., USA) was used to generate g-code, with 
filaments and layers spaced and rotated as specified (detailed in Appendix 1), which 
controlled a melt extruder, the BioExtruder (designed by Domingos et al. [72]) 
through Mach3 CNC Controller software (Newfangled Solutions LLC, USA). All 
scaffolds were fabricated from poly--caprolactone (PCL; CAPA 6500, molecular 
weight (MW) 50 kDa; Perstorp, Sweden) to a porosity of 60 ± 5 weight percentage 
(wt. %), with four experimental variants of lay-down angle and offset (OS; 0 or 0.5) 
between layers: A (90 °), B (60 °), C (90 °OS), D (60 °OS) (Figure 2.2 (a – d) 
rendered in SolidWorks 2009 (Dassault Systèmes S.A., France)). Weight porosity 
refers to the weight of the actual scaffold versus a solid cylinder of the same volume 
of the chosen material. Groups were chosen based on geometry, with predictions 
formed on mechanical properties and pore size. Namely; (A): the highest number of 
axially aligned layers and hence largest pores and stiffest construct; (B): the second 
highest number of axially aligned layers with decreased pore size and lower stiffness; 
(C): the 90 ° design allowing for a dramatic increase in axial surface area and an 
associated decrease in pore size; and (D): the 60 ° design with the same 
modifications as group C, giving smaller pore size and higher axial surface area 
compared with B. Scaffold diameter (12 mm) was based on the prior classification of 
‘small’ defects (< 2 cm2) [151]. Scaffold height varied between groups (10 mm, 4.5 
mm), as described below. 
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Figure 2.2: The four scaffold architectural variants and characterisation data. 
SolidWorks renders of the designs, sectioned at 3 mm from one edge to reveal 
internal geometry; a) A: 90 °; b) B: 60 °; c) C: 90 ° offset (OS); d) D: 60 °OS. Micro-
computed tomography (μCT) scan renders of sections of the four scaffold types (e–
h). Characterisation data from μCT: i) Porosity distribution; j) pore size; k) filament 
thickness. Statistically similar groups share Roman numerals (p < 0.05). 
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2.2.2 Scaffold Characterisation and Mechanical Testing 
Scaffold porosity was determined gravimetrically using weight porosity 
calculations. Scaffolds were scanned using micro-Computed Tomography (μCT; 
Scanco Medical μCT 40; Figure 2.2 (e – h)) to verify weight porosity was accurate 
(i) and establish mean pore size (j) for samples. These were calculated using values 
for total volume and bone volume as determined by a triangularised surface plate 
model, producing output for bone volume, total volume, trabecular thickness and 
trabecular spacing. In this case trabecular thickness and spacing correspond to 
filament thickness and pore size. Data are presented as mean ± standard deviation. 
Axial permeability of scaffolds was quantified by measuring flow of water through 
the structures within a confined tube, using an Instron MicroTester (Model 5848; 
Instron®, USA), then calculating permeability using Darcy’s law, as applied by 
Melchels et al. [152]. Scaffolds were held at the bottom of a tube with a thin wire, 
with the base of the tube blocked against a rubber stopper and mounted on the 
MicroTester. The tube was filled with water, and the MicroTester head was retracted, 
which broke contact with the rubber stopped and allowed free flow of fluid through 
the scaffold. Force data was recorded to measure the beginning and end of flow, with 
this also used to determine a flow rate and the subsequent permeability value. Axial 
mechanical compression tests to failure were conducted on 4.5 mm tall scaffolds (n = 
6 per type) using the Instron MicroTester in dry (room temperature (RT)) conditions 
and in Dulbecco’s Phosphate Buffered Saline (PBS; Invitrogen, USA) at 37 °C, with 
a displacement rate of 0.5 mm·s-1 up to 66 % strain. This strain level was chosen as 
to ensure complete failure of the constructs, whilst the strain rate was chosen to 
provide a slow and controlled failure devoid of any high energy fractures. 
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2.2.3 Surface Modification and Sterilisation 
All scaffolds were incubated in 5 M NaOH (5 h at 37 °C) then rinsed in Milli-Q 
water (Merck Millipore, USA) until pH 7 [153]. Samples were sterilised with 60 min 
70 % EtOH immersion, evaporation and subsequent 60 min UV-C irradiation. Axial 
compressive tests (as above) were conducted to assess degradation. 
2.2.4 Perfusion Bioreactor Construction 
A perfusion system was designed to allow continuous bidirectional media flow 
axially through scaffolds. This consisted of front-end reservoirs (50 mL syringe; 
Terumo) attached by silicone tubing to 6-port connectors (Value Plastics, USA) that 
split to scaffold chambers (5 mL syringe; Terumo) and terminated at back-end 
reservoirs (50 mL syringe; Terumo) (Figure 2.3). Aervent Disposable 0.2 μm Filters 
(Merck Millipore) were attached to both ends of the system. A programmable 
syringe pump (AL-6000, World Precision Instruments, USA) external to the 
incubator was used to perfuse media by displacing air from two 50 mL syringes. 
Four-way stopcocks (Value Plastics) were used to allow for media change during 
culture. Sections of the silicone tubing were used to separate scaffolds within 
chambers. 
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Figure 2.3: Custom-built perfusion bioreactor schematic. 
A 6-bay syringe pump (shown as a single-bay) was used to push air forward and 
backward, displacing media during culture (illustrated in reservoirs and scaffold 
chamber). Each scaffold type had a separate inlet reservoir, chamber and outlet 
reservoir. 
2.2.5 Computational Fluid Dynamics 
Computational fluid dynamic (CFD) analysis was conducted using Ansys 
Fluent (Ansys, Inc., Cecil Township, PA, Build Oct 12 2010) with a flow rate of 1 
mL·h-1. Analysis was done for wall shear stress; a limit of 3 Pa was used [154]. 
Further details on the experimental model may be found in Appendix 2. 
2.2.6 Cell Culture 
MC3T3-E1 cells (ATCC, USA) were cultured in -minimum essential medium 
(MEM) (Invitrogen) with 10 vol. % fetal bovine serum (FBS; Invitrogen) and 1 vol. 
% penicillin-streptomycin (10000 U·mL-1 - 10000 μg·mL-1; Invitrogen); henceforth 
‘culture media’. Culture conditions of 37 °C, 98-100 % humidity and 5 % CO2 were 
maintained. Osteogenically inductive media (henceforth ‘osteogenic media’) was 
made using the same procedure, with the addition of ascorbic acid (0.1 %, 100 mM; 
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Sigma-Aldrich, USA – henceforth “Sigma”), dexamethasone (0.1 %, 1 mM; Sigma) 
and -glycerophosphate (1 %, 1 M; Sigma).  
Static Culture 
Scaffolds of 10 mm height (henceforth “seeding experiment”) were seeded 
with 1.25 million cells within 500 μL of culture media, pipetted axially. Plates were 
incubated for 2 h, whereafter 4 mL·scaffold-1 of culture media was added. Media (4 
mL·scaffold-1) was changed on days 1, 3 and 7 of culture. Scaffolds of 4.5 mm 
height (henceforth “differentiation experiment”) were cultured in well plates, with 
625,000 cells within 225 μL of culture media pipette-seeded into the top of each 
scaffold (to maintain the same cell / media concentration of the 10 mm group). The 
4.5 mm design was chosen as it provided sufficient height so as to maintain structural 
effects on the cells whilst improving the efficiency of the polymer, processing, 
culture and cell system required for the experiment. Plates were incubated for 2 h, 
whereafter culture media was added (2 mL·scaffold-1). Media (2 mL·scaffold-1) was 
changed on days 2, 5 and 7. Scaffolds were then transferred into new plates and split 
into control and osteogenic media, and 2 and 4 week time points (n = 6 of each 
type/condition/time point). Media was changed on day 1, 3 and 5 each week. 
Perfusion Culture 
Seeding experiment scaffolds (4.5 mm height) were seeded with a cell 
suspension of 1.25 × 106 cells·6.5 mL-1 of culture media per scaffold, infused into 
bioreactor reservoirs. The pump was programmed to loop infinitely at a rate of 1 
mL·h-1 per chamber (0.61 μm·s-1, 15 mL volume, bidirectional). Media was changed 
to cell-free on day 1. Chambers were terminated on days 1 & 7. Differentiation 
experiment scaffolds were pre-cultured as in static culture methods. The scaffolds 
were then transferred to bioreactor chambers. The perfusion system in this case was 
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used exclusively for osteogenic culture. Media was slowly introduced into the system 
(< 1 mL·h-1), so as to not disturb or detach pre-cultured cells. Perfusion consisted of 
0.5 mL·h-1 (31 μm·s-1, 12 mL volume) flow per chamber; media was changed 
weekly. 
2.2.7 Cell-Construct Characterisation 
Assessment of cell seeding efficiency, homogeneity of attachment, viability, 
proliferation, differentiation and cell/scaffold morphology was conducted. 
Cell Attachment and Morphology 
Cell seeding homogeneity, spreading, attachment, viability and morphology 
were assessed with fluorescence microscopy (Zeiss Axio Imager M2), confocal 
scanning laser microscopy (CLSM; Leica SP5 Confocal Microscope) and scanning 
electron microscopy (SEM; Quanta 200 SEM). Live/dead staining was conducted 
(seeding experiment day 7), with 5 μg·mL-1 fluorescein diacetate (FlDA; Invitrogen) 
and 0.5 μg·mL-1 propidium iodide (PrI; Invitrogen) in PBS. Samples were washed in 
PBS and cut to produce a thin (2 mm) centro-axial section (Figure 2.4). These were 
transferred to the staining solution and incubated at 37 °C for 5 min. Samples were 
imaged using fluorescence (excitation: 488 nm (FlDA) and 568 nm (PrI)). CLSM 
assessment (seeding experiment day 7) samples were sectioned using the same 
method, after which sections were rinsed in PBS (Ca++ Mg++) then fixed in 4 % 
paraformaldehyde (PFA; Sigma) prior to a final PBS rinse. Sections were transferred 
to a PBS solution containing 5 μg·mL-1 of 4',6-diamidino-2-phenylindole (DAPI; 
Invitrogen) and 0.8 U·mL-1 concentration of rhodamine-conjugated phalloidin 
(Invitrogen) and kept at 4 °C in darkness for 24 h. Excitation wavelengths of 358 nm 
(DAPI) and 480 nm (rhodamine-conjugated phalloidin) were used to visualize nuclei 
and actin. SEM assessment (seeding experiment day 7) samples were bisected 
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axially, fixed with 3 % glutaraldehyde and stored at 4 °C. On the day of treatment, 3 
washes of 0.1 M cacodylate buffer (Sigma) were followed by an incubation in 1 % 
osmium tetroxide (Sigma) in cacodylate buffer. Samples were then dehydrated using 
incremental ethanol incubations, and chemical drying using 100 % 
hexamethyldisilazane (HMDS) (Sigma) was performed thereafter. Samples were 
sputter coated with gold in a 103 Pa argon atmosphere (EMS150R S; Electron 
Microscopy Sciences, USA) prior to imaging the cut surface.  
 
Figure 2.4: Centro-axial scaffold section schematic illustration. 
Scaffolds were cut along the two illustrated planes to allow for imaging across the 
full depth and width of the structures. Image was produced and rendered in 
SolidWorks. 
Seeding Efficiency, Proliferation and Differentiation 
Cell seeding efficiency and proliferation were assessed using the Quant-iT™ 
PicoGreen® dsDNA assay kit (Invitrogen). Seeding experiment scaffolds were 
removed at day 1, whilst differentiation experiment scaffolds were removed at days 
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14 and 28. Samples were stored at -80 °C in 0.2 % Triton™ X-100 (Sigma) in PBS 
to induce cell lysis [155]. Upon thawing, scaffold sections were placed in micro-
centrifuge tubes (Quantum Scientific; LabAdvantage) along with lysate, prior to 
processing with 0.1 mm diameter glass beads (Bullet Blender Beads GB01, Next 
Advance Inc., USA) using the Bullet Blender® Storm (BBY24M-CE, Next Advance 
Inc., USA). The PicoGreen assay was conducted as per manufacturer’s instructions 
(Invitrogen), prior to microplate reading with the POLARstar Omega (BMG 
LABTECH GmbH, Germany). An excitation wavelength of 480 nm and emission of 
520 nm were used; samples were analysed in triplicate. Results for seeding (day 1) 
were calculated using cell number based on dsDNA content (one cell containing 7.7 
pg DNA [156]), and the seeding efficiency was taken as the percentage of cells 
remaining from the initial seeded amount. Proliferation was quantified by dsDNA 
content over the analysed points. Differentiation was quantified at days 14 and 28 by 
measuring activity of alkaline phosphatase (ALP) using the pNPP ALP assay, as per 
manufacturer’s instructions (Sigma), and contrasted using μg ALP per ng DNA 
content for each sample. 
Statistical Analyses 
Analysis of Variance (ANOVA) tests were used to assess differences, with 
Tukey’s post-hoc tests used to determine inter-type relationships. Tests were 
conducted using SPSS 21.0 with p-values < 0.05 taken as significant. Figure bars in 
the figures presented in the results show mean ± standard deviation unless defined 
otherwise. Statistically significant differences are indicated using Roman numerals or 
symbols; any groups sharing a Roman numeral are statistically similar whilst groups 
without a like numeral are different. 
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2.3 RESULTS 
2.3.1 Scaffold Characterisation 
Structural Quality, Computational Fluid Dynamics and Permeability 
Four scaffold types were produced: A (90 ° - most axially stacked filaments 
and largest pore size), B (60 ° - second highest number of axial stacking, reduced 
pore size), C (90 ° with offset (OS) – greater axial surface area than standard design) 
and D (60 ° with OS – again greater surface area than standard design), as shown in 
Figure 2.2 (a - d) schematically and by μCT (e – h). Analysis of μCT data showed 
porosity was clearly controlled across the four scaffold types whilst a decreasing 
pore size was imposed (n = 6; Figure 2.2 i, j). Further, no statistical differences were 
found between μCT and wt. % data. 
CFD was used to establish wall shear stress values within the scaffold 
structures. Data was obtained for the four scaffold types, yielding an overall 
distribution of wall shear stress across the axis of each design (Figure 2.5 a – d, data 
in (f)). The majority of data points in the box plot fit below a shear stress of 1 Pa, 
with outliers imposing shear stress maximums across the groups of (A) 0.837 Pa, (B) 
1.103 Pa, (C) 1.979 Pa and (D) 2.527 Pa. Significance was found between the four 
types with structural offset imposing the strongest changes in the data. Scaffold 
permeability data corroborated predictions, with types featuring higher permeability 
undergoing lower shear stress magnitude (Figure 2.5 e - g). 
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Figure 2.5: Computational fluid dynamics (CFD) data from experimental 
groups.
(a-d): vector plots indicating wall shear stresses within the four tested scaffold types 
at a flow rate of 1 mL·h-1. (e): scaffold permeability, , calculated from scaffold 
resistance to axial water flow. (f): wall shear stress across the four scaffold types as 
calculated by CFD. Differing Roman numerals indicate significant difference 
between tested groups (p < 0.05). (g): histogram of wall surface shear stress (Pa); 
expressed as a percentage of elements within a stress range for scaffold types A-D, 
as indicated on plots. 
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Mechanical Testing 
PCL is a highly hydrophobic polymer and hence cell attachment potential as 
well as fluid ingression through dense structures is limited in the native material. 
Surface treatment of the polymer was used to decrease hydrophobicity and enhance 
biological applicability. Treatment was found to reduce mean scaffold stiffness by 10 
% (not significant; data not presented). Compressive testing was performed on 
untreated samples, under both dry conditions (RT) and in a 37 °C PBS immersion. 
Scaffold compressive modulus, yield stress and strength (Figure 2.6 a – c) as well as 
strain at yield and at strength (e, f) were calculated from the stress-strain relationship 
demonstrated in (g) and the tangent modulus (h). The tangent modulus was used to 
expose relevant peaks to allow determination of the structural yield and strength. The 
relevant inflection points are indicated (h), with the same strain values used to mark 
where these values would fall on the stress-strain curve (g). The recovered height of 
scaffolds after testing increased more in scaffolds tested after PBS immersion (d). 
Scaffold architecture has a clear influence on the mechanical values of the scaffolds, 
with a decrease in stiffness, yield stress and strength observed across the scaffold 
types. 
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Figure 2.6: Mechanical characterisation of PCL scaffold groups. 
Axial compression was performed dry (at room temperature) and immediately after 
immersion in 37 °C PBS for 30 min. (a): compressive modulus taken over 4–6 % 
strain of the resultant non-linear curve; (b): yield stress; (c): stress maximum at 
failure (strength); (d): height recovery after testing (original height 4.5 mm; 
compressed to 1.5 mm); (e): strain at the yield point; (f): strain at the strength point; 
(g): stress strain curve example of a tested scaffold sample; and (h): tangent modulus 
of the same sample. Peaks determined from the tangent modulus (slope of stress) 
were used to calculate yield stress (broken circle) and strength (full circle) and are 
indicated in both (g) and (h) at the same strain levels. Statistically similar groups 
share Roman numerals (p < 0.05); upper case and lower case Roman numeral sample 
groups were tested independently to each other. Each individual group was compared 
between dry and PBS using a t-test, with stars indicating significant difference 
between condition pairs (as indicated by bars; p < 0.05). 
2.3.2 Cell Culture 
Cell Viability and Morphology 
Cell viability was assessed to determine cell survival within the deepest regions 
of the scaffold, whilst assessment of cell morphology provided data on the 
penetration of cells through the full scaffold depth as well as the cell spreading and 
bridging that occurred. FlDA/PrI imaged specimens indicated an overall high 
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viability throughout the entire scaffold depth, however a slightly higher proportion of 
dead cells was visible in perfusion cultured constructs. As scaffolds were sectioned 
with a scalpel blade, the cells that were cut and thus suffered membrane rupture 
appear as areas of red around the filament cross-section (static: Figure 2.7 a – d, 
perfusion: Figure 2.8 a – d). Slight green autofluorescence of PCL was observed. 
CLSM images indicated filament coverage and bridging between filaments for all 
scaffold types, most notably under static culture conditions (Figure 2.7 e – h), with a 
qualitatively lower observable cell number under perfusion (Figure 2.8 e – h). SEM 
again indicated static culture scaffolds having higher cell coverage, including visible 
bridging, compared with perfusion samples that had a contrastingly lower number of 
cells (static: Figure 2.7 i – l, perfusion: Figure 2.8 i – l). 
 
Figure 2.7: Qualitative images of PCL scaffold sections taken from static 
culture. 
(a–d): FlDA (live, green)/PrI (dead, red) fluorescent stain on day 7 – Z-stack of 
between 40 and 60 images; (e–h): DAPI (blue)/phalloidin (rhodamine, red); 
nuclei/actin stain on day 7 – maximum projection images; (i–l): SEM image of cells 
on scaffold filament junctions on Day 7 using 20 kV and 200× magnification. 
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Figure 2.8: Qualitative images of PCL scaffold sections taken from perfusion 
culture. 
(a–d): FlDA (live, green)/PrI (dead, red) fluorescent stain on day 7 – Z-stack of 
between 40 and 60 images; (e–h): DAPI (blue)/phalloidin (rhodamine, red); 
nuclei/actin stain on day 7 – maximum projection images; (i–l): SEM image of cells 
on scaffold filament junctions on Day 7 using 20 kV and 200× magnification. 
2.3.3 Seeding Efficiency, Cell Proliferation and Alkaline Phosphatase 
Expression
Seeding efficiency was assessed by DNA assays (Figure 2.9). There was an increase 
in seeding efficiency with decreasing scaffold permeability in static culture, whereas 
scaffolds in perfusion culture showed the opposite trend, possibly due to wall shear 
stress affecting cell attachment. Cell number in the bioreactor decreased from day 14 
to day 28, whilst cell numbers increased under static conditions (Figure 2.10 a). No 
significant differences were found between types at any singular time point apart 
from perfusion at day 28 (Figure 2.10 a). ALP activity per DNA values increased 
with time in perfusion culture, whilst peaking on day 14 in static culture and 
dropping by day 28 (Figure 2.10 b). 
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Figure 2.9: Mean cell seeding efficiency of all scaffold groups under both static 
and perfusion conditions. 
Seeding efficiency of cells in scaffolds expressed as a percentage of DNA quantities 
on day 1 post-seeding compared to seeded population. Significantly different groups 
are indicated with different Roman numerals while similar groups share symbols; p < 
0.05. 
 Chapter 2 53 
 
Figure 2.10: DNA content per scaffold and ALP activity per DNA for all groups. 
(a): scaffold DNA content data for 14 and 28 day cultures, with static control (SC), 
static osteogenic (SO), and perfusion osteogenic (PO) groups described; (b): ALP 
activity measured using pNPP assay with 30 min incubation, normalised to DNA 
content per scaffold, same groups as in graph (a). Significantly different groups are 
indicated with different Roman numerals while similar groups share symbols; p < 
0.05. 
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2.4 DISCUSSION 
I explored the influence of four different scaffold architectures (with controlled 
porosity and filament thickness) on scaffold pore size, fluid flow characteristics (wall 
shear stress and permeability), mechanical properties and osteoblast response under 
static and perfusion culture conditions in vitro. 
The variance in lay-down angle and introduction of offset into designs strongly 
influenced pore size at a constant scaffold pore density of 60 ± 5 wt. %. A clear, 
significant decrease was observed between types A – C, however the pore size 
reduction imposed by introduction of interlayer offset was negligible for the 0-60 ° 
lay down pattern. (C and D, n.s.). The 0-90 ° design pores are relatively large in all 
directions but are strongly reduced in size in the Z-direction upon the introduction of 
offset, whereas for the 0-60 ° pattern the pore size in the XY-plane is much smaller, 
and hence the overall pore size is less affected when offset is introduced. 
The trend observed in wall shear stress, modelled with CFD, mirrored the trend 
in pore size, however whilst the large sample size (~100,000 data points) in the CFD 
model caused a considerable number of outliers, unlike in pore size, significance was 
found between C and D type scaffolds. Again as in pore size, the experimentally 
determined permeability differed most between the lay-down patterns in the absence 
of an offset (A to B), however significant difference was also detectable for the 
offset-groups (C to D). The trends indicated by the computational and experimental 
systems were in agreement, which supported reliance on the CFD model for 
determination of maximum shear value thresholds of the bioreactor system. In 
reference to shear stress values, García et al. [157] tested shear stress required to 
detach osteoblasts from fibronectin (Fn) coated or no-Fn (control group, bovine 
serum albumin (BSA) only) glass slides, using a spinning disc device. It was found 
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that under control conditions a 2 Pa shear stress was sufficient to detach 50 % of 
cells, whilst Fn coating raised the required shear to 5 Pa or more. In contrast, the 
reference value used in our modelling was derived from Weinbaum et al. [154] who 
describe that a shear stress range of 0.8 – 3.0 Pa is exhibited on osteoblasts in vivo. 
With both the factor of safety imposed on the flow rate in the model (0.5 mL·h-1 in 
bioreactor, 1 mL·h-1 modelled), and the vector plot indicating only few peripheral 
filaments underwent high shear magnitudes, it was concluded that a bioreactor flow 
rate of 0.5 mL·h-1 would enact lower shear than this threshold value and thus be 
within the 0.8 – 3.0 Pa physiological range. 
Throughout the literature, different cell types have been tested with imposed 
fluid shear in vitro to assess response to the wall shear stresses. Notably, a shear 
stress of 1.6 Pa was found to positively influence chondrocyte glycosaminoglycan 
levels and morphology [158], whilst contrastingly a shear stress above 1.0 Pa caused 
apoptosis and cell detachment in endothelial cells [159]. It is clear that cell response 
to shear stress is both cell- and substrate-dependent and hence despite stress 
predictions and ceilings being imposed on the system, it is difficult to form 
predictive models on such parameters. Namely, PCL has not been characterised in 
terms of shear stress requirements for osteoblast attachment, and further work into 
the exposition of this may be advantageous in future. Further, expansion of CFD 
models to include less complex geometries yet a more in-depth analysis of the shear 
gradients at various flow rates may also improve future bioreactor system designs. 
The scaffold designs were chosen based on the predicted mechanical properties 
of each architectural variant. Whilst a 90 ° lay-down gives the most stacked filaments 
axially (along the long (Z) axis; 2 layers of scaffold form the two distinct angles with 
subsequent layers repeating this 2-layer sequence) and hence affords the strongest 
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axial arrangement possible within such a structure, a 60 ° lay-down (3 layer tiling), 
with triangular cross-sectional pores, offers stronger transverse rigidity. Introduction 
of an offset into types further increases number of layer in one tiled sequence (4 for 
90 °, 6 for 60 °). Offset designs were chosen to increase axial surface area, reduce 
permeability and offer a further modality through which pore size could be modified 
whilst maintaining scaffold density. It should be noted that whilst the primary 
physiological loading modality of osteochondral bone-phase scaffolds would be 
axial, various transverse and shear loads may be present in vivo. The design of the 
scaffolds imposed logistical constraints in transverse mechanical testing as a 
circumferential variability would exist. As the scaffolds would serve as the bone 
component of osteochondral scaffolds, shear loading would be primarily experienced 
in the cartilage phase. Any material failures caused by excess shear would thus occur 
at the top phase and transfer only transiently to bone scaffolds. Mechanical tests were 
hence only performed on the scaffolds in an axial orientation. Testing was performed 
both in ambient air (dry RT) and in simulated physiological solution (37 °C PBS), 
and consisted of high strain (66 %) compression past failure. As the melting point of 
PCL is ~60 °C, an increase in temperature from RT to 37 °C would increase the 
chain mobility in the amorphous phase of the polymer and lower structural stiffness. 
The strength of scaffolds indicated a stronger similarity to wall shear stress values, 
with offset providing a much more prominent impact on the maximum stress the 
structures could withstand. Significance was noted in offset, however there was no 
effect of lay-down angle in standard or offset samples. Immersion in PBS clearly 
impacted strength values, with significance present between dry and PBS in types C 
and D. 
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A high level of cell viability was observed across all groups (static culture 
Figure 2.7 a – d and perfusion culture Figure 2.8 a – d). Both culture methods 
showed a similar trend in cell spreading around strut circumferences and most 
prominently at the interface between struts. As the FlDA/PrI stains were performed 
on scaffolds from the initial culture, which had no pre-culture and were seeded 
within the perfusion system, a dramatic difference in seeding efficiency was noted. 
As the cells appeared to clump at the joints throughout the entirety of the 
structures, it may be inferred that if sufficient cellular infiltration was initially 
provided, scaffolds with lower permeability should sustain more cells due to a higher 
number of these joint-regions. On the other hand, as all the scaffolds are equal in 
density, sharing filament thickness and hence total filament length per scaffold, with 
surface area variance only due to differing inter-filament contact area, the maximum 
sustainable number of cells should not significantly differ between samples. 
Architecture may aid the spreading and bridging of cells in initial culture stages, but 
such relevance would diminish as constructs would mature in vitro or in vivo.  
CLSM and SEM images (Figure 2.7, Figure 2.8 e - l) clearly demonstrated 
that polymer filament coverage was much more comprehensive, with sheath 
development and bridging apparent at day 7, in static culture than in perfusion 
culture. It is clear from the results that static seeding efficiency can be improved by 
modifying scaffold architecture to decrease permeability and increase axial surface 
area. This is most clearly demonstrated when contrasting the standard and offset 
scaffold architectures (types A & B vs. C & D). Whilst static samples with zero 
offset achieved seeding efficiency commonly seen with macroporous PCL scaffolds 
[86, 160-162], the offset groups significantly surpassed the values, achieving seeding 
efficiencies measured in PCL scaffolds featuring nanometer-sized foam [160], or 
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scaffolds featuring pore size gradients [162]. Although the effects on axial surface 
area are similar between a pore size gradient and a scaffold layer-offset, it should be 
noted that using larger filament spacing (0.1 vs. 1 mm axially), we achieved 
improved seeding efficiencies (~70 % vs. ~86 %). As the scaffolds used were made 
of PCL etched with NaOH and featured macroscopic pores as evidenced by μCT 
porosity values, the efficacy of static seeding when performed on an offset design is 
noteworthy. It should be mentioned that unlike in tortuous foams, where high cell 
seeding density may be observed but cells may not penetrate through structures 
homogenously, or ‘conventional’ structures such as the non-offset scaffold presented 
herein, the offset architectures capture both homogeneous cell distribution and high 
seeding efficiency [152]. Seeding within the perfusion system exhibited the opposite 
trend to static, with decreases in permeability (and/or offset) resulting in a decreased 
cell adherence. It may be postulated that this is a result of increased wall shear stress 
that was imposed on the lower permeability structures; seeing as PCL remains 
somewhat hydrophobic despite NaOH etching, lower shear than predicted may be 
sufficient to cause cell detachment. The problem with our system may have resulted 
from simply an excess flow rate during attachment and not during sustained culture, 
however it has been found [102] that in scaffolds with pore sizes between 300 – 450 
μm, a perfusive flow of 9 mL·h-1 (12.43 μm·s-1 vs. our 0.31 μm·s-1) for 2 h was 
sufficient to improve seeding efficiency over a static condition. It may be debated, 
however, that as Alvarez-barreto et al. tested polystyrene and poly(L-lactic acid) 
(PLLA) with much lower filament thicknesses, cell-surface interactions on a 
microscopic scale may have been modulated. Design features of the bioreactor may 
have also influenced the outcomes of the culture. For instance, Wendt, et al., 
demonstrated increase in seeding efficiency when using a perfusion bioreactor (57 ± 
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5 % to 75 ± 6 %), on scaffolds made of Polyactive, a copolymer of poly(ethylene 
glycol) and poly(butylene terephthalate) [163]. Whilst again material variability 
should be accounted for, Wendt et al. also used FEP tubes and minimised contact 
area and dead corners in his set up. Overall, the trend exhibited by all 
aforementioned studies demonstrates an increase in cell adherence under perfusion. 
When the perfusion seeding method was replaced with a static seed and pre-
culture period to standardize the initial cell number, cell numbers were consistent 
across all scaffold types at the 14 day time point (although lower in perfusion than 
static). The type A scaffolds showed significantly higher cell proliferation than all 
other types under perfusion by day 28, comparable to that observed in the static 
culture groups. Static control scaffolds showed significant increase in cell number 
from day 14 to day 28, reaching levels exhibited in static osteogenic samples. 
ALP/DNA was higher on day 14 than day 28 in static osteogenic samples, 
conversely higher on day 28 vs. day 14 in perfusion samples and higher in perfusion 
day 28 than static day 14 or 28. A low DNA content was present in all perfused 
samples but type A on day 28, however ALP/DNA values were comparable across 
this time point. As the scaffolds had a large surface area to volume ratio, cell lysis 
was difficult to accomplish through traditional freeze-thaw cycles and hence the 
Bullet Blender® provided means through which a comprehensive lysis could be 
achieved. This theory was corroborated by testing the lysate contents of a scaffold 
group for DNA prior to spinning; no detectable DNA levels were found in the 
untreated samples. Additionally, a different flow rate such as non-continuous 
perfusion may be more beneficial for deposition of mineralized tissue, as purportedly 
a desensitisation occurs after prolonged mechanostimulation [131-133].  
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PCL is a biologically inert material [5]; architectural changes affect culture 
environment within the scaffold yet do not manifest as cell-surface stimuli at a 
cellular scale. Modifying scaffold surfaces prior to contrasting architectural influence 
would expose effects on a microscopic scale, by introducing a higher degree of 
interaction between cells and the substrate. The effect of such structures on cells 
would then probably vary between pore sizes of different scaffold types. However, 
the use of an inert material allows the institution of a highly controlled environment 
wherein macro- and microscopic fluid flow, the resultant shear stresses and the 
mechanical characteristics of the scaffold may be assessed. Controlling scaffold 
density whilst modifying architectural factors directly affects these parameters and 
thus may expose subtle variation in cell response. Overall, minimal direct effects 
were present in static culture, with architecture predominantly affecting seeding 
efficiency. Conversely, whilst perfusion culture offered additional challenges and 
produced variable results, the tailorability of the system possible through 
manipulations in flow, pore size and permeability showed that distinct behaviours 
may be encouraged through parameter optimisation. 
2.5 CONCLUSION 
Architecture had a clear effect on scaffold mechanical properties, including 
modulus and permeability, and also on cell seeding efficiency. Most significant 
differences were evident when a layer offset was used, with structural characteristics 
such as pore size, strength and plastic deformation exhibiting a larger change than 
when contrasting differences imposed by lay-down angle. Notably, the seeding 
efficiencies were much higher in static culture than in perfusion culture, with offset 
providing a dramatic increase in efficiency. Overall, architecture had minimal effects 
on cell response in static culture when using an inert thermoplastic, PCL, and future 
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work may benefit from using more bioactive materials. Nonetheless, cellular 
response does appear to be dependent on mechanical stimulation by perfusion 
culture, which can be altered by modifying scaffold permeability, pore size and 





Chapter 3 63 





Michal Bartnikowski 1, Ashwini Rahul Akkineni 2, Michael Gelinsky 2, Maria A 
Woodruff 1, Travis J Klein 1*
1 Institute of Health and Biomedical Innovation, Queensland University of 
Technology, Queensland, Australia 
2 Centre for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, 




 Chapter 3 65 
3.1 INTRODUCTION
Articular cartilage is a complex tissue, organised into a zonal structure with 
varied biochemical and biomechanical properties throughout each zone. Cartilage 
matrix is rich in collagens and proteoglycans, with the dominant collagen type (>90 
%) being collagen type II [164]. The zones of cartilage vary with depth, with 
collagen fibre orientation and chondrocyte morphology changing throughout the 
tissue, from the superficial layer (fibres parallel to surface, flattened cell 
morphology), to the transitional layer (fibres randomly oriented, rounded cell 
morphology) and finally the deep layer (fibres perpendicular to surface, columnar 
cell alignment). The zone of calcified cartilage (ZCC) is found beyond the deepest 
part of cartilage, linking the cartilage to the subchondral bone. The ZCC varies 
considerably from the cartilage, for instance in collagen II content: ~60 % dry weight 
in cartilage versus ~20 % in the ZCC [165]. Further, the percentage of 
hydroxyapatite (HAP) in the ZCC by dry weight is ~65 %, comparable with that of 
subchondral bone at ~86 % [165]. The ZCC is also rich in collagen X, which is 
absent from hyaline cartilage [3]. It is overall a transitional tissue, providing a 
gradient of mechanical properties between the more compliant articular cartilage and 
the stiffer underlying bone tissue [3]. 
As intrinsic cartilage repair is poor, numerous strategies for regeneration have 
emerged, such as the tissue engineering of cartilage scaffolds [13, 166-168]. This 
approach predominantly revolves around the use of hydrogels, highly hydrated and 
diffusive polymer matrices which provide nutrient exchange and a three-dimensional 
(3D) matrix whilst also providing a desired chondromimetic hypoxic environment 
[21, 169]. 3D-printing/plotting has also been used in tissue engineering of cartilage 
or osteochondral defects, wherein deposition of a polymer (melt or hydrogel) [170, 
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171] and/or ceramic paste (in the case of osteochondral scaffolds) [39, 80] is used to 
form a mesh-type structure on a computer-controlled stage, resulting in a scaffold 
structure with a desired morphology. Whilst hydrogel matrices are highly suited to 
work towards cartilage regeneration, bridging the gap into engineering full 
osteochondral defects is difficult and more complex [80], requiring the use of 
ordered structures with zonal variations. 
Herein we focus on the development of a novel scaffold system constructed 
using a combination of 3D plotting and gel casting with photopolymerisation. 
Gelatine, commonly produced through hydrolysis of extracellular matrix (ECM) 
collagens such as those found in bone and skin, retains desired matrix 
metalloproteinase (MMP)-sensitive degradation sites and cell binding motifs such as 
Arg-Gly-Asp (RGD) [172]. It is also chemically modifiable, yielding a 
photocrosslinkable hydrogel gelatine-methacrylamide (GelMA) [173]. Hyaluronic 
acid (HA), the most abundant glycosaminoglycan (GAG) found in cartilage, is also 
similarly modifiable (hyaluronic acid methacrylate, HAMA) and has been shown to 
promote chondrogenic differentiation in vitro [9]. In this work, we print grid 
scaffolds made of a hydroxyapatite/alginate paste to form a ZCC and combine these 
with a GelMA ± HAMA hydrogel system through ultraviolet (UV) 
photopolymerisation. We hypothesise that such constructs will ultimately be 
beneficial in innovation towards a complete osteochondral scaffold by entrapping 
hydroxyapatite in proximity to chondrocytes and hence encouraging a terminal 
differentiation and development of a ZCC. 
3.2 MATERIALS AND METHODS 
Gelatine (G2500; ~300 g bloom), and methacrylic anhydride (MAAh, 276685) 
were purchased from Sigma (Sigma-Aldrich, St. Louis, MO). Hyaluronic acid (HA; 
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MW 0.86 MDa) was purchased from Novozymes. 2-hydroxy-1-[4-(2-
hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959; IC) was purchased 
from BASF (BASF, Ludwigshafen, Germany). All quoted concentrations in percent 
are weight per volume (% w/v) unless otherwise noted. Alginate (9005-38-3) and 
methyl cellulose (9004-67-5 M0512, MW 88 kDa) were purchased from Sigma 
(Sigma-Aldrich, Steinheim, Germany) and hydroxyapatite (1.02196.1000) was 
purchased from Merck (Darmstadt, Germany). Calcium chloride dihydrate (10035-
04-8) was purchased from Roth (Karlsruhe, Germany). 
3.2.1 Polymer Functionalisation 
Functionalisation of gelatine (to gelatine methacrylamide, GelMA) and HA (to 
hyaluronic acid methacrylate, HAMA), was performed as previously described [174, 
175]. Briefly, gelatine and HA were dissolved in Milli-Q water (Merck Millipore, 
Billerica, MA) at 10 % and 1 %, respectively. In the case of gelatine, 0.6 g of MAAh 
per 1 g was added and reacted for 1 h at 50 °C [174]. HA was reacted with a 5-fold 
molar excess of MAAh to hydroxyl groups for 8 h on ice, with pH monitored and 
adjusted to 8 with 5 M NaOH [175]. After reaction, all gel solutions were subject to 
centrifugation to phase separate and allow the removal of insoluble MAAh. HAMA 
was precipitated with ice-cold 100 % ethanol and collected, after which both were 
separately dialysed against Milli-Q water to allow the diffusion of any remainder of 
MAAh or methacrylic acid. After dialysis, GelMA was filtered through 0.2 μm 
filters (Merck Millipore) under aseptic conditions, pH adjusted to 7.4, lyophilised 
with 0.2 μm filters exclusively providing air exchange then stored at -20 °C in 
sealed, sterile tubes. HAMA was subject to the same processing apart from initial 
filtration to avoid macromer loss due to the large molecular weight. 
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3.2.2 Degree of Functionalisation 
The degree of functionalisation (DOF) of GelMA and HAMA was assessed 
using proton nuclear magnetic resonance (1H NMR) spectroscopy. A Varian Direct 
Drive NMR spectrometer (Agilent Technologies, CA) operating at 400 MHz for 
hydrogen, was used to record 1H NMR spectra. All samples were dissolved at 1.0 % 
in D2O at a temperature of 50 °C. Spectra were recorded at an operational 
temperature of 50 °C, with 32 scans and a recycle delay of 30 s. For GelMA, 
methacrylamide shifts were normalised against the aromatic signal of phenylalanine, 
at a chemical shift () of 7.4 ppm [176]. DOF was defined as the proportion of 
modified lysine groups of gelatine, as previously described for collagen I 
methacrylamide [176]. The area obtained from the integral of intensities of the 
protons present at the methacrylamide carbon-carbon double bond () occurring at 
 5.6 and 5.8 ppm was normalised to proton number (	), and the area obtained 
from integrating the peak of the aromatic groups (
) was normalised to the protons 
interacting with the aromatic ring (). The prevalence of modified groups and 
aromatic residues were then normalised to their prevalence by number in porcine 
gelatine in order to allow for the quantitation of total methacrylamide to total 
possible lysine groups (Equation 3.1) [177]: 
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 Equation 3.1 
For HAMA, chemical shifts were normalised against the signal from the N-
acetyl group on the HA backbone at  2.0 ppm [178]. The DOF, which in this case 
was defined as the fraction of modified hydroxyl groups per repeating unit, was 
determined as previously described [178]. In brief, the average area found from 
integrating the proton peak at the double bond (~ 5.8 and 6.3 ppm; ) was 
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normalised to the number of protons at the double bond (	) and the area found 
from integrating the proton peak of the N-acetyl group (%&) was normalised to the 
number of protons in the N-acetyl group ('&(); the normalised double bond value 
was then divided by the normalised N-acetyl group value to give the number of 
functional groups, which was assessed as a fraction of )*, the total number of 
target reactive hydroxyl groups (4) present in a repeating monomer unit of HA, 
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3.2.3 Hydroxyapatite / Alginate Scaffold Plotting 
Pastes were made containing 42 % (wt/wt) hydroxyapatite (HAP), 1.74 % 
(wt/wt) alginate and Milli-Q H2O (for ALG/HAP scaffolds), and 10 % (wt/wt) 
methyl cellulose, 1.74 % (wt/wt) alginate and Milli-Q H2O (for pure alginate (ALG) 
control scaffolds).  
An iterative process was used for the development of the final paste 
composition, with the above blend of alginate and methyl cellulose providing highest 
fidelity and structural integrity of all of the attempted compositions. 
Pastes were 3D plotted in air using a BioScaffolder 2.1 (GeSiM, 
Großerkmannsdorf, Germany) into a 4×4×~0.5 mm grid using a 410 μm needle. 
Scaffold design consisted of 2 printed layers with 4 strands per layer. After plotting, 
scaffolds were stored in 1 M CaCl2 solution at 4 °C until the day of cell 
encapsulation. 
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Micro-Computed Tomography Imaging 
Micro-Computed Tomography (μCT) was used to visualize constructs 
containing ALG and HAP (Scanco Medical μCT 40, operated at 55 kVp and 145 μA; 
Scanco Medical, Brüttisellen, Switzerland). 
3.2.4 Cell Isolation and Expansion 
The full procedure for isolating chondrocytes is described elsewhere [12]. In 
brief, cartilage samples were removed from macroscopically normal regions of the 
femoral condyle of a patient undergoing full knee replacement surgery, with patient 
consent and ethical approval from the Prince Charles Hospital and Queensland 
University of Technology (ethics RM: 1400001024). After excision, chondrocytes 
were cultured and expanded in low-glucose DMEM with 10 % fetal bovine serum 
(Lonza, Waverly, Australia), 2 mM glutamax, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 0.1 mM non-essential amino acids 
(NEAAs), 0.5 μg·mL-1 amphotericin B (Fungizone®), 50 U·mL-1 penicillin G 
sodium, 50 μg·mL-1 streptomycin (all Invitrogen), 0.4 mM L-proline and 0.1 mM 
ascorbic acid (Sigma) and used at passage 3. 
3.2.5 Hydrogel Formation and Culture 
Stock solutions of GelMA, HAMA and IC were made in PBS on the day of gel 
formation. Groups consisted of (Figure 3.1): 
 10 % GelMA / ALG control scaffold (GelMA-ALG),  
 10 % GelMA / 0.5 % HAMA / ALG control scaffold (GelMA/HAMA-
ALG),  
 10 % GelMA / HAP scaffold (GelMA-ALG/HAP), and  
 10 % GelMA / 0.5 % HAMA / HAP scaffold (GelMA/HAMA-
ALG/HAP).  
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Figure 3.1: Schematic illustration of the groups included in the study. 
Groups used in the study comprised (A): gelatine methacrylamide (GelMA) with an 
alginate (ALG) paste scaffold; (B): GelMA with hyaluronic acid methacrylate 
(HAMA) with an ALG paste scaffold; (C): GelMA with a combined alginate and 
hydroxyapatite paste (ALG/HAP) scaffold; and (D): GelMA/HAMA with an 
ALG/HAP scaffold. 
ALG and ALG/HAP scaffolds were placed into custom Teflon moulds 
(50×4×2 mm strips) and rinsed twice with DMEM to reduce calcium content from 
storage. Hydrogel precursor solutions containing 106 chondrocytes·mL-1 and 0.05 % 
IC were pipetted into the moulds over the scaffolds and covered with glass slides. 
Physical crosslinking of 10 min at 4 °C was performed to equilibrate groups and 
minimise cell settling. UV crosslinking was done using 365 nm light for a total 
energy of 1500 mJ·cm-2 in a CL-1000L crosslinker (UVP, Upland, CA). Cell-free 
groups were made in the same fashion, with cellular volume accounted for in 
dilutions. After crosslinking, gel strips were cut to 4×4×2 mm and divided into 48-
well plates. After gels were divided, they were cultured for 28 days in chondrogenic 
differentiation media (high-glucose DMEM with 2 mM glutamax, 10 mM HEPES, 0.1 
mM NEAAs, 0.5 μg·mL-1 amphotericin B (Fungizone®), 50 U·mL-1 penicillin G 
sodium, 50 μg·mL-1 streptomycin, ITS-G (100× dilution; all Life Technologies), 1.25 
mg·mL-1 bovine serum albumin (BSA), 0.4 mM L-proline, 0.1 mM ascorbic acid, 0.1 
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μM dexamethasone (all Sigma) and 10 ng·mL-1 transforming growth factor-3 (TGF-
3; GroPep, Adelaide, SA, Australia). Media was changed three times a week.  
Viability Assay 
Viability was assessed on day 1 of culture. Gels were treated with fluorescein 
diacetate (FDA) and propidium iodide (PrI; both Invitrogen) to stain live and dead 
cells, respectively. Gels were rinsed twice in fresh PBS then incubated for 5 min at 
37 °C in a 5 μg mL-1 FDA, 0.5 μg mL-1 PrI PBS solution. Samples were imaged 
using fluorescence microscopy (Zeiss Axio Imager M2; excitation: 488 nm and 568 
nm, absorption 520 nm and 640 nm for FDA and PrI, respectively – 1.33 μm·pixel-1). 
Quantification was performed using ImageJ software (National Institutes of Health, 
USA). In brief, the RGB tiff file was split into separate colour channels. The 
processing parameter ‘subtract background’ was then applied with a 30.0 pixel 
rolling ball radius and sliding paraboloid enabled. Brightness and contrast were then 
adjusted to the ‘auto’ level and the change was applied. Thresholding was used to 
isolate the cells without capturing background noise (the level slightly varied for 
each sample) and was applied. The binary ‘watershed’ process was then used to 
distinguish any clumped cells. Finally, ‘analyze particles’ was used with a 20 – 500 
pixel2 area, with 0 – 1.0 circularity and ‘include holes’ checked to quantify the 
number of cells. This analysis was performed on both channels for every sample. As 
chondrocytes were used in this study, culture plate positive and negative staining 
controls were not used – the cells would be unable to recover a rounded morphology 
in this setting and thus provide erroneous control data. 
Mechanical Properties 
Mechanical testing was performed on days 1 and 28 on cell-free and cell-
containing samples using an Instron MicroTester (Model 5848; Instron, Norwood, 
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MA). Each sample was placed in a 37 °C PBS trough into which an aluminium 
plunger was submerged for compressive displacement. The testing regimen consisted 
of a preliminary height measurement (1force () = -0.01 2 as height criterion), 
followed by a 0.5 % strain (3)/sec (4) ramp to 16 %3 for compressive elastic modulus 
measurement. The value for elastic modulus was derived from the slope of the stress-
strain curve from 10 – 15 % strain. 
Biochemical Assays 
Gels harvested on days 1 and 28 were disrupted by passing through a 19 G 
needle and digested in 0.5 mg·mL-1 Proteinase K solution, on a shaker plate 
overnight at 56 °C. The DNA content was quantified using the Quant-iTTM 
PicoGreen® dsDNA assay kit (Invitrogen) according to the manufacturer’s 
instructions. 
GAG content of proteinase K-digested hydrogel and culture media samples 
were assessed using the dimethyl-methylene blue (DMMB) assay (pH 1.5) (sample 
GAG on days 1 and 28, media on days 14 and 28). Absorbances at 525 and 590 nm 
were taken, with the ratio of the two absorbances normalised to a chondroitin sulfate 
C (Sigma) standard to give the GAG content. All GAG content measurements were 
normalised using cell-free constructs to account for GAGs released from the 
hydrogels versus GAGs produced by the cells. 
Gene Expression 
RNA was extracted from constructs cultured for 28 days; gels were frozen at -
80 °C in 1 mL of TRIzol reagent (Invitrogen), and RNA was extracted according to 
manufacturer’s instructions. SuperScriptTM III First Strand Synthesis System 
(Invitrogen) was used to synthesise complementary DNA (cDNA). DNase digestion 
was performed prior to cDNA synthesis and RNase digestion was performed after.  
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Primer sequences were either obtained from the literature for RPL13A, 
COL1A1, COL2A1, ACAN and COL10A1 [169, 179] or designed using Primer-
BLAST (NCBI, Bethesda, MD) for TBP (5’3’ F: 
AGCCAAGAGTGAAGAACAGTC, R:CATCACAGCTCCCCACCATATT). Real-
time quantitative reverse transcriptase polymerase chain reactions (PCR) were 
performed in duplicates in a 7500 PCR system (Applied Biosystems, Foster City, 
CA) using SybrGreen Mastermix (Applied Biosystems/Invitrogen). The cycle 
threshold (CT) value of each gene was normalised to the geometric mean of the 
housekeeping genes RPL13A and TBP using the comparative CT method (2–CT). 
Immunofluorescence 
Gels from day 28 were frozen in Optimal Cutting Temperature compound 
(OCT, Sakura, Finetek, Tokyo, Japan) and sectioned on a cryo-microtome at -20 °C. 
Sections were fixed with ice-cold acetone for 15 min, followed by antigen retrieval 
with 0.1 % hyaluronidase (Sigma) for 30 min, which was only included in the 
collagen I and II staining procedures. Primary antibodies were diluted in 2 % goat 
serum in PBS (Jackson ImmunoResearch, West Grove, PA), and applied overnight at 
4 °C in a moist chamber. Antibodies for collagen type I (I-8H5, MP Biomedicals, 
Seven Hills, Australia, 1:300 dilution), collagen type II (II-II6B3, Developmental 
Studies Hybridoma Bank (DSHB), Iowa City, IA, USA, 1:200 dilution), collagen 
type X (14-9771-82 Clone X53, Jomar Bioscience Pty Ltd, Kensington SA Australia, 
1:300 dilution), aggrecan (969D4D11, Life Technologies 1:300 dilution) or isotype 
controls (mouse IgG, Jackson, 1:1000) were used. Subsequently, sections were 
incubated in 2 % donkey serum/PBS with IgG1-specific AlexaFluor®488-labelled 
goat anti-mouse secondary antibodies and IgG2a-specific AlexaFluor®594-labelled 
goat anti-mouse secondary antibodies (Jackson 1:150) and 5 μg·mL-1 4,6-diamidino-
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2-phenylindole (DAPI, Sigma) for 1 h at room temperature. Images were captured 
with fixed exposure times on a Zeiss Axio Imager M2 microscope with epi-
fluorescence attachment (Carl Zeiss, Jena, Germany).  
3.2.6 Statistical Analyses 
Analysis of Variance (ANOVA) tests were used to assess differences between 
groups, with Tukey’s post-hoc tests used to determine inter-type relationships in 
groups with equal variances assumed (e.g. cell free constructs); Dunnet’s T3 post-
hoc test was used for cell-containing samples, assuming unequal variances. Tests 
were conducted using SPSS 21.0 with p-values < 0.05 regarded as significant. Figure 
bars show mean ± standard deviation unless otherwise indicated. Captions state 
where independent sample t-tests were used instead of ANOVA. Statistically 
significant differences are indicated using Roman numerals or symbols; any groups 
sharing a Roman numeral are statistically similar whilst groups without a like 
numeral are different. 
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3.3 RESULTS 
3.3.1 Scaffold Manufacturing by 3D Plotting 
Scaffolds were successfully fabricated using the BioScaffolder 2.1 and 
remained intact from day 1 (Figure 3.2 A) to day 28 of culture (Figure 3.2 B). 
Visualisation of scaffolds in combination with gels was done using μCT and 
confirmed localisation of hydroxyapatite to the deep region of the construct (GelMA-
ALG Figure 3.2 C, GelMA-ALG/HAP Figure 3.2 D), as well as confirming the 
content of HAP as ~40 % within the paste. Four groups were chosen for the study 
(Figure 3.1), comprising HAP-containing (GelMA-ALG/HAP, GelMA/HAMA-
ALG/HAP) and HAP-free (GelMA-ALG, GelMA/HAMA-ALG) constructs. 
3.3.2 Degree of Functionalisation 
To form photocrosslinkable polymers, gelatine and hyaluronic acid were 
functionalised using varied molar excesses of MAAh. 1H NMR analysis was 
performed to obtain DOF from NMR spectra (Figure 3.3). GelMA was found to be 
76.2 % functionalised, and HAMA was 25.0 %. 
3.3.3 Viability 
Live/dead staining was performed using FlDA (live) and PrI (dead) to assess 
cytotoxicity of the scaffolds or the hydrogel system. No cytotoxic effects were 
detected from scaffolds on day 1 of culture in any group (Figure 3.4 A-D), with no 
significant difference between quantified scaffold viability (Figure 3.4 E; n = 3 
samples per group). A viability of 80 % is an expected value considering 
chondrocyte expansion, encapsulation and processing through UV radical 
polymerisation. 
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3.3.4 Mechanical Properties 
Mechanical testing was performed on cell-free and cell-containing (human 
articular chondrocytes, HAC) constructs to assess purely material-based stiffness as 
well as stiffness due to ECM deposition throughout culture. Elastic modulus was 
found to be slightly higher in cell-free HAP groups (Figure 3.5 A; n = 3 samples per 
group), with significant difference only observed between GelMA-ALG, 
GelMA/HAMA-ALG and GelMA/HAMA-ALG/HAP (day 1) and GelMA-ALG and 
GelMA/HAMA-ALG/HAP (day 28). Modulus of cell-free constructs did not 
increase during culture, which ensured changes in cell-containing gels were cell-
mediated. Cell-containing gels (Figure 3.5 B; n = 3 samples per group) were not 
significantly different on day 1, but all significantly increased over the culture 
period. It was found that GelMA-ALG (~50 kPa) was significantly lower than 
GelMA/HAMA-ALG (~65 kPa), with the two HAP groups significantly higher than 
the ALG control groups but statistically similar to each other (GelMA/ALG-HAP: 
~77 kPa, GelMA-HAMA/ALG-HAP: ~85 kPa). 
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Figure 3.2: Images of hydrogel/scaffold hybrid constructs. 
(A): photo illustrating ALG/HAP scaffolds crosslinked within GelMA hydrogels on 
day 1 and (B): day 28. Scale bar 4 mm. (C): scaffolds imaged using micro-computed 
tomography (μCT), with thresholding used to isolate high density components 
(coloured scale illustrates mg·cm-3 of HAP). GelMA-ALG and (D): GelMA-
ALG/HAP illustrated, scale bar 1 mm as indicated. 
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Figure 3.3: Proton Nuclear Magnetic Resonance (1H NMR) spectra of 
hydrogels.
(A): gelatine; (B): gelatine methacrylamide (GelMA); (C): hyaluronic acid (HA); 
(D): hyaluronic acid methacrylate (HAMA). Areas of interest are inset within each 
frame. Aromatic peaks in gelatine/GelMA are present at ~chemical shift () 7.4 ppm, 
with the two free protons on the methacrylate groups present at  5.6 and  5.8 ppm 
respectively. In HA, the peak from the N-acetyl protons is present at ~ 2.1 ppm, 
with the methacrylate protons used for degree of functionalisation (DOF) 
measurements present in HAMA at  5.8 and  6.3 ppm.  
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Figure 3.4: Cell viability in hydrogel groups on day 1 of culture. 
Images and quantitated data of cell viability measured using FDA/PI assay on day 1 
of culture. Quantification and image analysis was performed using ImageJ. (A): 
GelMA-ALG, (B): GelMA/HAMA-ALG, (C): GelMA/ALG-HAP, (D): GelMA-
HAMA/ALG-HAP, (E): quantified viability from n = 3 samples per group. Scale bar 
200 μm. 
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Figure 3.5: Mechanical testing results showing compressive elastic modulus. 
Elastic modulus of samples on days 1 and 28 of culture (n = 3 per group) with (A): 
cell-free and (B): cell-containing gels shown separately. The four groups in each time 
point were compared separately to the second time point, with upper case Roman 
numerals used for day 1 and lower case for day 28. When groups share Roman 
numerals they are statistically similar. Bars with stars indicate t-test comparison 
results between one group across two time points. 
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3.3.5 DNA and GAG Content 
Measurements of DNA content and GAG content were performed on all 
construct groups, with GAG content in media also measured. These data were 
collected to illustrate whether there were proliferative differences between groups 
(DNA content), and to assess chondrogenesis (GAG content). Normalisation of GAG 
content to DNA content was done to account for cell number skewing raw GAG 
content per wet weight data; constructs with higher GAG but lower cell number 
would be thus identifiable as showing a more chondrogenic outcome. 
Large increases in GAG / wet weight were observed between days 1 and 28, 
with all groups increasing from between 5- and 8-fold (Figure 3.6 A). GAG content 
per construct wet weight in the GelMA-ALG and GelMA-ALG/HAP groups were 
significantly different to the GelMA/HAMA-ALG and GelMA/HAMA-ALG/HAP 
groups, however no differences were found between ALG and ALG/HAP within 
each gel blend. All values illustrating GAG production have been corrected with 
values obtained from cell-free gels. Overall, HAMA appeared to have a positive 
effect on chondrogenesis during culture. 
The DNA content in constructs increased slightly over the culture period, 
which together with viability data, showed that cellular activity was maintained 
(Figure 3.6 B). GAG content per DNA content data shared the same trends as GAG 
content / wet weight, as would be expected with such stable DNA levels throughout 
the culture and between groups (Figure 3.6 C). GAG content per media was found to 
be consistent between day 14 and day 28, indicating that a similar low level of GAG 
was lost to the media throughout culture (Figure 3.6 D). 
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Figure 3.6: DNA and GAG content in constructs over the culture period. 
(A): comparison of day 1 and day 28 results of GAG content (μg) per gel wet weight 
(mg), (B): DNA content (μg) per gel, (C): GAG content (g) per DNA content (g) in 
gels and (D): GAG concentration in media (μg·mL-1) on days 14 and 28 of culture. 
The four groups in each time point were compared separately to the second time 
point, with upper case Roman numerals used for day 1 and lower case for day 28. 
When groups share Roman numerals they are statistically similar. Bars with stars 
indicate t-test comparison results between one group across two time points. All 
groups have n = 3 samples. 
3.3.6 Gene Expression 
Analysis of gene expression was performed to test the effects of the different 
hydrogel blends and scaffold materials on gene expression in the system. COL2A1 
and ACAN levels were tested to assess positive chondrogenesis, with COL1A1 and 
COL10A1 serving as indicators for fibrocartilage development and chondrocyte 
hypertrophy/calcification. 
Gene expression results showed an influence of HAMA, with a decrease in 
COL1A1 (Figure 3.7 A), increase in COL2A1 (Figure 3.7 B), increase in ACAN 
(Figure 3.7 C) and decrease in COL10A1 (Figure 3.7 D) in HAMA-containing gels. 
Whilst some slight variability existed within HAMA-free and HAMA-containing 
gels, no significant difference was detected with the presence of HAP. 
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Figure 3.7: Gene expression data for the four groups from day 28 samples. 
The four genes that were analysed were (A): COL1A1, (B): COL2A1, (C): ACAN and 
(D): COL10A1 on day 28 of cell culture shown as 2-CT value (after log2 conversion). 
Statistical analysis was performed on log2 data with each group containing n = 3 
samples. A Dunnet’s T3 post-hoc test was used to compare means, with p < 0.05 
taken as significant. Shared Roman numerals indicate statistical similarity between 
gel groups. 
3.3.7 Immunofluorescence 
Immunofluorescence was conducted on sections to corroborate gene expression 
data on an ECM-protein level. Staining was done for collagen I and II (I red, II 
green, Figure 3.8 A – D), aggrecan (E – H) and collagen X (I – L) on all groups (top 
row: GelMA-ALG, second row: GelMA/HAMA-ALG, third row: GelMA-
ALG/HAP, bottom row: GelMA/HAMA-ALG/HAP). Chondrocyte spreading and 
high collagen I expression was clearly observable at the surface of the gels compared 
with the interior of the constructs; the cells appeared less rounded than in the centre 
and stained very strongly for collagen I. Within the centre of the gels, a much more 
rounded chondrocyte morphology was observed, with collagen II staining present, 
which confirmed a chondrogenic response within the constructs. Aggrecan staining 
further supported the findings from collagen II, with staining found throughout the 
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matrix of all groups as well as at the surface. Collagen X appeared present 
throughout the ECM, with the strongest staining apparent at the HAP interface (as 
seen in the lowest area of panel K). Images were taken of the deep portion of 
hydrogels at the periphery of the scaffold meshes, with surface images inset. Overall 
a chondrogenic effect of HAMA was observed, with a very limited influence of 
HAP. Isotype negative controls in the form of mouse IgG were used to verify that no 
non-specific staining occurred in the samples (data not shown). 
 
Figure 3.8: Immunofluorescence images illustrating deep and surface sections. 
Staining of collagen I (red), collagen II (green), aggrecan (green) and collagen X 
(green) was performed on constructs from all groups on day 28 (as indicated; DAPI 
nuclei staining in light blue); (A, E, I): GelMA-ALG, (B, F, J): GelMA/HAMA-
ALG, (C, G, K): GelMA-ALG/HAP and (D, H, L): GelMA/HAMA-ALG/HAP. 
Images were taken from the deep hydrogel zone near to the ALG or ALG/HAP 
scaffold, with surface images inset; scale bar 50 μm. 
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3.4 DISCUSSION 
HAP-containing (GelMA-ALG/HAP, GelMA/HAMA-ALG/HAP) and HAP-
free (GelMA-ALG, GelMA/HAMA-ALG) scaffolds were produced through 3D 
plotting of alginate or alginate/hydroxyapatite paste and photocrosslinked with 
GelMA or GelMA/HAMA hydrogels to form hybrid constructs for the evaluation of 
preliminary osteochondral regeneration. Whilst hydrogels widely appear to give the 
most desired matrix in terms of hypoxia, high fluid content, ease of diffusivity and 
tailorable mechanical properties, there is no clear consensus on what type of material 
is most desirable for osteochondral regeneration [28, 125, 126, 129, 180, 181]. 
Whilst herein I presented a hybrid construct containing both chondro- and 
osteoconductive materials, it is in a preliminary state which does not afford the clear 
effects we may observe when instead using a homogeneous structure. Khanarian and 
colleagues present such a construct, showing that in a large volume scaffold with a 
homogenous composition, the potential of hydroxyapatite as a ZCC material is 
clearly shown [129]. In this study, alginate is used as the hydrogel component of the 
ceramic/hydrogel scaffold, although unlike in our study, the construct is not formed 
using 3D plotting. Alginate has previously been shown to be both supportive of 
chondrocytes in culture [79, 182, 183], and valid as a tissue engineering vessel [184-
186]. It also has desirable viscous properties for 3D plotting and ionic crosslinking 
capabilities that allow for a rapid sol-gel transition. Furthermore, alginate has been 
shown to be biocompatible and biodegradable, supportive of native chondrocyte 
morphology and matrix deposition, as well as promoting bone healing in certain 
cases [187, 188]; all of which led to our selection of alginate as a component of our 
ceramic paste. 
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Interestingly, the limited chondrocyte hypertrophy we observed (as evidenced 
by COL10A1 expression and immunofluorescent staining) was similar for Khanarian 
et al. [129], who reported that the exclusive use of deep zone chondrocytes gave a 
much better result in terms of hypertrophy and mechanical properties when 
compared with full thickness cells. It may be inferred that subdividing constructs in 
the future to isolate cell populations may be advantageous. For instance, the calcified 
layer of the scaffold may be printed with cells included within the paste, and/or a 
small layer of hydrogel containing deep zone chondrocytes may be photocrosslinked 
onto the mesh, followed by a layer of hydrogel containing superficial or full 
thickness chondrocytes for the remainder of the construct. Alternately, the printing of 
the entire construct may be possible if appropriate material optimisations are 
performed to ensure structural fidelity. Whilst the material choice is supported by 
literary evidence and conducive to chondrogenesis, there is a limited effect on 
calcification that indicates the scaffold system requires further development and 
characterisation. 
Use of layered constructs has been explored extensively in the literature, with 
three main methods used: 1) seeding of chondrocytes or neocartilage tissue directly 
onto a bone scaffold; 2) “assembling” a bilayered scaffold from two components; 
and 3) forming an “integrated” bilayered scaffold [189]. Our approach falls into 
category 3, and is also supported in principle and material choice (alginate) by a 
study focused on 3D plotting of layered scaffolds, where preliminary outcomes show 
chondrogenesis both in vitro and in vivo [125]. Data related to enhanced mechanical 
properties also reinforce the relevance of this work, with Hollenstein et al. showing 
improved bone-hydrogel interfacing when a ZCC was included in constructs [126]. 
Whilst all the aforementioned studies delve into innovations within this field, the fact 
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remains that further study is required in order to completely construct a relevant 
picture of what is required for successful osteochondral regeneration through the 
implementation of scaffold technologies. Namely, it is difficult to determine which 
chondrogenic and osteogenic components are most efficacious for the regeneration 
of a single component. In a combined environment, it is also difficult to determine 
whether their applicability to the regeneration varies upon combination or is affected 
by a biphasic system. In our approach we used a chondrogenic medium containing 
transforming growth factor (TGF)-3. It has been shown that TGF-3 is involved in 
both chondrogenic [190] and osteogenic [191, 192] differentiation, and hence it was 
considered as conducive to development in both areas of our construct. Future 
studies may benefit from an alternate culture approach however, as TGF-3 has been 
shown to decrease scar tissue formation through the attenuation of collagen type I 
synthesis; however these effects are largely demonstrated on skin lesions 
postoperatively and hence in fibroblastic cells [193-195]. Its effects on collagen type 
X synthesis are currently undefined and conversely to the above, it has also been 
observed to stimulate transcription of the COL1A2 gene [196]. Hence the level to 
which it may be influential on the development of the ZCC are yet undetermined and 
require further testing.  
Overall, in this study I presented a preliminary structure consisting of a two-
phase hydrogel polymer, and show that the combination yields a greater increase in 
mechanical properties than that of a control scaffold (ALG), and that the use of the 
ALG/HAP scaffolds does not negatively influence chondrogenic response of 
chondrocytes in vitro. Limited cytotoxicity was observed from either of the two 
scaffold types or the gels, as confirmed by fluorescent staining and subsequent image 
quantification. Elastic modulus increased considerably throughout the culture period, 
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with HAMA significantly increasing modulus in ALG groups and the use of 
ALG/HAP scaffolds increasing modulus relative to the ALG groups. It may be 
reasoned that the addition of hyaluronic acid within the hydrogel positively 
influenced both the cell activity throughout the culture period, as well as providing 
an additional material that is able to crosslink to both its own and to the GelMA 
network.  
There was an increased trend in modulus with ALG/HAP, which may be due to 
the significantly higher density in the scaffold. Scaffold strands were printed with the 
same diameter nozzle in both cases (ALG and ALG/HAP) and hence with the HAP 
groups a lesser proportion of water was present in each strand. The HAP content was 
in fact 42 %, and hence the concentration of alginate in water would also be higher in 
the ALG/HAP scaffold strands compared with the ALG alone. However, 
simultaneously the alginate network integrity may be disturbed by the presence of 
HAP particles within the construct strands, and any benefit to the increased 
concentration of ALG within the strand may be mitigated. Finally, if indeed the 
ALG/HAP scaffold matrix was stiffer than ALG, the increase in overall construct 
modulus may be caused by a lesser transverse expansion of the scaffolds under load. 
This hypothesis is supported by Khanarian et al. [124], who demonstrate an increase 
in modulus of scaffold constructs made entirely from alginate and hydroxyapatite, 
and hence it may be concluded that the presence of the HAP does in fact influence 
the stiffness of the construct strands. The mechanical properties obtained herein are 
over an order of magnitude lower than that of native cartilage tissue, however the 
mimicry of native values may be not required. The construct must of course be able 
to withstand the mechanical environment of the joint, but with appropriate stimulus 
(driven through the neotissue matrix) the matrix deposition of chondrocytes may be 
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encouraged. As this model was cultured in a static environment, the values of 
modulus are not representative of what would be attainable under compressive 
loading during culture. This was done however to simplify the process and allow the 
examination of parameters in a less complex system. It is unclear what mechanical 
properties are ideal for a tissue engineered cartilage construct, however it is the belief 
of the authors that this will become clearer as biomaterials research progresses. 
Examination of GAG and DNA content within the scaffolds showed consistent 
DNA levels between groups, and a comparable yet significantly different level of 
GAG secreted between the GelMA and the GelMA/HAMA groups. In all cases 
HAMA increased the level of GAGs produced, yet the varying of scaffold type from 
ALG to ALG/HAP failed to have an effect on this metric. It may be that the 
localisation of the scaffolds to the greatest depth of the gels along with their 
physiologically relevant thickness reduces any potential effects they may have on the 
majority of the chondrocytes within the gel phase. However, it is clear that inclusion 
of a prominent glycosaminoglycan such as HA within the gel has a positive effect on 
chondrogenic differentiation, whilst it is unknown what effect methacrylation of this 
compound has on its cellular interactions. This data confirms our research group’s 
previous findings, where HAMA was found to be supportive of chondrogenic 
differentiation [9]. As all GAG data were corrected using cell-free constructs, the 
influence of HAMA on the GAG assay was negated. 
PCR data showed a much higher expression of COL1A1 and COL10A1 in the 
HAMA-free gels, indicating a fibrocartilaginous phenotype, whilst COL2A1 and 
ACAN expression further supported this conclusion. Higher levels of collagen I and 
collagen X are indicative of dedifferentiated chondrocytes, with elevated levels 
observed in GelMA-only gels throughout the literature [9, 108]. This effect is namely 
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due to the high number of attachment (RGD peptide) sites present on gelatine that 
strongly promote cell attachment and hence spreading, along with the fact that the 
polymer is a derivative of largely collagen type I. 
Higher expression levels of chondrogenically relevant genes such as COL2A1 
and ACAN were observed in HAMA-containing gels compared against HAMA-free 
groups. There was no significant effect of ALG/HAP scaffolds on COL10A1 
expression, although a slight trend was noticeable. Immunofluorescence examining 
protein levels in the matrix indicated similar relationships to PCR, with higher 
collagen I staining found in HAMA-free gels and stronger collagen II and aggrecan 
staining observable in HAMA-containing gels. Collagen X staining appeared 
relatively even throughout the ECM, with GelMA-ALG/HAP showing staining 
surrounding the lowest region of the scaffold which was the area of interest in this 
case (Figure 3.8 K). The levels in all groups did not vary enough to show conclusive 
effects, however trends appeared to support PCR findings and hence are also 
explainable and in support of the previously listed reasoning. In all cases isotype 
negative controls consisted of mouse IgG and verified no non-specific staining of 
matrix occurred. 
In line with previous results [126, 128, 129], we found a slight increase in 
modulus after culture of ALG/HAP scaffolds, with comparable trends in cell free 
conditions. On the other hand, whilst others have shown that inclusion of bioactive 
glass increases GAG in hydrogels [181], we found ALG/HAP to have a limited 
effect in our system. As the ALG/HAP scaffolds were intact at the time of 
crosslinking and appeared to remain intact at day 28 of culture, it may be postulated 
that limited diffusion of HAP occurred throughout the culture period. It may thus be 
inferred that culture in a system such as a compression bioreactor may further 
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accentuate the observed trends and bring them to a significant and notable level. 
With appropriate structural modifications, perfusion bioreactors may also be suitable 
for this application [187]. Overall we showed that the combination of GelMA and 
HAMA with a HAP/ALG scaffold system is viable for cells, maintains positive 
chondrogenesis and provides a platform for the exploration of innovation into such 
scaffold technologies. 
3.5 CONCLUSION 
Scaffolds comprising human articular cartilage-containing hydrogels (GelMA 
or GelMA/HAMA) crosslinked through 3D printed paste meshes (alginate or 
alginate/hydroxyapatite) were cultured for 28 days under chondrogenic conditions in 
vitro. No cytotoxicity from scaffold components was observed overall. I verified that 
incorporation of HAMA into hydrogels improved chondrogenesis. The use of 
ALG/HAP versus ALG scaffolds did not encourage the formation of a ZCC, 
however changes in scaffold design and inclusion of a larger amount of HAP may be 
used in future to expand on this system. Overall the potential of a bilayered 
constructs was explored, and whilst the development of a ZCC was not significant, 
this preliminary work may now be followed by studies assessing such layered 
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4.1 INTRODUCTION
Articular cartilage tissue engineering has a major focus around the 
development and innovation of hydrogel technologies. Hydrogel materials offer 
desired characteristics, such as a high level of hydration and diffusive capacity, 
which positively influence chondrogenesis [9, 197, 198]. Whilst hydrogels that 
crosslink through mechanisms such as ion interactions avoid many issues of 
cytotoxicity that may be introduced during chemical crosslinking, 
photopolymerisation offers advantages that are not mirrored in other crosslinking 
systems. Photopolymerisation or photocrosslinking allows multifaceted control of 
reaction kinetics, a rapid transition from liquid to solid, largely uniform mechanical 
properties, negligible heat production, and provides the opportunity for in situ 
crosslinking solutions in the clinic [109]. 
The work herein focuses on two photocrosslinkable systems, the biocompatible 
hydrogels gelatine methacrylamide (GelMA) and gellan gum methacrylate (GGMA). 
Gelatine is a product of collagen derived from bones, skin and connective tissues 
subject to hydrolysis [199]. It is hence a protein hydrogel, consisting of natural ECM 
macromolecules that retain cell binding motifs such as Arg-Gly-Asp (RGD) as well 
as matrix metalloproteinase (MMP)-sensitive degradation sites [172]. The reaction of 
gelatine with methacrylic anhydride results in the formation of methacrylamide 
functional units which branch off lysine residues that are present in gelatine. This 
allows chemical crosslinking into a cytocompatible hydrogel [9, 173, 174].  
Gellan gum is a Food and Drugs Administration (FDA)-approved food additive 
produced by the bacterium Pseudomonas elodea. The repeating unit of gellan gum 
consists of a tetrasaccharide of one -L-rhamnose, one -D-glucuronic acid and two 
-D-glucoses [200-202]. Whilst it exists in both acetylated and deacetylated forms, 
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the deacetylated form is predominantly used in biomaterial science, forming strong, 
hard and brittle gels upon cooling. Gellan gum hydrogel stability is largely 
influenced by manipulating the presence, concentration and valence of cations that 
are present in the gel solution [200, 201, 203, 204]. Similar to gelatine, gellan gum 
may be modified through reaction with methacrylic anhydride, yielding gellan gum 
methacrylate, a cytocompatible and chemically crosslinkable hydrogel [197]. 
Photopolymerisation reactions are initiated when chemicals that are sensitive to 
a particular wavelength of light, type 1 photoinitiators (PIs), are exposed to light 
within their relevant excitation range and thus are decomposed into a high-energy 
radical state [110, 205]. This produces an initiating species (a free radical) that 
attacks a first monomer unit, with other units adding further in a chain 
polymerisation to form the final polymer macromolecule [110]. The carbon-carbon 
double bond found in vinyl monomers is the key linkage that reacts through radical-
initiated chain polymerisation [111]. Unlike the carbonyl (carbon-oxygen double 
bond) group found in aldehydes and ketones, which are also highly reactive groups 
used in photopolymerisation, the carbon-carbon double bond may respond to the 
initiator species by either homolytic or heterolytic bond breakage [111]. This lack of 
selectivity means that radical initiators react with almost any carbon-carbon double 
bond and hence almost all targets may stabilise the propagating radical by 
delocalising it over two or more atoms [111]. This is relevant as it shows the 
photocrosslinking reaction may be more likely to interact with cellular materials than 
a higher selectivity reaction. 
Photocrosslinkable hydrogels used in cartilage tissue engineering largely 
consist of biocompatible materials that have been chemically modified to attach the 
highly reactive vinyl groups to certain locations on the monomer and allow for easy 
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reaction with photoinitiators under ultraviolet (UV) curing conditions. Although 
vinyl groups react preferentially when radical polymerisation is taking place, carbon-
carbon double bonds are also present in other locations within the matrix, such as on 
other macromer amino acids (in the case of protein-based gels) or within cells 
themselves (when crosslinking cell-containing gels). As radical crosslinking is highly 
reactive and the cytotoxicity of photoinitiator (PI) compounds is well known [109-
111, 205], it is debatable as to what extent the reaction prefers functional groups as 
opposed to other reactive species. Further, the concentrations of photoinitiators such 
as the commonly explored 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-
propanone (Irgacure 2959; IC), have been described in the literature as anywhere 
from 0.05 to 0.5 % w/v [109, 197, 205]. In all of these cases however, there is a lack 
of detailed analysis on optimal photoinitiator concentration and in no source is there 
an assessment of the relevance of photoinitiator concentration and the number of 
reactive groups present in the precursor solution with respect to survival of 
encapsulated cells. In particular, it remains unclear whether potential damage to cells 
is predominantly linked to the amount of UV exposure or the action of excessive free 
radicals during cross-linking, as UV exposure has been identified as a cause of 
cytotoxicity [205]. Whilst use of UV curing systems may be done without cytotoxic 
effects at low dosages, advantages in mechanical properties may be reached when 
higher concentrations of both photoinitiator and UV are used, and hence optimisation 
of this system is desired in terms of a trade-off between cytotoxicity and mechanical 
properties. Further, as a comparison of multiple crosslinking technologies has led to 
the identification of differences between chondrocyte behaviour [206, 207], 
modification of UV dosage may have greater effects than simply those of 
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cytotoxicity and mechanical properties; influencing cells long-term through damage 
to DNA and proteins and hence affecting their ability to proliferate or differentiate. 
In this study I explore the cytocompatibility of IC at various concentrations 
coupled with various UV exposure times, within hydrogels that contain a varied 
number of reactive functional groups. I hypothesise that the concentration of 
photoinitiator should be based on the number of reactive groups present in the 
precursor, with manipulation of this ratio affecting cell viability by limiting or 
promoting the cytoprotective nature of the vinyl groups present on the reactive 
species of the precursor polymers. I also explore the effects of UV crosslinking time 
on chondrogenesis in a two week in vitro culture. I aim to form a deeper 
understanding of the interplay between PI concentration, reactive group number and 
UV exposure in chondrogenic hydrogel systems for tissue engineering. 
4.2 MATERIALS AND METHODS 
Gelatine (G2500), gellan gum (Gelzan™ CM G1910), and methacrylic 
anhydride (MAAh, 276685) were purchased from Sigma-Aldrich (St. Louis, MO). 2-
hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959; IC) 
was purchased from BASF (Ludwigshafen, Germany). All quoted percentages are 
weight per volume (% w/v). 
4.2.1 Polymer Functionalisation 
Hydrogel groups comprised methacrylate-functionalised gelatine in both high 
and low degrees of functionalisation (gelatine methacrylamide; GelMA-H and 
GelMA-L) and gellan gum (gellan gum methacrylate; GGMA). 
Functionalisation of gelatine and gellan gum was performed as previously 
described [174, 197]. Briefly, gelatine and gellan gum were dissolved in Milli-Q 
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water (Merck Millipore, Billerica, MA) at 10 % and 1 %, respectively. In the case of 
gelatine, 0.6 g of MAAh per 1 g was added for GelMA-H whilst 0.06 g of MAAh per 
1 g was added for GelMA-L, both were reacted for 1 h at 50 °C [174]. Gellan gum 
was reacted with 8 g of MAAh per 1 g for 6 hours, with temperature maintained at 
60 °C and pH monitored and adjusted to 8.0 with 5 M NaOH [197]. After reaction, all 
gel solutions were subject to centrifugation to phase separate and allow the removal 
of insoluble MAAh, after which they were dialysed at 37 °C (gelatine) or 60 °C 
(gellan gum) against Milli-Q water to allow the diffusion of any remaining MAAh or 
methacrylic acid. After dialysis, both GelMA solutions were filtered through 0.2 μm 
filters (Merck Millipore) under aseptic conditions, pH adjusted to 7.4, lyophilised 
with 0.2 μm filters exclusively providing air exchange then stored at -20 °C in 
sealed, sterile tubes. GGMA was subject to the same processing apart from initial 
filtration to avoid macromer loss due to long and variable chain lengths within 
batches (200 – 500 kDa). 
4.2.2 Degree of Functionalisation 
The degree of functionalisation (DOF) of GelMA-H, GelMA-L and GGMA 
was assessed using proton nuclear magnetic resonance (1H NMR) spectroscopy as 
described previously (Chapter 3.2.2). GelMA-H and GelMA-L groups were 
assessed as previously detailed (Chapter 3.2.2). 
For GGMA, chemical shifts were normalised against the signal from the 
methyl group of rhamnose at  1.45 ppm [202]. The DOF, which in this case was 
defined as the fraction of modified hydroxyl groups per repeating unit, was 
determined as previously described [197, 202]. In brief, the average area found from 
integrating the proton peak at the double bond (~ 5.8 and 6.3 ppm; ) was 
normalised to the number of protons at the double bond (	) and the area found 
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from integrating the proton peak of the methyl group of rhamnose (
) was 
normalised to the number of protons in the methyl group of rhamnose (); the 
normalised double bond value was then divided by the normalised rhamnose value to 
give the number of functional groups, which was assessed as a fraction of , the 
total number of reactive hydroxyl groups (10) present in a repeating monomer unit of 








! "## Equation 4.1 
The calculation was then repeated using the signal from the methyl group on 
the methacrylate functional unit (occurring ~ 2.09 ppm), with the mean of these 
taken for the overall DOF value for GGMA. 
4.2.3 Quantification of Photoinitiator and Reactive Groups 
The total number of molecules of PI were calculated using the molar mass of 
IC, whilst the degree of functionalisation and the number of modifiable species for 
GelMA and GGMA were used to calculate the total number of reactive functional 
groups (RG). These values were used to obtain the ratio of IC to RG (IC/RG). Details 
of this calculation are given in Appendix 3. 
4.2.4 IC Concentration Sweep 
Stock solutions of GelMA, GGMA and IC were made in phosphate-buffered 
saline (PBS) on the day of gel formation. 10 % GelMA-H, 10 % GelMA-L, and 1 % 
GGMA hydrogels were made with IC concentrations of 0.05, 0.1, 0.2 and 0.5 %. Gel 
precursor solutions with IC were pipetted into custom Teflon moulds (50×4×2 mm 
strips) and covered with glass slides. Physical crosslinking for 10 min at 4 °C was 
performed, as this would be done with cell-containing gels in future. UV crosslinking 
 Chapter 4 101 
was done using 365 nm light for a total energy of either 1500 or 2500 mJ·cm-2 (2.3 
mW·cm-2, 11 min and 18 min respectively), in a CL-1000L crosslinker (UVP, 
Upland, CA). After crosslinking, gel strips were cut to 4×4×2 mm and stored in 
DMEM at 37 °C overnight to allow for ionic equilibration prior to mechanical 
testing. Testing consisted of elastic modulus measurement, as described in the 
Mechanical Characterisation section below. 
4.2.5 Cell Isolation and Expansion 
Chondrocytes were isolated as detailed previously (Chapter 3.2.4). 
4.3 EFFECTS OF IC AND UV ON VIABILITY 
Stock solutions of GelMA-H, -L, GGMA and IC were made with PBS on the 
day of gel formation. As above, 10 % GelMA-H, 10 % GelMA-L and 1 % GGMA 
solutions were prepared containing either 0.05 or 0.2 % IC and 106  
chondrocytes·mL-1, and formed into gel strips. Gels were allowed to physically 
crosslink for 10 mins at 4 °C to ensure minimum cell settling by accelerating 
physical gelation of hydrogels, prior to UV irradiation to either 1500 or 2500  
mJ·cm-2. The 1500 mJ·cm-2 dosage was chosen based on previous work by our group 
and was known to be a cytocompatible dosage [9, 108]; 2500 mJ·cm-2 was chosen to 
provide a near two-fold increase in dosage and explore the effects of such a higher 
exposure on hydrogel stiffness and cell survivability. Gels were cut and equilibrated 
overnight as above prior to treatment with fluorescein diacetate (FlDA) and 
propidium iodide (PrI; both Invitrogen) to stain live and dead cells, respectively 
(Chapter 3.2.5 Viability Assay).  
4.3.1 Effects of UV Exposure on Differentiation 
Cell culture was performed on 1 % GGMA hydrogels formed using 0.05 % IC 
and either 1500 or 2500 mJ·cm-2 UV irradiation for reasons outlined above. As 
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previously described, all hydrogel solutions were prepared with 106 chondrocytes  
mL-1 mixed into the precursor solutions. The same crosslinking method was followed 
as above. After gels were divided into 48-well plates, they were cultured for 14 days 
in chondrogenic differentiation media as previously detailed (Chapter 3.2.5). Media 
was changed three times per week. Hydrogel samples were taken on days 1 and 14 to 
assess viability, mechanical properties, gene and protein expression as well as DNA 
and glycosaminoglycan (GAG) content. Samples of conditioned media were 
collected on day 7 and 14 to determine their GAG content.  
Biochemical Assays 
Gels harvested on days 1 and 14 were processed as previously described for 
DNA and GAG content (Chapter 3.2.5 Biochemical Assays). 
Gene Expression 
RNA was extracted from constructs cultured for 14 days to assess expression 
of RPL13A, TBP, COL1A1, COL2A1 and ACAN as described previously (Chapter
3.2.5 Gene Expression). 
Immunofluorescence 
Gels from day 14 were processed and imaged as previously described, apart 
from Collagen X imaging, which was not done in this study (Chapter 3.2.5 
Immunofluorescence). 
4.3.2 Mechanical Properties 
For all cases of mechanical testing, previously described methods were 
followed (Chapter 3.2.5 Mechanical Properties). In addition to cell-free gels, cell-
containing gels were tested on day 1 and 14. 
4.3.3 Statistical Analyses 
Statistical analysis was performed as previously described (Chapter 3.2.5). 
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4.4 RESULTS 
4.4.1 Degree of Functionalisation 
To form photocrosslinkable polymers, gelatine and gellan gum were 
functionalised using varied molar excesses of MAAh. 1H NMR analysis was 
performed to obtain DOF from NMR spectra (Figure 4.1). GelMA-L was found to 
be 20.5 % functionalised, GelMA-H was 95.9 %, and GGMA was 5.7 %.  
4.4.2 IC and UV Concentration Sweep 
Concentration of PI (IC) and UV dosage used in crosslinking of hydrogel 
precursors were varied to test their influence on hydrogel elastic modulus. Groups 
consisted of 10 % GelMA-L, 10 % GelMA-H and 1 % GGMA, crosslinked with 
0.05, 0.1, 0.2 and 0.5 % IC under either 1500 or 2500 mJ·cm-2 of UV irradiation. 
Compressive elastic modulus over 10-15 % strain was assessed a day after 
crosslinking on a sample size of n = 5 per group (Figure 4.2). An increase in 
modulus was observed in GelMA groups with an increase in IC concentration up to 
0.2 %, whereafter a plateauing was noted. Dose-response of GGMA to IC 
concentration was negligible. UV dose again had minimal effect on GGMA, whilst 
GelMA responded in both cases, with a higher number of functional groups resulting 
in a stronger response and hence a stiffer gel (i.e. GelMA-H vs. GelMA-L). These 
data suggest that a higher number of functional groups provides a stronger 
crosslinking response regardless of PI concentration, however from these results it is 
impossible to clearly determine the reason for the lack of response shown by GGMA. 
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Figure 4.1: Proton Nuclear Magnetic Resonance (1H NMR) spectra of 
hydrogels.
(A): gelatine; (B): gelatine methacrylamide low DOF (GelMA-L); (C): gelatine 
methacrylamide high DOF (GelMA-H); (D): gellan gum (GG); and (E): gellan gum 
methacrylate (GGMA). Areas of interest are inset within each frame. Aromatic peaks 
in gelatine/GelMA are present at ~chemical shift () 7.4 ppm, with the two free 
protons on the methacrylate groups present at  5.6 and  5.8 ppm respectively. In 
GG, the peak from the methyl group of rhamnose is present at  1.4 ppm, with the 
methyl group of the methacrylate group present in GGMA at  2.1 ppm. The 
methacrylate protons found in GGMA are visible at  5.8 and  6.3 ppm. 
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Figure 4.2: Dose-dependent response of elastic moduli of cell-free hydrogels to 
photoinitiator concentration and UV irradiation dose. 
Elastic moduli plots of (A): 10 % GelMA-L; (B): 10 % GelMA-H; and (C): 1 % 
GGMA. IC concentrations of 0.05, 0.1, 0.2 and 0.5 % and crosslink energies of 1500 
or 2500 mJ·cm-2 were used for comparison. Trend lines are indicated by dotted lines. 
Each gel type was repeated 5 times, with all repeats shown as points on the plots. 
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4.4.3 Effects of IC and UV on Viability 
To assess the effects of IC and UV dosage on chondrocyte viability, hydrogels 
were made using 10 % GelMA-L, 10 % GelMA-H, 1 % GGMA, 106 chondrocytes· 
mL-1, 0.05 or 0.2 % IC and 1500 or 2500 mJcm-2 UV irradiation. After overnight 
culture, viability was observed with live/dead staining and quantified using ImageJ 
as previously described (Chapter 3.2.5 Viability Assay; Figure 4.3 A).  
All groups showed an overall decrease in chondrocyte viability with an 
increase in IC and UV exposure. Most notably, protective effects of reactive 
functional groups appeared to manifest at 0.2 % IC, with both GGMA and GelMA-L 
having significantly lower cell viability when compared with GelMA-H at 1500 
mJ·cm-2. At 2500 mJ·cm-2 GGMA remained significantly lower than GelMA-H 
whilst GelMA-L did not achieve a significant difference. It may be seen however 
that there was a definite effect of IC/RG ratio on cell viability, with a higher number 
of reactive functional groups appearing to increase PI interaction and thus decrease 
cellular damage and cell death.  
The number of molecules of IC per reactive functional groups present on the 
monomers was quantified and normalised to GelMA-H levels to allow inter-group 
comparisons (IC/RG Figure 4.3 B). GelMA-L and GGMA shared a similar level of 
IC/RG, which was between three and four-fold greater than that calculated for 
GelMA-H.  
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Figure 4.3: Chondrocyte viability after 24 h culture with varied photoinitiator 
and UV dosage; quantified number of IC molecules / functional reactive groups. 
(A): viability of all tested groups at 24 hours of culture; 10 % GelMA-L, 10 % 
GelMA-H and 1 % GGMA with 0.05 or 0.2 % IC and 1500 or 2500 mJ·cm-2 UV 
dosage. Cell numbers were quantified using ImageJ as described in Chapter 3.2.5 
Viability Assay. (B): number of molecules of IC per reactive functional groups (RG) 
in the three hydrogel blends, normalised to GelMA-H for comparability. Data are 
shown as mean ± SD. n = 5 from each of two donors (total n = 10) for all cell groups; 
the quantified ratio in (B) does not have sample variability and is thus shown for the 
single calculated instance. Statistically similar groups share same-case Roman 
numerals or letters, * indicates significant difference between gel types at one IC and 
UV dosage (as indicated). 
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4.4.4 Effects of UV Exposure on Chondrocyte Differentiation 
Cell viability was high throughout the culture period (Figure 4.4 A-D), with 
quantification verifying this observation (Figure 4.4 E). Whilst UV dosage did not 
appear to variably affect cells at these levels or in combination with this level of PI, 
overall viability was decreased on day 14 across all groups when compared with day 
1. The viability did however remain high (~80 %). 
Unlike in cell-free testing, elastic modulus was found to be significantly 
different between day 1 constructs under two different UV irradiations. It is unclear 
why this may have occurred and it suggests that the presence of cells within the 
hydrogel precursor affects the photocrosslinking kinetics. Regardless, both UV 
dosage groups increased in modulus over the culture period, indicating ECM 
deposition (Figure 4.6). 
GAG content per hydrogel wet weight (μg/mg) increased in both groups over 
the culture period, indicating chondrogenic differentiation regardless of UV dosage 
(Figure 4.6 A). DNA content (μg) remained consistent throughout the culture and 
together with viability data was supportive of healthy and active cells as well as even 
cell number across constructs (Figure 4.6 B). GAG content per DNA content (g/g) 
appeared very similar to GAG per wet weight due to the consistent DNA values 
(Figure 4.6 C GAG in media was tested on days 7 and 14, with no difference 
detected across groups indicating that GAG synthesis was comparable between the 
groups (Figure 4.6 D). In all cases cell-free constructs were used to correct for any 
material-based content potentially interfering with the GAG measurements. 
Gene expression indicated a significant upregulation of COL1A1 (~4-fold 
change) throughout the culture period (Figure 4.7 A). Positively, a much higher 
upregulation of COL2A1 (~8000-fold) was observed over culture time, which was 
 Chapter 4 109 
indicative of chondrogenesis (Figure 4.7 B). This finding was corroborated with 
ACAN expression, which also increased considerably (~8 fold) throughout the culture 
(Figure 4.7 C). No differences in gene expression were detected between UV 
conditions apart from COL1A1. While there appeared to be significantly higher 
levels of COL1A1 mRNA in the 1500 mJ·cm-2 group compared to 2500 mJ·cm-2 on 
day 14, this difference was less than ~2-fold and not considered of note.  
Immunofluorescent staining of collagen I, collagen II and aggrecan was 
performed to verify gene expression on ECM protein levels (Figure 4.8). Pericellular 
staining of both collagen type I and collagen type II was found in gels from both UV 
conditions, with however limited matrix staining observed (Figure 4.8 A, B, E and 
F). Aggrecan (Figure 4.8 C, D, G, and H) showed both pericellular and matrix 
staining throughout the constructs. Overall immunofluorescent images confirmed 
gene expression results of chondrogenesis – both collagen type I and II were present 
in the construct, with a slightly higher level of collagen II observable and consistent 
aggrecan staining throughout the hydrogels. 
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Figure 4.4: Fluorescence image illustrating chondrocyte viability on day 1 and 
day 14 of culture; 1 % GGMA, 0.05 % IC and either 1500 or 2500 mJ·cm-2 UV. 
Live (green) and dead (red) cells in 1 % GGMA under chondrogenic conditions, with 
0.05 % IC on (A+B) day 1 and (C+D) day 14, at (A+C) 1500 mJ·cm-2 or (B+D) 2500 
mJ·cm-2. (E): viability of day 1 and day 14, 1500 and 2500 mJ·cm-2 quantified using 
ImageJ. n = 3 from one donor; scale bar is 200 μm. Groups that share Roman 
numerals are statistically similar. 
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Figure 4.5: Mechanical testing results detailing compressive elastic modulus of 
hydrogels on day 1 and day 14 of chondrocyte culture. 
Elastic modulus of 1 % GGMA hydrogels on day 1 and day 14 of chondrocyte 
culture, subject to either 1500 or 2500 mJ·cm-2 UV irradiation upon hydrogel 
formation. When groups share Roman numerals they are statistically similar. A p < 
0.05 was considered as significant; n = 6 samples from two donors. Shared Roman 
numerals indicate statistical similarity between gel groups. 
 
Figure 4.6: DNA and GAG content in constructs comprising 1 % GGMA,  
0.05 % IC and subject to either 1500 or 2500 mJ·cm-2 UV irradiation. 
(A): GAG content (μg) per gel wet weight (mg); (B): DNA content (μg) per gel and 
(C): GAG content (g) per DNA content (g) in gels cultured for one or 14 days. (D): 
GAG concentration in media (μg·mL-1) on days 7 and 14 of culture. When groups 
share Roman numerals they are statistically similar. All GAG content was corrected 
using cell-free constructs at the same culture period, n = 6 from two donors in all 
cases. 
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Figure 4.7: Gene expression data for constructs comprising 1 % GGMA, 0.05 % 
IC and subject to either 1500 or 2500 mJ·cm-2 UV irradiation. 
Gene expression for (A) collagen type I (COL1A1); (B) collagen type II (COL2A1); 
and (C) aggrecan (ACAN) from day 1 and 14 of chondrogenic culture. Data are 
shown as 2-CT value (after log2 conversion). Statistical analysis was performed on 
log2 data with each group containing n = 6 samples from two donors. A p < 0.05 was 
considered as significant. Shared Roman numerals indicate statistical similarity 
between gel groups. 
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Figure 4.8: Immunofluorescence of 1 % GGMA gels with 0.05 % IC on day 14. 
Gels were cross-linked with either (A, E, C and G) 1500 or (B, F, D and H) 2500 
mJ·cm-2 UV. Representative images of superficial (top row, A-D) and deep (bottom 
row, E-H) regions of gels are shown with (A, B, E and F) collagen I (red) and 
collagen II (green) staining or (C, D, G and H) aggrecan (green) staining; nuclei are 
stained by DAPI (light blue). Scale bar is 50 μm. 
4.5 DISCUSSION 
Hydrogels (gelatine and gellan gum) were functionalised to derive three groups 
with either varied degree of functionalisation (DOF; GelMA-L versus GelMA-H) or 
a different polymer with a similar number of functional groups (GelMA-L versus 
GGMA). This was done to test the hypothesis that cytoprotective effects occur when 
a hydrogel with a higher number of reactive functional groups is crosslinked with 
UV irradiation in the presence of a photoinitiator, and to expose differences between 
gel types. A 14 day culture of GGMA was then conducted with two different UV 
dosages used for crosslinking to assess the effects of UV on chondrogenesis. 
Functionalisation of gelatine and gellan gum successfully yielded 
photocrosslinkable polymers. Use of a 10-fold lower amount of MAAh during the 
reaction caused a near 5-fold decrease in DOF of GelMA (~95 % versus ~20 %). The 
complexity of the reaction kinetics during the functionalisation is such that disparity 
between these values was expected, and overall the DOF values reached for GelMA-
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H and GelMA-L fell within the desired range. Functionalisation of GGMA resulted 
in a 5.7 % DOF, which was slightly lower than expected considering the molar 
excess of MAAh used in this case. However, the GGMA reaction is with primary 
(two per repeating unit) and secondary (eight per repeating unit) hydroxyl groups 
rather than amine groups, is pH sensitive, and requires a 6 h reaction period [197]. 
These sensitivities, along with the sheer number of hydroxyl groups in GG (10 per 
repeating unit) render such a DOF acceptable and still representative of a 
methacrylated polymer [197]. Examination of this through assessing the IC/RG as in 
Figure 4.3 (B) showed that comparable values were reached between GelMA-L and 
GGMA, with GelMA-H featuring more functional groups overall. 
Crosslinking cell free gels at various concentrations of IC and doses of UV 
light produced constructs with varied mechanical properties. The effects of IC 
concentration were most prominent in GelMA-L, where a doubling of modulus was 
observed from 0.05 to 0.1/0.2 % IC. Interestingly, whilst both GelMA groups 
showed some benefit from increased UV dosage, GGMA appeared largely 
unchanged. This may be due to it reaching a threshold modulus for the level of 
functionalisation and ion concentration during reaction. In all cases the increase of IC 
from 0.2 to 0.5 % did not yield a notable increase in modulus, with a plateauing of 
values observable.  
Elastic modulus increased from day 1 to 14 in both cell-containing UV dose 
groups, with 2500 mJ·cm-2 UV also resulting in stiffer hydrogels at both time points. 
This is in contrast to the findings of cell-free crosslinking, where both UV doses 
resulted in the same elastic modulus for 1 % GGMA. Whilst it is difficult to 
conclude why the varied dose was effective in this context, assessing constructs from 
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day 1 versus day 14 shows a positive result, with increases in modulus indicating 
ECM deposition throughout the culture. 
Viability testing of chondrocytes exposed to various IC concentrations and UV 
dosages resulted in all groups showing decreased viability with increases in IC 
concentration and UV exposure. Most notably, GelMA-H was significantly higher in 
viability at 0.2 % IC than both gels (at 1500 mJ·cm-2) and GGMA at 2500 mJ·cm-2, 
which is indicative of the protective effect I hypothesised may take place. It is 
difficult to compare these data to previous literature as no studies exploring this 
specific concept have yet been done. It may be inferred that the higher number of 
functional groups (and thus lower IC/RG ratio; Figure 4.3 B) in GelMA-H yielded 
protective effects on the cells when exposed to a higher percentage of IC. Overall no 
difference was found between GelMA-L and GGMA, indicating that substrate does 
not influence cell viability at the given toxicity levels. As these data are exclusively 
representative of two hydrogel systems, it is important to confirm this effect prior to 
drawing general conclusions on the efficacy of such criteria within hydrogel 
engineering. 
These results suggest that by testing higher, more cytotoxic UV doses, a clearer 
image of the protection afforded by a low IC/RG ratio during and after crosslinking 
may be formed. An interesting yet indirect comparison to this work is that of 
Williams et al. [205], who show significant cytotoxicity of IC on bovine 
chondrocytes and human mesenchymal stem cells at 0.1 % IC and 1200 mJ·cm-2 UV. 
In this case, however, cells are plated and hence are lacking appropriate phenotype as 
well as being subject to direct illumination with no refraction caused by the hydrogel. 
Alternately, Mironi-Harpaz et al. [109] examined cytotoxicity of various 
photoinitiators and found that at 0.2 % IC and 1500 mJ·cm-2, bovine aortic smooth 
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muscle cells remained ~80-90 % viable at day 1, which is representative of viability 
levels confirmed by our findings. 
Furthermore, Fedorovich et al. explored the effects of photopolymerisation on 
stem cells embedded in hydrogels [208]. The authors herein assessed the effects of 
various concentrations of IC (0.0, 0.05 and 0.1 % w/v) on the viability, proliferation 
and osteogenic differentiation ability of goat multipotent stromal cells (MSCs) both 
in monolayer and encapsulated within either HAMA or methacrylated hyperbranched 
polyglycerol gels. All groups were irradiated with UV light to a total energy of 0, 
180, 360, or 1800 mJ·cm-2. It was found that viability decreased from days 1 to 3 
post-irradiation, with a greater decrease observed in groups that used both IC and UV 
as opposed to a single component in isolation, as well as a dose-dependent response 
(0.05 % IC 1800 mJ·cm-2 UV: ~70 % day 1, ~60 % day 3; 0.1 % IC 1800 mJ·cm-2 
UV: ~50 % day 1, ~45 % day 3). Our results confirm this phenomenon, where 
throughout our 14 day culture, I observed a decrease in viability from ~90 % to 75-
80 % (Figure 4.4 A-E).  
Contrastingly, whilst Fedorovich and colleagues showed a decrease in MSC 
ability to proliferate after ultraviolet exposure within a PI-containing environment, 
Hu et al. [209] demonstrated that chondrocytes maintained proliferation after 
crosslinking at either 0.05 or 0.1 % w/v IC within a modified 2 % chitosan hydrogel 
system. This disparity may exist due to the differences in sensitivity to treatments of 
MSCs compared with chondrocytes, as in both cases the cells were treated in 
monolayer.  
Whilst viability was seen to decrease under treatment in all examined sources 
[109, 205, 208-210], which was further confirmed by our findings, Fedorovich et al. 
found there to be no effect on the ability of the MSCs to osteogenically differentiate 
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in monolayer after PI and UV treatment (after normalizing to cell number to account 
for decreased viability). Our results also confirm this finding, with overall high 
indication of chondrogenic differentiation. 
Namely, in our culture, GAG content per hydrogel wet weight and GAG 
content per DNA content were indicative of chondrogenic differentiation, with an 
increase of GAG levels observed throughout the culture period in both groups. GAG 
levels achieved values representative of chondrogenic hydrogel models seen in 
literature [9, 82, 211]. Analysis of DNA content throughout the 14 day culture 
indicated that cells did not proliferate regardless of UV dosage (Figure 4.6 A, B and 
C). GAG in media was consistent throughout the period, and indicated an even level 
of GAG retention amongst all constructs despite the noteworthy GAG loss from the 
systems [9]. 
Whilst gene expression showed a chondrogenic outcome, with significant 
upregulation of collagen II and aggrecan in all groups, collagen I was also elevated 
throughout the culture period. However as this elevation was consistent between the 
groups, it is impossible to attribute this to the UV dosage. Immunofluorescence 
images supported the trends illustrated by PCR on an ECM protein level, with both 
groups showing collagen II-containing pericellular matrix (PCM), with some cells 
devoid of PCM, or showing a higher level of collagen I staining (Figure 4.8 A, B, E, 
and F). All groups showed aggrecan staining within the PCM as well as throughout 
the entire ECM (Figure 4.8 C, D, G, and H). Taken together, the cytotoxicity of UV 
at this concentration of IC was not sufficient to hamper cell viability or reduce 
chondrogenic capacity. The chondrogenesis observed from gene expression and 
immunofluorescent data is representative of levels attained by other groups 
examining hydrogel models for chondrogenesis and hence may be considered a 
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successful chondrogenic outcome [82, 83, 212]. Overall, this is a novel approach in 
which I demonstrate that an optimum level of PI such as IC 2959 along with UV 
dose may be attainable, with such an optimisation resulting in tailorable mechanical 
properties, acceptable levels of viability and a potential to enhance differentiative 
capacity of cells. Such optimisations may also be possible with alternate PIs, such as 
VA-086, which was found by Rouillard and colleagues to form alginate methacrylate 
hydrogels with comparable mechanical properties to gels formed with IC, however 
with higher viability than the IC system [210]. Rouillard et al. however used bovine 
articular chondrocytes in this study, and found very low levels of viability (~50 %) at 
only 0.03 % w/v of IC 2959. This response is similar to the previously mentioned 
work of Williams et al., who also used bovine chondrocytes [205]. This leads to the 
conclusion that the realm of optimisation of photocrosslinkable hydrogel systems is 
in need of further study, for example not only are the relationships explored within 
this study is as of yet incompletely characterised, the type of photoinitiators used 
may offer further advantage within the context of this work. The effect of varied UV 
dosage on chondrocyte differentiation in photocrosslinkable systems appears to be 
limited, however further analysis of all of these parameters may be necessary to push 
innovation in this area to more tangible levels. 
4.6 CONCLUSION 
Low (GelMA-L) and high (GelMA-H) degree-of-functionalisation gelatine 
hydrogels were compared with the functionalised polysaccharide, GGMA, in terms 
of cytotoxicity under various photoinitiator and UV conditions. Tailoring of the 
number of photoinitiator molecules to the number of reactive functional groups on 
the hydrogels was explored. Most notably, whilst increases in photoinitiator and UV 
dose decreased viability overall, GelMA-H showed a higher level of viability at 
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higher photoinitiator concentrations when compared with the other groups, indicating 
some cytoprotective effects of more reactive functional groups. Differences in 
chondrogenic gene expression were not observed under different UV doses. These 
findings lead to the conclusions that, firstly, PI concentration needs to be adjusted 
based on the number of reactive functional groups present on the precursor 
molecules, and secondly, that UV dosage appears to be less critical for cell behaviour 
than PI toxicity and relatively high UV dosages at broadly accepted PI levels do not 
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5.1 INTRODUCTION
Viscoelasticity is present in numerous materials, appearing within the majority, 
if not all, biological tissues [115, 116, 213]. It describes the simultaneous viscous and 
elastic response of a material, and is typically observed not only due to the properties 
of the structural components of a material (such as fibres or filaments), but also the 
fluid flow between these components, and the chemical (e.g. ionic) interactions of 
any fluid and the structural components [112, 213, 214]. Hydrogels are viscoelastic 
materials that are commonly used in tissue engineering (TE), however in 
compression it is only their elastic properties that are typically characterised, and 
viscoelasticity in compression is rarely used as a deterministic criterion for scaffold 
design. 
Viscoelastic materials have a more complex behaviour than elastic materials, 
meaning that the standard compressive elastic (Young’s) modulus does not capture 
the nature of the material being tested - it only provides a general overview of 
stiffness. Viscoelastic characteristics including elastic modulus (), equilibrium 
modulus (), elastic storage and loss moduli ( and  respectively) and loss 
factor/tangent (	
) may provide a more accurate quantification of material 
response to loading.  and  describe the raw stiffness of the material and of the 
solid material components, respectively.  and  are indicative of the character of 
the elastic and viscous components of the tested materials under variable strain rates, 
whilst 	
	indicates the ratio of  to  (the tangent of the angle between the  
and  vectors) or the proportion of viscous response to elastic response.  
The tailoring of viscoelasticity may be beneficial in the field of TE, where the 
emulation or mimicry of the mechanical properties of various biological tissues may 
result in greater outcomes for tissue formation. Of the tissues typically targeted in 
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TE, articular cartilage is a significantly viscoelastic material, exhibiting such 
behaviours in tension [114, 214], compression [112, 115, 215] and shear [112, 113, 
216], and was hence chosen for a preliminary analysis within this work.  
Within cartilage TE, hydrogels are frequently used as scaffolds, since they 
provide a highly hydrated viscoelastic matrix and a desirable hypoxic environment, 
similar to the native tissue [217]. However in all applications, hydrogel systems do 
exhibit several limitations, primarily encountered in the trade-off between 
mechanical properties and cytocompatibility [109]. Whilst it is currently difficult to 
achieve cytocompatible hydrogels with mechanical properties of native tissues, more 
complex viscoelastic properties such as loss tangent may be a tailorable property.  
The hydrogel systems used herein consist of biocompatible gelatine, gellan 
gum (GG) and their methacrylated derivatives. Gelatine is a solid polymer obtained 
by partial hydrolysis of collagen derived from skin, bones or connective tissues 
[199]. It is comprised of modified natural ECM components (98-99 % protein by dry 
weight) and hence is an attractive material due to the retention of natural cell binding 
motifs such as Arg-Gly-Asp (RGD), and matrix metalloproteinase (MMP)-sensitive 
degradation sites [172, 173]. Modification of the lysine amino groups of gelatine via 
reaction with methacrylic anhydride yields a light- and chemical-crosslinkable 
hydrogel which is associated with long-term cell viability and response [9, 173, 174, 
218].  
Gellan gum, an FDA-approved food additive, is a linear anionic exocellular 
heteropolysaccharide secreted by the bacterium Pseudomonas elodea [200-202]. 
Gellan gum comprises a tetrasaccharide repeating unit of one rhamnose, one 
glucuronic acid and two glucoses [200]. GG forms aqueous solutions of low 
viscosities at high temperatures (temperatures in excess of 70 °C are required in 
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order to achieve full hydration of the structure [201]), and forms strong and hard but 
brittle gels upon cooling through a coil-helix transition, with helical aggregation and 
hydrogel stability being dependent on the presence, concentration and valence of 
cations in the solution [200, 203, 204]. GG is also a highly suitable material for three 
dimensional (3D) printing, a now-frequently explored approach to tissue engineering, 
due to its relatively prominent pseudoplasticity and ionic tailorability [170]. 
For the most efficient encapsulation of cells, a rapid liquid-to-solid phase 
transition is desirable. Light-activated free-radical polymerisation 
(photopolymerisation) is an attractive concept in this context as it provides rapid 
reaction rates, acceptable levels of cytotoxicity and results in uniform material 
properties [109]. In this regard, ultraviolet (UV) light-activated photoinitiators (PIs) 
such as 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 
2959; IC), have been frequently used with success. Similarly, chemical 
initiator/accelerator systems, such as the oxidising agent ammonium persulfate 
(APS) and catalyst tetramethylethylenediamine (TEMED), are comparable 
options for scenarios where light activation is not viable, although crosslinking has 
been reported to take up to an order of magnitude longer for the same concentration 
of initiator and hence result in less homogeneous material properties and increased 
cytotoxicity [109]. 
In this study I used hydrogel blends consisting of the crosslinkable, methacrylic 
anhydride-functionalised monomers gelatine methacrylamide (GelMA) and gellan 
gum methacrylate (GGMA), in various combinations with gellan gum (GG). I also 
initially included blends with methyl cellulose for improving mixability at 37 °C. I 
proposed that blending of polymers into multi-network gels would promote increased 
moduli and the combination of physical and chemical crosslinks would allow the 
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tailoring of viscoelasticity. I assessed the effects of these manipulations on the above 
parameters to determine tailorability and compared the constructs with explanted 
cartilage tissue to establish potential biological relevance. 
5.2 MATERIALS AND METHODS 
Gelatine (G2500), gellan gum (Gelzan™ CM G1910), methyl cellulose 
(M0512) and methacrylic anhydride (MAAh, 276685) were purchased from Sigma 
(Sigma-Aldrich, St. Louis, MO). 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-
methyl-1-propanone (Irgacure 2959; IC) was purchased from BASF (BASF, 
Ludwigshafen, Germany). All quoted concentrations in percent are weight per 
volume (% w/v) unless otherwise stated. 
5.2.1 Polymer Functionalisation 
Hydrogel groups comprised of methacrylic anhydride-functionalised gelatine 
(gelatine methacrylamide; GelMA) and gellan gum (gellan gum methacrylate; 
GGMA), plain gellan gum (GG) and methyl cellulose (MC) in various blends. 
Methyl cellulose was included during initial stages to aid hydrogel miscibility at 37 
°C. 
Functionalisation of gelatine and GG was done as previously, with 0.6 g 
MAAh per 1g gelatine and 8 g MAAh per 1 g GG (Chapter 3.2.1). 
5.2.2 Degree of Functionalisation 
The degree of functionalisation (DOF) of GelMA and GGMA was assessed 
using proton nuclear magnetic resonance (1H NMR) spectroscopy as described 
previously and using the same source for amino acid prevalence (Chapter 3.2.2, 
4.2.2). 
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5.2.3 Rheological Characterisation 
Hydrogel groups (detailed in Table 5-1; mixed in phosphate buffered saline 
(PBS; Invitrogen, Carlsbad, CA) or an isotonic blend of NaCl and D-mannose (24 
and 252 mM, respectively [170]; henceforth N+M) were analysed using a Rotational 
Rheometer RHEOTEST® RN 4.1 (RHEOTEST Medingen GmbH, Germany) with a 
precise thermal control unit. Testing consisted of multiple measures on each sample 
for analysis of gelation temperature (	) and viscosity ( across the temperature 
sweep. Firstly, the rheometer was set up with the 1 ° cone in cone and plate 
configuration, and the idle temperature was set to 60 °C to avoid gelation prior to 
testing. Hydrogel blends were made, and 500 μL of premixed, preheated hydrogel 
solution was pipetted onto the rheometer platform. The chamber was closed and a 
constant shear rate () of 50 s-1 was applied whilst temperature was reduced from 60 
to 20 °C at a rate of 1 °C·20 s-1, with time (), temperature () and  monitored 
constantly. 
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Table 5-1: Summary of groups used for rheological characterisation. 
HAC = human articular cartilage; GelMA = gelatine methacrylamide; GG = gellan 
gum; GGMA = gellan gum methacrylate. 
Hydrogel Groups Assessed Rheologically 
Abbreviation 
Constituents (% w/v) 
GelMA GG GGMA MC 
GelMA 10 0 0 0 
GelMA 0.25 % GG 10 0.25 0 0 
GelMA 0.25 % GG 0.25 % MC 10 0.25 0 0.25 
GelMA 0.25 % GGMA 10 0 0.25 0 
GelMA 0.5 % GGMA 10 0 0.5 0 
GelMA 1.0 % GGMA 10 0 1 0 
GelMA 1.0 % GGMA 0.25 % MC 10 0 1 0.25 
0.5 % GGMA 0 0 0.5 0 
1.0 % GGMA 0 0 1 0 
2.0 % GGMA 0 0 2 0 
0.5 % GG 0 0.5 0 0 
1.0 % GG 0 1 0 0 
 
5.2.4 Hydrogel and Explant Preparation 
Physical Crosslinking Prior to UV 
Stock solutions of GelMA, GG, GGMA and IC were made with N+M on the 
day of gel formation. 10 % GelMA, 1.0 % and 2.0 % GG and GGMA gels were 
made at an IC concentration of 0.05 % using just the individual components at the 
listed concentrations; all groups are included in Table 5-2. Gels were pipetted into 
custom-made Teflon moulds (50×4×2 mm strips) and covered with glass slides. 
Physical crosslinking consisted of UV (immediate UV), RT+UV (room temperature 
(RT) for 20 min prior to UV) or 4+UV (4 °C for 10 min prior to UV), with UV 
crosslinking initiated by irradiation at 365 nm for a total energy of 1500 mJ·cm-2 (2.3 
mW·cm-2, 11 min), in a CL-1000L crosslinker (UVP, Upland, CA). GG-only gels 
were not mixed with IC but only subjected to the temperature conditions described 
 Chapter 5 129 
above. After crosslinking, gel strips were cut to 4×4×2 mm and stored in Dulbecco’s 
Modified Eagle Medium (DMEM) at 37 °C overnight to allow for ionic equilibration 
prior to mechanical testing. Testing consisted of elastic modulus measurement, as 
described in the Mechanical Theory and Analyses section below. 
Table 5-2: Summary of hydrogel groups used to test the effects of physical 
crosslinking prior to chemical crosslinking through ultraviolet (UV) radical 
polymerisation.
All gels were mixed with NaCl + mannose. GelMA = gelatine methacrylamide; GG 
= gellan gum; GGMA = gellan gum methacrylate. UV = immediate UV crosslinking; 
RT+UV = 20 min physical crosslinking at room temperature (RT) prior to UV 
crosslinking; 4+UV = 10 min physical crosslinking at 4 °C prior to UV crosslinking. 
UV-only group was not included in the GG/GGMA comparisons as GG cannot be 
UV crosslinked. 
Hydrogel Groups Assessed for Physical Crosslinking 
Abbreviation 
Constituents (% w/v) Crosslink method 
GelMA GG GGMA UV RT+UV 4+UV 
GelMA 10 0 0 X   
GelMA 10 0 0  X  
GelMA 10 0 0   X 
1.0 % GG 0 1 0  X  
1.0 % GG 0 1 0   X 
1.0 % GGMA 0 0 1  X  
1.0 % GGMA 0 0 1   X 
2.0 % GGMA 0 0 2  X  
2.0 % GGMA 0 0 2   X 
 
Formation of Composite Hydrogel Blends 
Stock solutions of GelMA, GG, GGMA and IC were made with N+M on the 
day of gel formation. Specific hydrogel precursor solutions were prepared containing 
0.05 % IC and formed into gel strips; the gel compositions are detailed in Table 5-3. 
Gels were formed as above, using the RT+UV protocol. Gels were cut and 
equilibrated as above prior to mechanical testing. 
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Explant Preparation 
Full-thickness articular cartilage explants were cut from macroscopically 
normal regions of femoral condyles of two osteoarthritic female donors undergoing 
total knee replacement with patient consent and ethical approval from The Prince 
Charles Hospital and Queensland University of Technology and stored in PBS at 4 
°C overnight prior to testing. Cross-sectional area dimensions were cut similar to the 
hydrogel samples (4×4 mm) whilst height was kept maximised to include the full 
thickness of the tissue in each case. Mean heights of human donor cartilage (HDC) 
samples were HDC 1: 2.72 ± 0.19 mm; HDC 2: 3.39 ± 0.37 mm; n = 5 for both 
cases. Whilst typical cartilage relaxation time for equilibrium conditions is longer 
than the 10 min stress-relaxation described below [115], it was decided that to 
maintain controlled testing between hydrogels and cartilage explants the cartilage 
testing would be performed in the same way as the hydrogel testing. 
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Table 5-3: Hydrogel groups used for mechanical characterisation and details of 
constituents. 
All gels were mixed with NaCl + Mannose. HAC = human articular cartilage; 
GelMA = gelatine methacrylamide; GG = gellan gum; GGMA = gellan gum 
methacrylate. 
Hydrogel Groups assessed Mechanically 
Abbreviation 
Constituents (% w/v) 
GelMA GG GGMA 
HAC D1 N/A: Human Donor 1 
HAC D2 N/A: Human Donor 2 
GelMA 10 0 0 
GelMA 0.25 % GG 10 0.25 0 
GelMA 0.25 % GGMA 10 0 0.25 
GelMA 0.5 % GG 10 0.5 0 
GelMA 0.5 % GGMA 10 0 0.5 
GelMA 1.0 % GG 10 1 0 
GelMA 1.0 % GGMA 10 0 1 
1.0 % GG 0 1 0 
1.0 % GGMA 0 0 1 
2.0 % GG 0 2 0 
2.0 % GGMA 0 0 2 
 
5.2.5 Mechanical Characterisation 
Mechanical testing was performed using an Instron MicroTester (Model 5848; 
Instron, Norwood, MA). Each sample was placed in a 37 °C PBS trough into which 
an aluminium plunger was submerged for compressive displacement. The testing 
regimen consisted of a preliminary height measurement (force () = -0.01  as 
height criterion), followed by: a 0.5 % strain per second (%  ) ramp to 16 % 
for compressive elastic modulus measurement ( over 10-15 %) after which the 
sample was unloaded to 0 %; a 0.5 %   ramp to 10 % where a 10 min stress 
( )-relaxation was held; sinusoidal compression over a range of frequencies (for 
calculating compressive storage () and loss () moduli), consisting of an 
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exponential decrease from 5.12-0.01 !", 2 % amplitude, midpoint at 10 %; and a 
final 0.5 %   ramp to 15 % for a second 10 min stress-relaxation hold ( 
over 10-15 %). For the characterisation of crosslinking reagents, testing only 
consisted of elastic modulus measurement. It should be noted that sinusoidal testing 
was performed with decreasing frequency to reduce stress-relaxation that may occur 
during low-frequency tests. Additional details may be found in Appendix 4. In all 
cases one sample was used for all measurements, with the entire regimen repeated 
per sample (n = 5 for all groups). 
5.2.6 Mechanical Theory and Analyses 
The compressive elastic moduli () of all samples were obtained by calculating 
the slope of the  
 function over the 10-15 % region, to ensure values were 
obtained from the linear region of the stress-strain curve. For the equilibrium 
modulus (), stress at the end of each relaxation point was calculated (10 and 15 
%), with the gradient of the linear relationship between the two points deemed to be 
# The elastic and equilibrium moduli are illustrated schematically on a stress-
strain plot in Figure 5.1. 
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Figure 5.1: Schematic of elastic and equilibrium moduli on a stress-strain plot. 
(A): elastic modulus measured as the gradient of the stress-strain slope over 10 – 15 
% strain; (B): equilibrium modulus measured as the gradient of the stress-strain slope 
over 10 – 15 % strain, with each stress measurement taken at the end of a 10 min 
stress relaxation hold. 
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Hydrogels and cartilage are viscoelastic and hence have a stress-lag during any 
dynamic strain.  and  were calculated using viscoelastic theory (Equation 5.1) 
[219]: 
 $ %&'& ()  Equation 5.1.a 
 $ %&'& *+  Equation 5.1.b 
Where 	is the loss angle (lag or lead) between the stress and the strain, and  , 
and , signify stress and strain sine amplitudes, respectively. This relationship is 
illustrated in Figure 5.2.  
 
Figure 5.2: Schematic of a phase angle between viscoelastic strain and stress. 
The magnitude of stress ( ,) and strain (,) curves is used along with the phase angle 
() to calculate the storage () and loss () moduli as shown in Equation 5.1. 
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In order to obtain the data required for these equations, the raw data were 
processed into separate frequency cycles and curve-fitted using a MATLAB script 
(The MathWorks, Inc., Natick, MA), which gave outputs of amplitude, frequency 
and phase angle for each curve. These values were then adjusted to account for 
machine inertia and noise, and analysed, resulting in values for  and . The value 
for the loss tangent (
) was obtained by taking the tangent of the loss angle or 
the ratio of  to  (Equation 5.4): 

 $ 	 --	-	  Equation 5.4 
5.2.7 Cell Isolation and Expansion 
The procedure for cell isolation and expansion is as described previously 
(Chapter 3.2.4). 
5.2.8 Cell Encapsulation and Hydrogel Culture 
Preliminary cell culture was performed on hydrogel groups (in N+M): GelMA 
(10), GelMA/GG (10/0.25) and GelMA/GGMA (10/0.25) to assess cell viability in 
the hydrogel blends. As previously described, all hydrogel solutions were prepared 
with 0.05 % IC, with 2×105 chondrocytes·mL-1 mixed into the precursor solutions. 
The same crosslinking method was followed as above. After gels were divided into 
48-well plates, they were cultured in a 5 % CO2 incubator at 37 °C for 7 days in 
chondrogenic differentiation media as described previously (Chapter 3.2.5). 
5.2.9 Cell Viability 
Viability was assessed on days 1 and 7 using fluorescein diacetate (FlDA) and 
propidium iodide (PrI; both Invitrogen) to stain live and dead cells, respectively as 
described previously (Chapter 3.2.5 Viability Assay). 
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5.2.10 Statistical Analyses 
Statistical analysis was done as previously (Chapter 3.2.6). 
5.3 RESULTS 
5.3.1 Degree of Functionalisation 
Gelatine and gellan gum were functionalised using varied molar excesses of 
MAAh as described in Chapter 3.2.2 and 4.2.2. 1H NMR analysis was performed to 
obtain DOF from NMR spectra (Figure 5.3). GelMA was found to be 76.2 % 
functionalised, whilst GGMA was 3.6 %. Relevant chemical structures are further 
detailed elsewhere [174, 197]. 
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Figure 5.3: Proton Nuclear Magnetic Resonance (1H NMR) spectra of 
hydrogels.
(A): gelatine; (B): gelatine methacrylamide (GelMA); (C): gellan gum (GG); and 
(D): gellan gum methacrylate (GGMA). Areas of interest are inset within each frame. 
Aromatic peaks in gelatine/GelMA are present at ~chemical shift () 7.4 ppm, with 
the two free protons on the methacrylate groups present at  5.6 and  5.8 ppm 
respectively. In GG, the peak from the methyl group of rhamnose is present at  1.4 
ppm, with the methyl group of the methacrylate group present in GGMA at  2.1 
ppm. The methacrylate protons found in GGMA are visible at  5.8 and  6.3 ppm. 
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5.3.2 Rheological Characterisation 
Rheological testing was conducted to assess miscibility of hydrogel blends 
cytocompatible temperatures (< 40 °C) and hence their suitability for future mixing 
with cells. Inclusion of gellan gum (GG) significantly increased gelation temperature 
compared with GelMA alone, or other GelMA blends, as illustrated by increases in 
viscosity around 40 °C across all GG groups. Using an isotonic solution with a lower 
ionic concentration (24 mM NaCl, 252 mM D-mannose; N+M) decreased gelation 
temperatures, yielding hydrogels that were mixable under cytocompatible conditions 
(< 40 °C), and hence drove the use of the N+M blend in all further hydrogel testing. 
Use of MC as a temporary diluent to reduce viscosity was ineffectual, with limited 
decreases in gelation temperature (all above details illustrated in Figure 5.4 and 
Figure 5.5).  
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Figure 5.4: Rheological measurements of viscosity of hydrogel components. 
Measurements were taken over the temperature range of 60 – 20 °C, with (A): PBS 
groups and (B): NaCl + mannose groups. Colours are shared between PBS and NaCl 
+ mannose gel groups, with the latter indicated by dashed lines. n = 1 in all cases. 
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Figure 5.5: Rheological measurements of viscosity of blended hydrogels. 
Viscosity of blended hydrogel groups, over the temperature range of 60 – 20 °C, with 
(A): PBS and (B): NaCl + mannose. Colours are shared between PBS and NaCl + 
Mannose gel groups, with the latter indicated by dashed lines. n = 1 in all cases.  
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5.3.3 Composite Hydrogel Blends and Explants 
Elastic moduli and equilibrium moduli were measured for all single component 
hydrogels, hydrogel blends and human donor tissue explants, in order to assess basic 
material stiffness and stiffness after 10 minutes of stress relaxation at two strain 
levels. The elastic modulus of GelMA (~ 100 kPa) proved comparable with that of 
2.0 % GG and almost twice that of 1.0 % GG (p < 0.05). Both 1.0 and 2.0 % GGMA 
moduli were less than 20 kPa and not significantly different (Figure 5.6 A). 
Increases in elastic modulus were observed with the addition of either GG or 
GGMA, with the inclusion of 1.0 % GG giving a significantly higher modulus than 
all other groups (Figure 5.6 B). However, whilst moduli of donor tissues were 10-
fold greater than the moduli measured from any gel blend (Figure 5.6 C), they were 
within expected ranges for healthy cartilage tissue [220, 221]. Relative differences 
between elastic and equilibrium moduli were smallest for GelMA, with an 
equilibrium modulus of ~70 kPa (Figure 5.6 D). Conversely, whilst all GG / GGMA 
single-gel groups decreased in modulus dramatically when equilibrated, GG groups 
suffered the largest decrease in modulus, with 1.0 % GG being statistically similar to 
both GGMA groups, and 2.0 % GG attaining ~10 kPa. The decrease in modulus with 
GG was shared in the blended groups, with a significant increase in modulus now 
observed in the 0.5 % GGMA group, and a decrease in modulus compared with 
GelMA alone found in the 1.0 % GG group (Figure 5.6 E). Donor tissues showed a 
dramatic decrease in equilibrium modulus, with values decreasing 5 – 10-fold 
(Figure 5.6 F).  
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Figure 5.6: Elastic and equilibrium moduli of single hydrogel components, 
blended hydrogels and human donor cartilage tissue explants. 
Summary of elastic moduli of all mechanically tested groups, with (A): individual 
gel components; (B): blended hydrogels; and (C): human donor cartilage tissue 
explants. Equilibrium moduli are also shown for (D): individual gel components; (E): 
blended hydrogels; and (F): human donor cartilage tissue explants. Asterisks (*) 
indicate significant difference compared to all other groups. Groups that share 
Roman numerals are statistically similar; n = 5 in all cases. 
Storage and loss moduli for hydrogels and donor explants were approximately 
one order of magnitude different (Figure 5.7 A, C). Overall, human tissues appeared 
to have a consistent increase in storage modulus with increasing frequency, whilst 
loss modulus did not vary greatly with frequency, apart from a decline between the 
highest frequencies tested (2.56 to 5.12 Hz; Figure 5.7 A, C). The storage modulus 
of hydrogels containing only MA-modified polymers (GelMA, GGMA, and their 
blends) was stable over the tested frequency range, whereas that of hydrogels 
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including non-modified GG increased with increasing frequency (Figure 5.7 B). 
Loss modulus generally decreased with increasing frequency for all hydrogel groups 
(Figure 5.7 D), and thus loss modulus was overall a lesser fraction of complex 
modulus with increasing frequency. Notably, GG-containing gels and GG-only gels 
maintained the greatest viscous character, reaching the ~10 % loss/storage ratio that 
was observed in donor tissues (Figure 5.7 B), indicating that covalent 
photocrosslinking limits viscoelasticity. Closer examination of the viscous 
characteristics, as described by 
, showed that the behaviour of 1.0 % and 2.0 
% GG and GelMA / 1.0 % GG was most like that of native tissue (Figure 5.8).  
5.3.4 Cell Viability 
Human articular chondrocytes (HACs) were cultured for 7 days under 
chondrogenic conditions to assess cytotoxicity of the N+M blend or the hydrogel 
components. Cells were homogeneously mixed throughout all hydrogel groups, with 
high levels of viability observed (~90 %; Figure 5.9). The seven-day culture (Figure
5.9, Day 1 (A-C), Day 7 (D-F)) on GelMA (A, D), GelMA/0.25 % GG (B, E) and 
GelMA/0.25 % GGMA (C, F) revealed no signs of cytotoxicity or incompatibility of 
the hydrogels with HAC. 
5.3.5 Physical Crosslinking 
To determine the effects of thermal gelation prior to covalent crosslinking, 
GelMA and GGMA hydrogels were made with either UV immediately after 
preparation (UV), following 20 min at room temperature (RT+UV), and following 10 
min at 4 °C (4+UV). Thermal gelation prior to UV crosslinking resulted in higher 
elastic moduli for both GelMA and GGMA regardless of condition (RT+UV and 
4+UV; Figure 5.10).  
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Figure 5.7: Storage and loss moduli of single hydrogel components, hydrogel 
blends and human donor tissue explants. 
Storage moduli of (A): all mechanically tested groups; (B): hydrogel groups with 
explant samples omitted. Loss moduli of (C): all mechanically tested groups; (D): 
hydrogel groups with explant samples omitted. In each case the mean of n = 5 
samples is presented with error bars indicating standard error of the mean. 
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Figure 5.8: Loss tangent as a function of frequency of all mechanically tested 
groups.
Loss tangent as a function of frequency of all mechanically tested groups. Data is 
presented on a logarithmic scale for frequency (Hz) and on a linear scale loss tangent 
(
). Values are presented as mean of n = 5 samples with error bars indicating 
standard error of the mean. 
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Figure 5.9: Viability of human articular chondrocytes within hydrogels mixed in 
a 24 mM NaCl and 252 mM D-mannose solution over a 7 day culture. 
(A-C): day 1 and (D-F): day 7 of culture, conducted on GelMA (A, D), GelMA/0.25 
% GG (B, E) and GelMA/0.25 % GGMA (C, F). FlDA stained live cells green whilst 
PrI stained dead cells red. Scale bar 100 μm as indicated. 
  
 Chapter 5 147 
 
Figure 5.10: Comparison of elastic moduli of hydrogels with various physical 
crosslinking prior to ultraviolet (UV) irradiation. 
(A): GelMA gels and (B): GGMA gels. Crosslinked immediately (UV; dotted bars), 
after setting at room temperature (RT+UV; white bars) or at 4 °C (4+UV; cross-
hatched bars) prior to UV crosslinking. IC concentration 0.05 % w/v, UV dosage 
1500 mJ·cm-2, incubation prior to UV of 20 min for RT+UV and 10 min for 4+UV. 
Lines indicate groups compared using independent samples t-test, asterisks (*) 
indicate significant difference, p < 0.05, n = 5 in all cases. GG and GGMA were not 
tested with immediate UV as GG cannot crosslink through this method and no 
comparison would be possible. 
5.4 DISCUSSION 
Hydrogel blends consisting of GelMA and GG or GGMA were made to 
establish whether viscoelastic properties were tailorable within these hydrogel 
systems. Further, these properties were compared to the viscoelasticity of human 
articular cartilage as a model biological tissue. Gels were characterized using 1H 
NMR and rheology prior to being subjected to a number of mechanical analyses in 
order to evaluate their viscoelasticity.  
The degree of functionalisation (DOF) of hydrogels was measured using 1H 
NMR spectroscopy (Figure 5.3). Quantification of spectra was simple in the case of 
GG/GGMA, where the modified groups could be normalised to the total number of 
modifiable species. However, the variability of animal tissue-sourced materials such 
 148 Chapter 5 
as gelatine/GelMA introduced some complexity into spectral quantification, as the 
amino acid constituents within gelatine products are somewhat variable and a 
measure of modified lysine groups was normalised to a phenylalanine standard based 
on proportion of amino acids. The proportion of amino acids in gelatine was obtained 
from literature [177], which gave an overall DOF estimate. In any case, GelMA was 
highly functionalised (76.2 %) whilst GGMA was functionalised to a lesser extent 
(3.6 %). However, lysine is not a highly prevalent amino acid in gelatine (~1-4 %) 
whilst there are 10 potential functional hydroxyl groups per repeating unit of GG and 
hence, with the higher percentage of functionalisation and at concentrations used 
herein (10 % for GelMA vs. 1 % for GGMA), the number of functional reactive 
groups per mL of solution would be comparable between the two gel types. The 
degree of crosslinking was not determined in these gels. However, based on previous 
experiments and modelling of GelMA hydrogels [77], we expect that ~42 % of the 
maximal attainable compressive modulus was reached in our experiments. Whilst 
UV dose could be used to increase the degree of crosslinking and hence modulus, 
this would likely result in greater cytotoxicity [109, 222]. The current study focused 
on assessing the potential to tailor viscoelasticity in cytocompatible hydrogel 
systems. 
Rheological analysis (presented in Table 5-1, Figure 5.4, and Figure 5.5) was 
conducted to assess reduction in gelation temperature by using PBS as a solvent 
versus a 24 mM NaCl + 252 mM -mannose (N+M) isotonic solution, or by mixing 
methyl cellulose (MC) within the hydrogels. MC was included to dilute the mix 
during handling/processing, with MC diffusing out after crosslinking and subsequent 
immersion in medium [223]. It was found that the use of MC did not achieve this 
outcome whilst the use of an N+M solution was very effective, with the low ion 
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concentration maintaining GG in a loosely crosslinked state that remained pipettable 
due to the pseudoplasticity of the material [170].  
GG forms gels through the initial formation of double helical junction zones 
which then aggregate, forming a three-dimensional network by complexation with 
cations and hydration of the network [202]. Methacrylation of polysaccharides such 
as GG involves the modification of the hydroxyl groups, which reduces 
deprotonating capacity, water retention and the propensity to form coordination 
complexes between helices, thus reducing the gelation temperature of the substance 
in ion-rich solutions such as PBS when compared with standard GG [170, 202]. 
Whilst this clearly reduces the ability for GGMA to form physical ion bound 
hydrogels at low gel concentrations, it also facilitates the production of hydrogel 
precursor solutions that are liquid at physiological temperatures, as demonstrated 
herein. 
Whilst methacrylation of GG is one approach to achieve lower gelation 
temperatures, a simpler method is the use of a low-ion physiologically isotonic 
solvent (N+M). Furthermore, the inherent pseudoplasticity of GG, which is 
advantageous for 3D printing [170], allows high fidelity deposition without flow rate 
irregularities as well as aiding in the stability of the printed structure. This is a 
disadvantage when it comes to conventional handling; the ability to pipette the 
solution into moulds for crosslinking is lost before the gel is completely set and 
attempts at manipulation at lower temperatures simply result in the introduction of 
bubbles. Hence all mechanical testing in this study was performed on gels mixed in 
an N+M solution. 
Whilst mixing hydrogel precursors at 37 °C allows a physiological 
environment for cells and decreases viscosity, such that processing is possible, 
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reproducibility of mechanical properties between groups becomes a potential issue 
when considering varied incubation times at RT prior to the photopolymerisation. 
This may be overcome by maintaining gels at 37 °C within moulds but is 
accompanied by an increased risk of cell settling due to the decreased gel viscosity at 
higher temperatures [224]. 
The formation of tertiary structures (interactions and associations between 
aggregates) is influenced by the rate of cooling, especially when the time taken prior 
to photopolymerisation may vary [225]. The hydrogels used in this study become 
increasingly crosslinked physically or through ionic interactions at lower 
temperatures without UV irradiation. Once UV exposure is initiated, the speed of 
radical polymerisation will largely exceed that of physical crosslinking, which will 
also be reduced due to the ~37 °C temperatures that result from passive heat of the 
UV bulbs throughout the process (data not shown). The combination of various 
hydrogel components may also impede physical interactions and cause the 
aggregates of one gel type to become entrapped within the network of the other 
[170]. UV irradiation immediately after precursor processing would thus form a 
hydrogel crosslinked predominantly through the radical reaction, rather than a 
combination of the thermal-setting physical crosslink followed by the chemical 
crosslinking. 
Incubation at RT or 4 °C prior to photopolymerisation allows for: the 
maintenance of cells within the hydrogel matrix at an even distribution without cell 
settling; a reduction in the influence of physical gelation (which occurs at any time at 
RT) on mechanical properties between groups; and an increase in base mechanical 
properties due to the formation of more coherent tertiary structures (through these 
physical crosslinks). A comparison of the elastic modulus of GelMA crosslinked 
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immediately (UV) versus crosslinking by incubation at RT (RT+UV) and 4 °C 
(4+UV) (Table 5-2, Figure 5.10 A) illustrates the significant increase in modulus 
that physical crosslinking prior to chemical crosslinking may provide due to the 
superior structural arrangement in the hydrogel [77]. In this system, increasing 
cooling rate does not appear to affect GelMA stiffness, whilst GG and GGMA are 
more notably (and significantly) affected (Figure 5.10 B). As GG/GGMA form 
solids through a multi-stage process including the formation and aggregation of 
helices in relation to ionic concentration, it may be postulated that the increased 
cooling rate allows for helices to become established faster, which then allows more 
time for ionic interactions between helices and thus a stronger hydrogel. 
Alternatively, helices may not have sufficient time to form discretely and instead 
form a disordered tangle that is stronger due to a greater degree of overlap. All of 
these gelation mechanisms however are very complex and extensive study beyond 
the scope of this work would be required to define the processes comprehensively. 
Nonetheless, the materials and methods used in this study were cytocompatible 
(viability ~90 %), which is acceptable and typical of photocrosslinkable hydrogel 
systems using Irgacure 2959 [9, 205, 226]. 
In terms of mechanical testing, GelMA hydrogels were found to be 
predominantly elastic. GG and GGMA was added to GelMA hydrogels to ascertain 
whether viscoelasticity could be tuned using a primarily ion-bound hydrogel (GG) or 
a primarily covalently-bound gel (GGMA). Contrast of the two gel blends also 
exposed whether an interconnected covalent network (such as in GelMA/GGMA) 
would afford increased mechanical properties, compared with an entwined yet only 
physically entrapped network (such as that between GelMA/GG). Examination of the 
elastic moduli of the gel groups and explants (Figure 5.6 A-C), showed that the 
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inclusion of either GG or GGMA proved to increase the modulus above that of 
GelMA alone. However, these effects were predominantly less than 25 % and not 
statistically significant, apart from the increase (~75 %) in the GelMA/1.0 % GG 
group. It may be inferred that it was only at this concentration that the GG achieved 
sufficient network density to enhance the overall modulus, i.e. the GG was able to 
form stable intramolecular crosslinks, in addition to mixing through and physically 
entangling with the GelMA network. When the gels were made in N+M solution, the 
higher GG concentration produced a matrix that allowed them to recover structurally, 
with helical association promoted by ion reinfusion [170].  
In contrast, photocrosslinking of GGMA in a low-ion solution caused the 
network to become locked in place and reinfusion of ions was not able to recover 
modulus through network rearrangement. Notably however, addition of GGMA to 
the GelMA did increase the modulus to a greater extent than the sum of individual 
moduli, with all concentrations giving a ~25 % increase, similar to GG blended 
groups. Comparison with human articular cartilage donor tissues showed a dramatic 
10-fold difference between hydrogels and native tissue. Variability was also found 
between donors, which will remain a considerable factor in the future design of 
tissue engineering structures, however values represented those found in literature for 
elastic modulus of healthy elderly individuals (1 – 3 MPa) [221]. 
Equilibrium modulus (Figure 5.6 D-F) clearly illustrated the non-covalent 
nature of the GG, with a drop of ~30 % in GelMA and GGMA moduli but ~80 % in 
GG modulus after relaxation for 10 min at each of two strain levels. This trend was 
also observed in the blended groups, with the modulus of the 1.0 % GG blend being 
significantly lower than all other composites, apart from 0.25 % GG. The cohesion of 
the GG network was again suggested by this trend. A more significant interaction 
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between GG and itself versus GG entrapment within GelMA would explain this 
phenomenon. The viscoelasticity achieved in the hydrogels was contextualised by the 
native tissues, which also demonstrated a dramatic decrease in modulus after 
relaxation. 
The greater physical complexity of the donor tissues was further demonstrated 
by storage () and loss () moduli (Figure 5.7 A, C) where, across all frequencies, 
the donor explants maintained a relatively consistent loss modulus. As all hydrogels 
are subject to fluid flow through the matrix when compressed, some degree of 
hysteresis in loading must occur independent of which crosslinking modalities are 
used. Despite this, testing revealed that in the absence of ion-bound hydrogels such 
as GG, a large decrease in viscosity was observed in hydrogel groups evidenced by 
lower loss moduli (e.g. GelMA, GelMA/GGMA, GGMA; Figure 5.7 D). 
Furthermore, even in hydrogel groups with relatively high loss modulus, this 
modulus was much more frequency-dependent when compared with the native 
tissues, and primarily manifested at the lowest frequencies. This may be due to the 
weaker bonding of the ionic hydrogels versus the highly complex and ordered 
cartilage structure, in addition to the much greater water content in the hydrogels 
(maximum 90 % versus 75-80 % in articular cartilage) [227]. A primarily 
homogenous hydrogel crosslinked through ionic interactions will exhibit a largely 
elastic response at high frequencies, similar to that expressed by covalently 
crosslinked hydrogels. The release of sufficient fluid requires a longer duration 
strain, which will allow the disruption of ionic associations and thus the relaxation of 
associations between aggregated polymer strands. This complex interplay between 
molecules allows cartilage to maintain a loss modulus within ~20 % of the starting 
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value regardless of frequency, whilst a near 75 % decrease is seen in 2.0 % GG over 
0.01 – 5.12 Hz.  
The comparison of hydrogels and cartilage is significantly simplified when the 
loss tangent (	
) is considered Figure 5.8). The loss tangent illustrates the ratio 
of loss to storage modulus (the angle between the two vectors). It was clear that the 
majority of hydrogel groups in this study did not consistently produce viscoelastic 
response, with only GelMA/0.5 % GG, GelMA/1.0 % GG, 1.0 % GG and 2.0 % GG 
achieving values above 0.05, or being comparable with native tissues. The 
consistency of loss tangent exhibited in native tissues is clear, with a decrease from 
~0.2 to ~0.1 observed in the samples. Conversely the hydrogels show a much greater 
decrease over the frequency range, with 1.0 % GG appearing closest to native values. 
Whilst 2.0 % GG appears somewhat variable over the range, the data suggest that 
stabilisation of a higher concentration of GG within GelMA may reveal trends more 
similar to native tissue.  
Analysis of double network gels has been explored in the literature primarily 
by the group of Gong et al. [228-231]. However the systems cited herein comprise a 
network of a hard, brittle gel formed using photopolymerisation with a soft, ductile 
gel at a much higher molarity infused within and then crosslinked through a second 
photopolymerisation. This yields a loosely crosslinked ductile gel within a brittle and 
stiff network and allows for dramatic increases in elastic modulus, strength, strain at 
failure and toughness [228]. The system presented within the aforementioned study 
is unlike ours, where the hydrogel components are mixed in-solution prior to 
moulding and crosslinking. Further, whilst these systems afford high level 
mechanical properties, they also tend to display the Mullins Effect, wherein 
hysteresis is only observable upon first-cycle loading to an initial maximum stress 
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and subsequent cycles to the same stress level show limited hysteresis and are hence 
limited in viscoelasticity [118]. Webber et al. propose that these data are supportive 
of the Lake-Thomas [232] mechanism where energy exceeds the threshold above 
which permanent damage is caused upon repeated loading, and that the initial 
hysteresis is associated with breaking of covalent links within the network. This is 
again in contrast with our system, where we found an increase in physical crosslinks 
directly increasing hysteresis, and being the largest contributor to the manifestation 
of viscoelasticity. 
The work of the Vilgis group [119] identifies similar trends to those observed 
in our work, showing that with increased covalent crosslinks there is limited 
hysteresis in loading and with increased physical crosslinking there is a higher 
stretching ratio and increased hysteresis. However, they support the theory of a 
Mullins effect within their system, which would indicate permanent crosslink 
degradation and hence a lack of viscoelastic property. This conclusion is in direct 
contrast to our findings, where all hysteretic data are taken from multiple cycles, with 
initial and terminal cycles excluded to ensure reproducibility and reduce edge effects. 
As these loads are reproducible throughout multiple cycles (> 200 in the case of 5.12 
Hz) it is clear that a Mullins Effect and Lake-Thomas microfractures [232] are not 
occurring, and that the breaking and reforming of physical/ionic bonds of the GG 
must be a large driving factor in the establishment of viscoelasticity, as I initially 
indicated. 
Overall, it is clear that the emulation of the biological aspect of viscoelasticity 
may be achievable through the use of appropriate hydrogels, ideally crosslinked 
through multiple means to take advantage of multiple systems, such as the previously 
mentioned cell attachment-promoting effects of gelatine. Whilst it may be predicted 
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that the elastic modulus of such structures will still fail to reach that of native tissues, 
this may in fact be desirable, as cellular stress/strain is ultimately required to 
stimulate matrix production and formation of cartilage in situ. Further, it has been 
previously demonstrated that hydrogels with lower initial stiffness can result in 
constructs with higher mechanical properties after culture [233, 234].  
The work presented herein illustrated that viscoelasticity may be tailored in 
hydrogels depending on physical and chemical crosslinking of networks. Further 
study of such hydrogel systems and verification of the role of viscoelasticity in the 
formation of biologically relevant constructs should be explored in future. Inclusion 
in bioreactor cultures where the viscoelastic properties may have an influence on cell 
behaviour will help to determine whether these relationships translate to 
improvement in areas such as cartilage TE, within a preliminary in vitro setting. 
5.5 CONCLUSION 
The fabrication of the hydrogels GelMA, GG and GGMA alone and in a range 
of blends resulted in varied mechanical properties and viscoelastic characteristics. 
Most significantly, GG, or GG in combination with GelMA, resulted in loss tangent 
values. Loss tangent values of GG, and to a lesser extent GelMA/GG, were 
comparable to native cartilage. Elastic properties of hydrogels were tailorable 
through composition, but did not attain levels of native tissues. Within the gels used, 
cells remained viable after a one week culture, which was a promising outcome. The 
testing method demonstrated in this work provides means through which the 
viscoelasticity of various biological tissues may be tested and emulated within 
biomaterial systems. 
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Chapter 6: Summary and Discussion 
6.1 SUMMARY
Treatment of joint diseases such as osteoarthritis is complex and challenging. 
The lack of intrinsic repair capacity of the joint tissues plays a major part in the 
difficulty of management, with attempts at treatment generally resulting in poor 
outcomes long-term. Tissue engineering (TE) therapies aim to use scaffold systems 
to support injured sites whilst promoting scar-free healing. Although TE research has 
made advancements over the past two decades, a complete cartilage or osteochondral 
healing solution is yet to be comprehensively developed. This thesis aimed to 
progress the knowledge in the field of TE, more specifically in the development and 
characterisation of thermoplastic and hydrogel scaffolds for use in bone, cartilage 
and osteochondral systems.  
Although melt-extruded polymer constructs for bone TE have been commonly 
characterised throughout the literature, the lack of control over a given parameter 
(such as porosity) has limited the conclusions that can be made about all scaffold 
parameters. In this thesis, I systematically analysed the effects of scaffold 
architecture while keeping porosity constant (Chapter 2). Architectural differences 
resulted in a range of pore sizes, axial permeabilities and mechanical properties, 
which in turn influenced cell attachment. Scaffolds with larger pore sizes appeared to 
fare better in terms of osteoblast proliferation and differentiation. Overall the 
influence of architecture in a porosity-constant environment was described, with 
specifics of fluid flow and mechanical properties clearly elucidated. 
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Work progressed to the development of a biphasic bone and cartilage TE 
scaffold system for osteochondral applications (Chapter 3). A hydrogel/scaffold 
system was designed comprising a hydrogel cast around a hydroxyapatite paste 
scaffold which formed the base of the structure. The design was made to include a 
cartilage component (hydrogel) and a zone of calcified cartilage component (gel 
filling the pores of the hydroxyapatite scaffold and the scaffold itself). Two scaffold 
designs were made with a control scaffold lacking hydroxyapatite; these were then 
crosslinked with two different hydrogel compositions to form a total of four groups. 
Overall I demonstrated that low cytotoxicity was found using this hydrogel/scaffold 
system. Although chondrogenesis was observed in all groups, with one hydrogel 
composition performing better than the other, limited effects of the hydroxyapatite 
scaffolds were present and thus there is potential for further improving these 
osteochondral scaffolds.  
My study focus then transitioned to in-depth characterisation of 
photocrosslinkable hydrogel systems for cartilage TE (Chapter 4). 
Photocrosslinking methods are very frequently used within cartilage TE, but there 
has been a lack of detailed characterisation along with reasoning as to why certain 
dosages of photoinitiator or UV are used. It appears that concentrations that are 
found to be cytocompatible are simply adopted by all subsequent users of the 
systems without determination of whether optimisation of the dosages may be 
possible. In order to address this limitation, I performed a study wherein 
photoinitiator concentrations and UV light doses were varied across a number of 
hydrogel systems. I hypothesised that although the photopolymerisation reaction is 
complex and many components influence its kinetics, the number of reactive 
functional groups on a monomer may determine the cytotoxicity of the photoinitiator 
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at certain concentrations – that is the more molecules of photoinitiator versus the 
number of functional group molecules would be influential in determining 
cytotoxicity, as opposed to simply the overall concentration of the photoinitiator. 
This theory was assessed using two different photoinitiator concentrations as well as 
two different UV dosages at each concentration. It was found that a higher ratio of 
functional groups to photoinitiator molecules indeed did afford some protective 
effects on the cells, especially at higher concentrations of photoinitiator. The effects 
of UV dosage were less clear although a higher level of UV may have shown a more 
pronounced cytotoxicity and hence a greater cytoprotective effect at higher ratios. 
Two UV dosages were then used on a chondrogenic culture with one hydrogel 
system, to assess the effects of UV on the differentiative capacity of chondrocytes. In 
this case there did not appear to be a significant effect, however again a higher level 
of UV with increased cytotoxicity may have influenced the cells to a greater extent. 
Overall, this study revealed an important criterion on which the dosages of 
photoinitiator and UV may be determined in future hydrogel TE studies. 
Lastly, I focused on the viscoelastic properties of hydrogel systems for TE, 
largely in terms of their tailorability (Chapter 5). As cartilage is a highly viscoelastic 
material and hydrogels are frequently used with varied results in terms of 
chondrogenesis [9, 10, 32, 77, 84, 87, 108, 124, 128, 173, 180, 235-237], we focused 
the testing of hydrogel viscoelasticity against that of native cartilage. Hydrogels 
comprising physical, covalent or physical and covalent crosslinked blends were 
formed and characterised using proton nuclear magnetic resonance to determine 
degree of functionalisation. Elastic, equilibrium, storage and loss moduli, and loss 
tangent were determined for hydrogel blends and human donor tissue explants. 
Testing revealed the tailorability of viscoelasticity depending on the proportion of 
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physical and chemical crosslinks. Similarities in the proportion of viscous to elastic 
response were found between native tissue and hydrogels of certain blends, with 
physical crosslinks proving most viscoelastic, and a blend giving the best elastic 
response in combination with viscoelasticity. Covalent-only gels showed a very 
limited viscous response, primarily showing elastic behaviour. Hydrogels did not 
reach the elastic or equilibrium values of the donor tissues, however this was not 
expected. The study showed that it is possible tailor viscoelastic characteristics of 
biomaterials, and in principle may reach values comparable to that of native cartilage 
tissue.  
6.2 CLINICAL USE OF BIOMATERIAL POLYMERS FOR CARTILAGE 
As previously detailed in the literature review section of this thesis (Chapter 
1.3.4), there are numerous approaches used clinically for the treatment of cartilage 
defects and for the regeneration of cartilage along with, in some cases, the underlying 
bone. The work presented in this thesis does not focus on clinical-level applications, 
but does describe several materials that could be useful for future clinical use. It is 
important to keep in mind the regulatory issues surrounding approval of such 
materials. Thus, further details herein will address USA Food and Drugs 
Administration (FDA), Australian Therapeutic Goods Administration (TGA) and 
European Conformité Européenne (CE) approvals of materials used within this thesis 
and within cartilage or osteochondral tissue engineering.  
In an attempt to ease regulatory processing time and allow for cross-market 
sale of products, a number of efforts have been made between the three major 
regulatory bodies, however issues remain regarding ease of access to new or 
previously approved medical devices globally. Notably, there is a Mutual 
Recognition Agreement between Australia and the European Union (EU), the EC 
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MRA, which allows for Australian medical device sponsors to import European 
products and accepts CE Marking certificates as evidence of conformity to TGA 
standards. The agreement was begun in 1998 and has since provided a much easier 
method for providing patients with CE-approved medical devices [238]. 
On the other hand, the TGA and the FDA do not share such an approval 
certification and separate approvals are required for use of FDA-approved devices in 
Australia; in certain cases exceptions are made through the TGA Special Access 
Scheme (SAS) which allows for the use of a TGA-unapproved device where 
alternatives are not available [239]. Also, whilst the FDA affords accelerated product 
development programs such as ‘Breakthrough’, Australia has no formal expedited 
process, with a typical 14-15 month duration required for approval [240]. Whilst 
assessing clinical viability of osteochondral or cartilage products, it is important to 
maintain awareness of the difficulties associated with global access to devices 
because of limitations in medical device approval systems.  
Safety issues surrounding the use of gelatine within a medical context 
primarily concern transmissible spongiform encephalopathy (TSE), more specifically 
bovine spongiform encephalopathy (BSE), commonly known as ‘Mad Cow disease’ 
[241]. These concerns are shared by both the TGA and the FDA, with the TGA 
specifically producing legislation referring to all diseases transmittable by prions 
such as BSE, Scrapie in sheep and goats, Chronic Wasting Disease in deer and Kuru, 
Creutzfeldt-Jakob Disease and variant in humans [242]. Despite the potential issues 
with gelatine manufacture and contamination, it has been generally regarded as 
having ‘low risk’ of containing such contaminants [243], and pharmaceutical grade 
materials are produced in conformation with ISO 9001 and strict regulations from the 
FDA, the European Committee for Medicinal Products for Human Use (CHMP) and 
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the European Pharmacopoeia [244]. Whilst these data apply to gelatine itself, a 
separately processed gelatine-based material such as gelatine methacrylamide would 
require a standardised manufacturing procedure under approved conditions along 
with a separate approval process in order to be applicable within a medical context. 
Alternatives may be explored, including gelatine in combination with enzymatic 
crosslinkers such as transglutaminase, which is detailed in section 6.3 below. 
As previously mentioned, gellan gum is FDA-approved for use in food 
products, as well as being certified as a food additive in the EU with E number 418 
[245]. The US Agricultural Marketing Service has presented a detailed account of 
uses and applications of gellan gum worldwide [246], wherein across the reviewed 
sources there are no indications of any toxic effects of the substance – even when 
consumed in a human clinical trial at 175 mg·kg-1·day-1 for 7 days and 200  
mg·kg-1·day-1 for a subsequent 16 days [247]. Despite its wide use within the food 
industry, gellan gum does not bear any regulatory information with regards to its use 
in medical applications. Although the substance is easy to digest and has been shown 
through numerous studies to be biocompatible and highly suited to use as a 
biomaterial hydrogel – there is no regulatory approval which explicitly states its 
applicability within medical devices and such approvals would need to be sought 
prior to institution of this material within clinical trials or subsequently as a 
component of medical devices. Also, as with gelatine, gellan gum in its 
methacrylated form would be subject to additional regulations in terms of 
manufacturing protocols and rigorous evaluations to ensure safety. 
Hyaluronic acid is currently in-use as a medical device, for example in the 
Hyasis® product offered by Novozymes [248]. Whilst the use of hyaluronic acid 
methacrylate in a medical context would require further regulatory approval, the 
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current approval of HA does form a precedent that may help when further approvals 
are being sought. 
Both sodium and calcium alginate have been approved by the FDA for use in 
food products under the adherence of specific guidelines [249, 250]. Commercial 
variants of alginate also exist within a biomaterial context, such as FMC 
Corporation’s NovaMatrix® alginate [251]. In this case, FMC state that they 
manufacture according to GMP guidelines, ICH Q7 and ISO standards 9001:2008 
and 13485:2003, adding that they have also submitted a Drug Master File to the 
FDA. If approved, this may mean that medical applications of alginate will be able to 
be more easily explored within a research context. 
Hydroxyapatite is currently used within a number of medical and therapeutic 
applications, including pharmaceutical aids such as mineral supplements used for 
treatment of calcium deficiency or phosphate deficiency [252], or as a ceramic 
coating for metal biomedical implants [253]. As HAP is a highly established 
biomaterial and supplement, achieving regulatory approval for its use within a 
medical device appears to be of less concern than with more novel materials. 
However, in any case, each new application of a material requires a separate 
assessment to ensure that undesirable effects (such as considerable migration of HAP 
from the target site to other tissue systems) do not occur. 
Thermoplastic polymers such as PCL, PLA, PGA and PLGA all have 
regulatory approval from either the FDA or CE across a number of medical devices. 
As such, it may be inferred that use of these types of naturally degrading polymers is 
advantageous from a regulatory standpoint as many precedents are present. 
Overall, the materials currently in use in cartilage and osteochondral tissue 
engineering research that have been reviewed herein are promising in terms of 
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approvability, with some cases having regulatory approval within specific devices or 
under specific guidelines. As all of the materials have been proven to be non-toxic, 
biodegradable and biocompatible it can be said that once breakthrough findings are 
made using any of these materials within the tissue engineering system, the 
progression through clinical trials and into the medical device industry may be 
simpler than for materials which have no previous approvals or records. However, 
despite the suitability of these materials for a medical context, the relatively slow 
regulatory process would still have to be fulfilled prior to full institution of such 
devices. Bringing medical products to the market will always remain difficult 
because of the large liabilities associated with poor regulatory decisions and these 
aspects must always be considered when developing devices for use in medical 
systems – simplicity and efficacy will always be the best solution. 
6.3 ALTERNATE CROSSLINKING MODALITIES 
Within the domain of hydrogel cartilage tissue engineering, there are a number 
of various crosslinking technologies available for use. Each system offers particular 
advantages and disadvantages, which leads to a more or less prevalent use in the 
field. Notable approaches include chemical crosslinking using for example the 
radical initiator system comprising ammonium persulphate (APS) and ..-
tetramethyl ethylenediamine (TEMED) [254], use of enzymes, such as in the 
enzymatic crosslinking of gelatine by transglutaminase [75, 255-257], or the more 
novel approach of using orthogonal chemical groups such as thiol-methacrylate or 
thiol-norbonene [258-260]. 
Crosslinking systems such as APS/TEMED have become less common in light 
of current photocrosslinking technologies. Type 1 radical photocrosslinking reactions 
afford greater ease to achieve higher material homogeneity, increased tailorability of 
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crosslinking time within cytocompatible limits, a greater ease of handling and much 
lower overall cytotoxicity when compared with such initiator systems [109]. 
However, the APS/TEMED reaction does allow the use of opaque materials, which 
present problems for ultraviolet-irradiated system. Throughout the development of 
the hydrogel systems used in this thesis, I explored the suitability of using an 
APS/TEMED reaction for crosslinking GelMA with HAP mixed in-solution. With 
the UV system, I found that with an only the top half of the hydrogel thickness (~1 
mm) would crosslink as it was opaque, and even this section was crosslinked poorly 
compared with a completely transparent gel processed under the same conditions. I 
assessed APS/TEMED as an alternative crosslinking system because of this 
limitation, using concentrations of APS/TEMED that would allow for moduli 
comparable with standard photoinitiator/UV concentrations. Preliminary data of 
these comparisons, assessed through elastic modulus measurement of 10 % GelMA 
with two IC concentrations and a number of APS/TEMED molar concentrations, are 
presented in Figure 6.1. 
 
Figure 6.1: Elastic modulus of 10 % GelMA crosslinked using various 
concentrations of Irgacure 2959 and APS-TEMED. 
Elastic modulus of 10 % GelMA gels crosslinked with 1500 mJ·cm-2 UV and 0.025 
% and 0.05 % IC, or alternately with various molar concentration of the chemical 
initiator system APS/TEMED. Statistically similar groups share letters, n = 5 per 
group. 
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It was found that using APS/TEMED even at a concentration of 20 mM did not 
afford the same modulus as 0.05 % IC, and the increase in modulus versus initiator 
concentration was much less than with the photocrosslinkable system. As 20 mM of 
APS/TEMED is equivalent to 0.46 % w/v and it has been previously shown to be 
highly cytotoxic at even 0.2 % w/v [109], I decided to not pursue this system further. 
Regardless of these drawbacks, systems such as APS/TEMED do afford flexibility in 
terms of crosslinking in situations where light penetration is limited. In terms of the 
opaque GelMA-HAP block, it is possible to potentially utilise this in the formation of 
a layered hydrogel, wherein a thin (< 1 mm) layer of GelMA-HAP is precisely 
deposited within the mould, and a pure GelMA (or alternate hydrogel, depending on 
the model) solution is deposited on top. This should allow for the crosslinking 
through the transparent GelMA layer and into the GelMA-HAP, forming an 
integrated, layered hydrogel. 
The use of transglutaminase and gelatine within tissue engineering has been 
explored in a number of studies over the last decade [255, 256, 261-263]. 
Transglutaminase crosslinking affords similar advantages over photocrosslinkable 
systems as APS/TEMED crosslinking, however at much lower cytotoxicity. A 
nominal disadvantage of the system is that it is an enzymatic crosslinking that binds 
the -amino group of a lysine residue to a -carboxamide group of a glutamine 
residue and hence is only applicable within protein hydrogel systems such as 
gelatine, or synthetic polymer hydrogels with specific amino acid sequences 
incorporated. As such, whilst transglutaminase offers a number of benefits over 
alternate crosslinking strategies, it limits the use of materials significantly. Further, 
there may be issues of continued crosslinking as there is no mechanism to initiate nor 
terminate the reaction apart from the combination of the enzyme with the target sites. 
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Also the reaction is general slower than that of UV-activated radical polymerisations. 
In terms of cartilage tissue engineering, these limitations may be of such significance 
that viable solutions may be unable to be produced based solely on this approach. 
In general, covalently bound hydrogels can be formed through one of two 
major reactions: radical-mediated polymerisation or bio-orthogonal click reactions. 
The aforementioned systems all rely on radical polymerisation, wherein radical 
species propagate across vinyl groups present on precursor polymers. As this process 
is essentially a chain-reaction, the resulting macromer units are largely 
heterogeneous and of high molecular weights. Major advantages of using such 
crosslinking reactions are outlined above, and generally include the ability to use 
photocrosslinking and as such limit cytotoxicity, tailor mechanical properties and 
maintain control of the start and termination of the chemical reaction. In order to take 
advantage of the benefits offered by photocrosslinking and yet mitigate the issues of 
heterogeneous chain lengths and the formation of reactive oxygen species (ROS), 
Anseth et al. [264] developed a novel system consisting of radical-mediated step-
growth polymerisation based on the orthogonal reaction between thiol and 
norbornene [258, 260].  
This reaction system is unique as it includes advantages from both bio-
orthogonal click reactions and radical polymerisation. Whilst largely the approaches 
still use UV light and a photoinitiator, there is a great reduction in the potential 
damaging effects of reactive oxygen species within the systems. Within a standard 
crosslinking system, radicals rapidly interact with oxygen and form ROS, which are 
incapable of initiating the crosslinking reaction and instead accumulate within the 
polymer [258]. This results in a lag whilst oxygen is being consumed and light-
activated photoinitiator molecules are not yet crosslinking hydrogel components. 
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Within this novel system however, unlike in standard acrylate or methacrylate 
crosslinkable systems, the reaction proceeds through the interactions of thiols with 
either acrylate, methacrylate or norbornene. In this case radicals react with thiol 
groups, which abstract a hydrogen and are transformed into thiyl radicals that are 
then able to also react with a receptive species such as an acrylate, methacrylate or 
norbornene group. Within this system, already-formed ROS are also capable of 
abstracting hydrogens, which deactivates the reactive species and reduces their 
impediment of the crosslinking as well as any detrimental effects on cells. 
Furthermore, the thiol-norbornene system may be used with visible light, with 
such reactions using a type II (non-cleavage type) photoinitiator, such as eosin-Y or 
rose bengal [258]. Whilst the reaction is less efficient than the UV-mediated reaction, 
it may be suited to applications where UV exposure is undesirable [258]. There is a 
multitude of crosslinking technologies currently available within tissue engineering 
and the development and optimisation of such technologies is very important to the 
progression of the field and to the achievement of biomimetic chondroinductive 
constructs. 
In addition to the aforementioned alternatives, the use of natural protein 
hydrogels such as collagen type I has been extensively explored in the past [265]. 
Parameters influencing collagen I hydrogel gelation include collagen source [266, 
267], concentration [268, 269], solubilisation method [270], polymerisation 
temperature [271], ionic strength [271] and polymerisation pH [271]. Whilst the 
influence of fabrication method, polymerisation, mechanics, structure and transport 
have been reasonably assessed [265], numerous limitations within the field remain, 
such as a lack of hydrogel characterisation in terms of deformation modality, fibre 
structure, and certain contradictions across the literature [265].  
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6.4 FUTURE WORK 
There is a great deal of innovation and further research that may be derived 
from the work of this thesis. This may be approached in terms of a) scaffold 
innovations in terms of specific designs and b) the further characterisation of 
methods for scaffold assessment. 
Specifically, the study presented in Chapter 2 may be expanded into the 
further development of scaffold architectures, such as the optimisation of pore size 
versus porosity for maximum proliferative and differentiative outputs of 
thermoplastic polymer scaffolds. This would consist of assessing similar pore sizes at 
different porosities or alternately similar porosities at different pore sizes. Use of a 
perfusion bioreactor system may also be instituted in this case, as the influence of 
fluid flow is an important metric to consider and further results may be achieved 
through the use of such stimulation during culture. A more technical study may be 
performed assessing the influence of various levels and types of shear stress on cell 
response, expanding work that is present in literature [154, 157-159]. This work 
would ideally be performed on human donor osteoblasts for clinical relevance. 
Establishment of a desired shear stress level may then be translated to scaffold 
architecture design, attempting to achieve this shear stress on the cells when within a 
physiological fluid-flow setting. After establishment of these two preliminary studies 
in vitro, work may be progressed to a large animal model (such as a tibial ovine 
model [71]), where the concept is further verified. Whilst the materials and 
associated mechanical properties of bone scaffolds are not yet completely 
characterised such that a successful implant may replace current clinical strategies, 
such work would provide novel and highly relevant data on further scaffold 
development. 
 170 Chapter 6: Summary and Discussion 
Regarding hydroxyapatite scaffold work demonstrated in Chapter 3, the use of 
such a hybrid hydrogel system affords a high level of material tailorability. Future 
developments may include culture within a compression bioreactor (or a perfusion 
bioreactor given the appropriate modifications), wherein mechanical stimulation will 
aid in the transport of hydroxyapatite throughout the matrix of the gel, as well as 
providing mechanical stimulation to the cells. This would again require extensive 
characterisation however, as it is sometimes difficult to determine what bioreactor 
loading regime would produce an optimal result. Further, the use of such a hybrid 
construct may be combined with a bone TE scaffold, with the aim of developing a 
truly gradated transition throughout the depth of the construct. This structure may 
allow better integration in situ as well as providing a scaffold that bridges the full 
depth of an osteochondral defect. Work may also involve the development of bone 
scaffolds for the subchondral bone, focusing on the unique transition between the 
bone and the zone of calcified cartilage. In the context of this chapter, further 
development of osteochondral scaffolds should involve the subdivision of the large 
overall goal into individual tissue components that may incrementally advance 
knowledge in each area, leading to a clinically relevant solution. Testing of the 
efficacy of various 3D plotting machines will of course be an integral part of this 
approach if it is to be translated to the clinic. 
In the case of Chapter 4, the potential for achieving protective effects on cells 
by functional reactive groups in hydrogels should be further explored, with higher 
levels of cytotoxicity assessed and alternate hydrogel systems included. This should 
also involve further confirmation of the demonstrated phenomenon through 
assessment of the effect in GelMA and GGMA featuring a number of DOF groups. 
The influences of UV on chondrocyte differentiation should also be further tested at 
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higher levels of UV exposure and with other hydrogel systems, to test whether 
effects are indeed present at more cytotoxic doses and also to assess the influence of 
hydrogel substrate on these effects. Furthermore, the cytotoxic effects associated 
with this crosslinking process may be examined in more detail to determine whether 
they are due to radical interactions, photoinitiator by-products, or any other 
mechanism associated with the crosslinking process. 
Lastly, in terms of characterisation methods (Chapter 5), the assessment of 
compressive viscoelasticity is rarely-explored as a deterministic criterion of hydrogel 
suitability in TE. It is as of yet undetermined whether this property has any influence 
on chondrocyte response. If response does exist, it is also unknown whether it stems 
from the mechanotransduction directly affecting the cells, fluid flow in the matrix, a 
combination of these factors, or completely unrelated to any of them. Finite element 
modelling (FEM) offers a way in which to assess microscopic-level material 
response in such systems, accounting for complex material properties. The modelling 
of a viscoelastic hydrogel containing a model chondrocyte and comparison of this 
with current FEM on cartilage with chondrocytes [272] would provide further useful 
data on which hydrogel innovations may continue. A great deal of work is still 
possible in this area, with compressive bioreactor cultures and finite element 
modelling providing the most relevant means in which these effects may be exposed 
and assessed. Additionally, this work may be expanded by assessing the effects of 
hydrogen abstraction on the crosslinking process. As GelMA is a methacrylamide 
and GGMA is a methacrylate, the crosslinking mechanics may vary and hence 
produce hydrogels with varied properties. This approach may involve strategies such 
as assessing UV-mediated photocrosslinking of un-functionalised gels to test any 
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effects, or attempting to isolate the different effects of the functional gel groups by 
quantifying them directly, or modulating their ratio in the hydrogels. 
In a more general sense, numerous short-term innovations may be performed 
with relative ease within this field. For example, improvements in compression 
bioreactor design would greatly benefit many research groups and could be achieved 
within an acceptable time frame assuming relevant funding was present. Once 
comprehensive characterisation and development has been done in vitro, 
experimentation with animal models may then also be suitable for certain scaffold 
systems. It is my belief that a greater understanding of the causal factors of joint 
disease and their treatment methods should be reached prior to a large drive towards 
in vivo work with scaffold technologies. This would enable a faster transition through 
animal trials and to the clinic, minimising ethical issues and poor outcomes in vivo. 
The main issues to be solved in order to form a viable osteochondral regeneration 
platform thus include an understanding of desirable: mechanical properties, chemical 
constituents and biodegradability times of cartilage constructs; porosity, mechanical 
properties, surrounding tissue integration and biodegradability of bone constructs. 
Only once an understanding of the requirements for these criteria is formed and 
innovation within each component is performed will more viable osteochondral 
solutions emerge. 
6.5 CONCLUSION 
This thesis explored investigation into specific scaffold designs for bone and 
osteochondral tissue engineering, as well as the formation of complex criteria on 
which cartilage hydrogel scaffolds may be assessed. I found that fluid flow within 
bone tissue scaffolds provides a criterion on which efficacy may be assessed, and 
desired flow patterns may be promoted. Further, the combination of hydrogels and 
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ceramics may be done successfully, producing chondrogenic outcomes with high cell 
viability – development of these materials must be further explored to accommodate 
the complexity of the osteochondral region. I established a set of criteria on which 
the concentration of photoinitiators in photocrosslinkable hydrogel systems may be 
optimised to maximise mechanical properties (elastic modulus) and cell viability. I 
also assessed viscoelasticity of hydrogel blends using oscillatory motion and found 
that they are tailorable by varying ratios of physical and chemical crosslinks.  
Overall, treatment of joint diseases such as osteoarthritis is difficult and 
requires extensive developments in tissue engineering for adequate solutions to 
emerge. Continued innovation in projects such as this one may be beneficial to 
understanding the requirements of the joint environment in an OA-context. This may 
then lead to constructs that perform desirably from both mechanical and biological 
standpoints, resulting in complete, tissue-engineered osteochondral solutions. 
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Appendix 1 
Chapter 2: Melt Extrusion Matlab Code 
Matlab was used to formulate scaffold printing g-codes. The geometry of a 
circle was used, with specific locations along the circumference referred to by their 
Cartesian location using mathematical statements. Rotational matrices were 
employed to rotate each layer by an incremental number of degrees (as specified by 
the user), whilst ‘if’ statements were used to determine the behaviour of the code at 
the start and terminal sections of the circle. Finally the entire layer section was 
included in a ‘for’ loop wherein the Z-direction was incrementally increased for the 
scaffold printing. The following is the entire g-code generating Matlab code, with the 
input parameters set to produce a 90 ° 0 OS laydown scaffold. The code also includes 
sections for repeating layers, adding an interface of a different diameter or height, 
pausing at certain locations and the ability to mirror or flip certain layers. None of 
these parameters were used in the final work presented in Chapter 2 however they 
remain features of the code. 
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%{
% Geometry %
RO = handles.RO;         % Outer radius
RI = handles.RI;         % Inner radius
FD = handles.FD;         % Filament distance
T = handles.T;           % Layer thickness (spacing)
H = handles.H;           % Overall height
XX = handles.XX;         % Starting coordinate (x-axis)
YY = handles.YY;         % Starting coordinate (y-axis)
dth = handles.dth;       % Angle between layers
FR = handles.FR;         % Stage velocity (mm/min)
P = handles.P;           % Pause time at semi-circular interface 
(seconds)






RO = 6; % Outer radius
RI = 0; % Inner radius
FD = 2; % Filament distance
T = 0.248; % Layer thickness (spacing)
H = 10; % Overall height
XX = 20; % Starting coordinate (x-axis)
XX_2 = XX - 80;
YY = 30; % Starting coordinate (y-axis)
dth = 90; % Angle between layers
FR1 = 250; % Stage velocity (mm/min)
FR2 = 180;
P = 0; % Pause time (seconds)




TL = 0; % Trace each layer back again
I = 0; % Increase of filament distance
OS = 0; % Offset each subsequent layer in the cycle by this 
fraction of the filament distance
CIR = 5; % Circles CIR * outer radius when transitioning 
layers
%%%% Interface - Decreased Diameter %%%%
H2 = 0; % Height of plug segment
DS = 2; % Amount of decrease in radius
FD2 = 1; % Filament distance of plug segment
%%%% Output File Name %%%%
output = sprintf('%s-Cylinder-RO%.2f-RI%.2f-FD%.2f-T%.2f-dth%d-FR1-
%d-FR2-%d-H1-%.2f-MR-%.2f-OS%.2f.nc', datestr(now, 'yy-mm-dd-
HHMMSS'), RO, RI, FD, T, dth, FR1, FR2, H, MR1, OS);
%%%% Process Code %%%%
FO = fopen(output, 'w');
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th = -dth;
fprintf(FO, 'G17 G21 G40 G49 G54 G80 G90 G94 F%d\n', FR1);
fprintf(FO, '(Start of part)\n');
% 'count' increments by 1 for every layer that is within a given dth 
path
count = 0;
% 'cycle' indicates the stage of offset (OS) increment - it 
increases by 1
% every time the REP (amount of different layers over 180°) is fully





% If the tiled layers are used, then the CODED thickness (LT) must 
be set
% to twice the ACTUAL/SPECIFIED thickness (T)
if TL == 1;
    LT = 2*T;
elseif TL == 0;
    LT = T;
end
% The inverse of the offset (OS) fraction; this shows the amount of 
repeats
% that are needed to reach a loop (loop meaning a state where the 
offset
% distance actually is the same as the original design)
OSN = 1/OS;
% When mirroring isn't used, the layers are actually repeated over 
180°
% rather than 360°, although the layers in the second half of the 
360°
% cycle are approached from the opposite side of the scaffold
REP = 180/dth;
% This entire section of code is repeated twice within this 'if' 
statement,
% with the only difference being the absence/presence of the 'G04 P'
% elements - this is necessary as even if the CNC controller is 
given a
% P0.00 command, it will pause for 0.2 seconds
if P == 0;
% This for loop increments the Z of the scaffold, starting at a 
thickness
% of T, it increments by LT (either = T or = 2*T depending on if the 
layers
% are tiled (doubled)), until it reaches a height of H
for Z = T:LT:H
% This line confirms the state of the tiled layers (TL) being either 
on (= 1)
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% or off (= 0), as well as verifying that the count is larger than 0 
(which
% it isn't on the first layer!). This way the program knows to keep 
the
% first layer at a LT of T, whilst the subsequent layers will be at 
a LT of
% 2*T when doubling
if TL == 1 && count > 0;
            LT = 2*T;
else
            LT = T;
end
% This increments the theta by the specified angle (dth), and 
transforms
% the degrees into radians (as Matlab uses radians)
        th = th+dth;
        theta = th*(pi/180);
        fprintf(FO, 'G04 P0.40\n');
        fprintf(FO, 'G01 Z%.4f\n', -15+Z);
% This 'if' statement verifies the number of the count; if it is 
under the
% highest (360/dth), then it is incremented, otherwise it is reset. 
The
% second 'if' statement then uses the first layer in the count (= 1) 
or the
% first layer after the repetition (= REP + 1) to increment the 
cycle
% count. The cycle count also must be less than the OSN value (as 
this will
% mean that the original filament position has been reached using 
offset,
% and the cycle can repeat) - the cycle value is not reset within 
this
% statement, it is reset after the layer is completed
if count < (360/dth);
            count = count + 1;
else
            count = 1;
end
if (count == 1 || count == (REP + 1)) && cycle < OSN-1;
            cycle = cycle + 1;
else
end
% This statement checks the count - if it is larger than REP (and 
mirroring
% is not used), then the layer will be initiated from the other side 
-
% hence the offset needs to go backwards and cycle must be negative 
in
% order for this to make structural sense
if count <= REP;
            cycle = -cycle;
else
end
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if rem(count,MR1) == 0 || rem(count,MR2) == 0 || rem(count,MR3) 
== 0 || rem(count,MR4) == 0;
        FDI = FDI + I;
else
end
% This statement checks if the script is on the first layer of the
% scaffold, if yes then it draws the direct toolpath (or a little 
square
% around the start which avoids tangling a bit better), or it goes 
to the
% normal layer-incremented section
if Z==T;
if XX>0;
                fprintf(FO, 'G01 X%.4f Y%.4f\n', (-RO)+XX, YY);
else
                fprintf(FO, 'G01 X%.4f Y%.4f\n', XX+20, YY-(2*RO));
                fprintf(FO, 'G01 X%.4f Y%.4f\n', XX-(2*RO), YY-
(2*RO));
                fprintf(FO, 'G01 X%.4f Y%.4f\n', XX-(2*RO), YY);
                fprintf(FO, 'G01 X%.4f Y%.4f\n', (-RO)+XX, YY);
end
else
% New looping - different size circle, dip a layer down 
with a
% pause (trying to get better adhesion - not using this 
at the
% moment)
%fprintf(FO, 'F200\nG02 X%.4f Y%.4f R%.4f\n', (((-
RO)*cos(theta))-(0*sin(theta))+XX), (((-
RO)*sin(theta))+(0*cos(theta))+YY), RO);
%fprintf(FO, 'G01 Z%.2f\n', -15+Z-T);
%fprintf(FO, 'G04 P%.2f\n', 0.2);
%fprintf(FO, 'G01 Z%.2f\n', -15+Z);
% Standard looping - circle size determined by the (-
#*RO)
% parts in the brackets - has to do either clockwise or
% counterclockwise turns depending on if there's doubled 
layers
% or not
if TL == 1;
                fprintf(FO, 'F%d\nG03 X%.4f Y%.4f R%.4f\n', FR2, 
(((-CIR*RO)*cos(theta))-(0*sin(theta))+XX), (((-
CIR*RO)*sin(theta))+(0*cos(theta))+YY), RO/2);
                fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n',
FR1, P, (((-RO)*cos(theta))-(0*sin(theta))+XX), (((-
RO)*sin(theta))+(0*cos(theta))+YY));
else
                fprintf(FO, 'F%d\nG02 X%.4f Y%.4f R%.4f\n', FR2, 
(((-CIR*RO)*cos(theta))-(0*sin(theta))+XX), (((-
CIR*RO)*sin(theta))+(0*cos(theta))+YY), RO/2);
                fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n',
FR1, P, (((-RO)*cos(theta))-(0*sin(theta))+XX), (((-
RO)*sin(theta))+(0*cos(theta))+YY));
end
% New 'dip' at the start of each layer
%fprintf(FO, 'G04 P%.2f\nG01 Z%.4f\n', -15+Z-T);
%fprintf(FO, 'G01 Z%.4f\n', -15+Z);
end
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% This is the main extrusion section the if statement verifies 
whether or
% not to use mirrored layers (using a remainder system: count / MR 
layer
% number gives a value (either a remainder or not), if not then it 
does the
% code as described, otherwise it check if TL = 1 (doubling) and 
does the
% two doubled layers, finally if neither the mirror nor the double 
criteria
% are met, it does the normal layer in the final step
% The actual toolpath is determined from the equation for a circle 
R^2 =
% X^2 + Y^2, which is then rearranged for X and Y. Finally, the 
rotation
% matrix R = [cos th -sin th, sin th, cos th] is used to produce a 
point
% relevant to the rotation (th). 
% So 
% x = original (non-rotated) x value
% y = original (non-rotated) y value
% x' = new x value = x*cos(th) - y*sin(th)
% y' = new y value = x*sin(th) + y*cos(th)
% This way, the co-ordinates of any point on the circle may be 
calculated
% using a specified RO (and hence the calculated X and Y depending 
on the
% FD and location along the path), and an angle th
if rem(count,MR1) == 0 || rem(count,MR2) == 0 || 
rem(count,MR3) == 0 || rem(count,MR4) == 0;
for X = (FD+FDI):2*(FD+FDI):2*RO



















elseif TL == 1;
for X = (FD+FDI):2*(FD+FDI):2*RO




                    fprintf(FO, 'F%d\nG01 X%.4f Y%.4f\n', FR1, ((((-
RO+X)*cos(theta))-(((((RO^2)-((-RO+X)^2))^0.5))*sin(theta)))+XX),
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(((((-RO+X)*sin(theta)))+((((((RO^2)-((-
RO+X)^2))^0.5))*cos(theta))))+YY));











            fprintf(FO, 'G04 P%.2f\nG01 Z%.4f\n', 0.4, -15+Z+T);
for X = (FD+FDI):2*(FD+FDI):2*RO




















for X = (FD+FDI):2*(FD+FDI):2*RO
if X == (FD+FDI) && cycle ~= 0 && cycle > 0 && OS > 
0;




















                    fprintf(FO, 'F%d\nG03 X%.4f Y%.4f R%.4f\n', FR2, 
(((((-RO+X+(FD+FDI)+(OS*FD*cycle))*cos(theta))-((-(((RO^2)-((-
RO+(FD+FDI)+X+(OS*FD*cycle))^2))^0.5))*sin(theta))))+XX), (((((-
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RO+X+(FD+FDI)+(OS*FD*cycle))*sin(theta))+((-(((RO^2)-((-
RO+(FD+FDI)+X+(OS*FD*cycle))^2))^0.5))*cos(theta))))+YY), RO);





elseif (2*RO)-X < 3*FD && cycle > 0;












































% To retain continuity in the cycle increment, it is reset back to 
its
% positive value here
if count <= REP;
            cycle = -cycle;
else
end
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% This is the place where the end of the cycle increment is verified 
- if
% the scaffold is on the last of the REP layers (i.e. count = 2REP) 
as well
% as the cycle being at the last needed cycle increment (OSN-1 as it 
starts
% at 0 and not 1), then the cycle number is reset to -1 (it is 
incremented
% by the counter at the start of the next layer back to 0)
if count == ((2*REP)) && cycle == OSN-1;




%   Interface
    th = -dth;
    fprintf(FO, '(Start of interface)\n');
    count = 0;
    fprintf(FO, 'F%d\nG01 X%.4f Y%.4f\n', 500, (XX_2), (YY-((2*RO)-
DS)));
    fprintf(FO, 'F%d\n', FR1);
for Z = T:T:H2
        th = th+dth;
        theta = th*(pi/180);
%   fprintf(FO, 'G04 P0.2\n');
        fprintf(FO, 'G01 Z%.4f\n', -15+H+Z);
        count = count + 1;
        D = DS;
        fprintf(FO, 'F%d\nG02 X%.4f Y%.4f R%.4f\n', FR2, (((-
CIR*(RO-D))*cos(theta))-(0*sin(theta))+XX_2), (((-CIR*(RO-
D))*sin(theta))+(0*cos(theta))+YY), (RO-D)/2);
        fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n', FR1, P, 
(((-(RO-D))*cos(theta))-(0*sin(theta))+XX_2), (((-(RO-
D))*sin(theta))+(0*cos(theta))+YY));
        fprintf(FO, 'G04 P%.2f\n', P);
%fprintf(FO, 'G01 Z%.4f\n', -15+H+Z-T);
%fprintf(FO, 'G01 Z%.4f\n', -15+H+Z);
if rem((count/MR1),1) == 0 || rem((count/MR2),1) == 0 || 
rem((count/MR3),1) == 0 || rem((count/MR4),1) == 0;
for X = FD2:2*FD2:2*(RO-D)









                    fprintf(FO, 'F%d\nG02 X%.4f Y%.4f R%.4f\n', FR2, 
((((-(RO-D)+X+FD2)*cos(theta))-(((((((RO-D)^2)-((-(RO-











for X = FD2:2*FD2:2*(RO-D)





















%    fprintf(FO, 'G02 X%.4f Y%.4f R%.4f\n', (XX_2), (YY+1), 1);
%    fprintf(FO, 'G02 X%.4f Y%.4f R%.4f\n', (XX_2), (YY-1), 1);
end
else
for Z = T:LT:H
if TL == 1 && count > 0;
            LT = 2*T;
else
            LT = T;
end
        th = th+dth;
        theta = th*(pi/180);
        fprintf(FO, 'G04 P0.20\n');
        fprintf(FO, 'G01 Z%.4f\n', -15+Z);
if count < (360/dth);
            count = count + 1;
else
            count = 1;
end
if (count == 1 || count == (REP + 1)) && cycle < OSN;
            cycle = cycle + 1;
else
            cycle = 1;
end
if rem(count,MR1) == 0 || rem(count,MR2) == 0 || rem(count,MR3) 
== 0 || rem(count,MR4) == 0;
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                fprintf(FO, 'G01 X%.4f Y%.4f\n', (-RO)+XX_2, YY);
else
                fprintf(FO, 'G01 X%.4f Y%.4f\n', 0, YY-(2*RO));
                fprintf(FO, 'G01 X%.4f Y%.4f\n', XX_2-(2*RO), YY-
(2*RO));
                fprintf(FO, 'G01 X%.4f Y%.4f\n', XX_2-(2*RO), YY);




%fprintf(FO, 'F200\nG02 X%.4f Y%.4f R%.4f\n', (((-
RO)*cos(theta))-(0*sin(theta))+XX_2), (((-
RO)*sin(theta))+(0*cos(theta))+YY), RO);
%fprintf(FO, 'G01 Z%.2f\n', -15+Z-T);
%fprintf(FO, 'G04 P%.2f\n', 0.2);
%fprintf(FO, 'G01 Z%.2f\n', -15+Z);
% Standard looping
if TL == 1;
                fprintf(FO, 'F%d\nG03 X%.4f Y%.4f R%.4f\n', FR2, 
(((-CIR*RO)*cos(theta))-(0*sin(theta))+XX_2), (((-
CIR*RO)*sin(theta))+(0*cos(theta))+YY), RO/2);
                fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n',
FR1, P, (((-RO)*cos(theta))-(0*sin(theta))+XX_2), (((-
RO)*sin(theta))+(0*cos(theta))+YY));
else
                fprintf(FO, 'F%d\nG02 X%.4f Y%.4f R%.4f\n', FR2, 
(((-CIR*RO)*cos(theta))-(0*sin(theta))+XX_2), (((-
CIR*RO)*sin(theta))+(0*cos(theta))+YY), RO/2);
                fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n',
FR1, P, (((-RO)*cos(theta))-(0*sin(theta))+XX_2), (((-
RO)*sin(theta))+(0*cos(theta))+YY));
end
% New 'dip' at the start
%fprintf(FO, 'G04 P%.2f\nG01 Z%.4f\n', -15+Z-T);
%fprintf(FO, 'G01 Z%.4f\n', -15+Z);
end
if rem(count,MR1) == 0 || rem(count,MR2) == 0 || 
rem(count,MR3) == 0 || rem(count,MR4) == 0;
for X = (FD+FDI):2*(FD+FDI):2*RO
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elseif TL == 1;
for X = (FD+FDI):2*(FD+FDI):2*RO




















            fprintf(FO, 'G04 P%.2f\nG01 Z%.4f\n', 0.3, -15+Z+T);
for X = (FD+FDI):2*(FD+FDI):2*RO





















for X = (FD+FDI):2*(FD+FDI):2*RO
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%   Interface
    th = -dth;
    fprintf(FO, '(Start of interface)\n');
    count = 0;
    fprintf(FO, 'F%d\nG01 X%.4f Y%.4f\n', 500, (XX_2), (YY-1));
    fprintf(FO, 'F%d\n', FR1);
    for Z = T:T:H2
        th = th+dth;
        theta = th*(pi/180);
    %   fprintf(FO, 'G04 P0.2\n');
        fprintf(FO, 'G01 Z%.4f\n', -15+H+Z);
        count = count + 1;
    %{
        D = DS;
        fprintf(FO, 'F%d\nG02 X%.4f Y%.4f R%.4f\n', FR2, (((-
CIR*(RO-D))*cos(theta))-(0*sin(theta))+XX_2), (((-CIR*(RO-
D))*sin(theta))+(0*cos(theta))+YY), (RO-D)/2);
        fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n', FR1, P, 
(((-(RO-D))*cos(theta))-(0*sin(theta))+XX_2), (((-(RO-
D))*sin(theta))+(0*cos(theta))+YY));
        fprintf(FO, 'G04 P%.2f\n', P);
        %fprintf(FO, 'G01 Z%.4f\n', -15+H+Z-T);
        %fprintf(FO, 'G01 Z%.4f\n', -15+H+Z);
        if rem((count/MR1),1) == 0 || rem((count/MR2),1) == 0 || 
rem((count/MR3),1) == 0 || rem((count/MR4),1) == 0;
            for X = FD2:2*FD2:2*(RO-D)














                    fprintf(FO, 'F%d\nG04 P%.2f\nG01 X%.4f Y%.4f\n', 
FR1, P, (((((-(RO-D)+X+FD2)*cos(theta))-((-((((RO-D)^2)-((-(RO-
D)+FD2+X)^2))^0.5))*sin(theta))))+XX_2), (((((-(RO-
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D)+X+FD2)*sin(theta))+((-((((RO-D)^2)-((-(RO-
D)+FD2+X)^2))^0.5))*cos(theta))))+YY));
            end
        else
            for X = FD2:2*FD2:2*(RO-D)



















            end
        end
    %}
        fprintf(FO, 'G02 X%.4f Y%.4f R%.4f\n', (XX_2), (YY+1), 1);
        fprintf(FO, 'G02 X%.4f Y%.4f R%.4f\n', (XX_2), (YY-1), 1);
    end
%}
end
%fprintf(FO, '(End of part)\nG01 Z0.0000\nM05\nM02\n');
%fprintf(FO, '(End of part)\nG01 X0.0000 Y0.0000\nM05\nM02\n');
fprintf(FO, '(End of part)\nG01 Z0.0000\n');




 206 Appendices 
Appendix 2 
Chapter 2: Computational Fluid Dynamics Detailed Methods 
For computational fluid dynamics (CFD) analysis, ANSYS Fluent was used in 
combination with models created in SolidWorks. SolidWorks models of scaffolds 
were made initially as illustrated in Figure 2.2, however the sharp corners at the 
circumference of the scaffold caused errors with ANSYS meshing. Models were then 
modified such that rounded corners were used. In all cases, the scaffold volume was 
subtracted from the volume of a section of the bioreactor chamber, which left a fluid 
volume that was usable for Fluent CFD analysis, as illustrated in Figure A2.1. 
Figure A2.1: All scaffold variants shown as SolidWorks models of fluid volume. 
Scaffolds shown as fluid volumes with the scaffold architecture hollowed out of the 
solid “water” block. These were used as the water volume for the ANSYS Fluent 
model used in CFD analysis for wall shear stress. (A): scaffold type A; (B): scaffold 
type B; (C): scaffold type C; (D): scaffold type D. 
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These models were then incorporated into the CFD system, which was set up to 
have an inlet at the top side of each design, outlet at the bottom, a wall boundary 
condition at the circumference of the cylinder and a flow rate of 1 mL·h-1. This was 
translated into a flow velocity as shown in Table A2.1. 
Table A2.1. Velocity of flow calculations for ANSYS Fluent model. 
Flow Rate Q = A·v m3·s-1 
 Q = 1 mL·h-1 
 Q = 0.01667 mL·s-1 
Divided by 4 chambers Q = 0.004167 mL·s-1 per chamber 
 Q = 4.167E-09 m3·s-1 
Cross-sectional Area A = ·r2 m2 
 A = ( * (62) ) * 10-6 m2 
 A = 1.13E-04 m2 
Velocity of flow v = Q·A-1 m·s-1 
 v = 4.167E-09 / 1.13E-04 m·s-1 
 v = 3.68E-05 m·s-1 
 
The output of the fluid model was thresholded using various constraints, as 
shown in the main body of Chapter 2 – Figure A2.2 below shows plots of the four 
scaffold designs with vector maxima limited to maximum shear stress values. 
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Figure A2.2: All scaffold variants shown with vector plots of wall shear stress. 
Scaffold fluid volumes in ANSYS Fluent illustrating vector plots of wall shear stress 
(Pa). Images are thresholded for each design instead of using a global min-max limit 
to give an alternate illustration of the shear stress distribution. (A): scaffold type A, 
threshold of 0.05 – 0.8 Pa; (B): scaffold type B, threshold of 0.05 – 1.2 Pa; (C): 
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Appendix 3 
Chapter 4: Quantification of Reactive Functional Groups 
The quantification of reactive functional groups was performed using the 
aforementioned data for gelatine amino acid composition, along with molecular 
weight (MW) data for methacrylic anhydride and a repeating unit of gellan gum. 
Degree of functionalisation values were determined as described in Chapter 4 for 
the hydrogels, with the quoted percentages used in the following calculation. For the 
number of reactive functional groups, a model system was initially formed. This 
model system comprised a 10 % GelMA or 1 % GG hydrogel, in 1000 μL of 
solution.  
For GelMA, the mean percentage concentration of the amino acid lysine was 
determined from the aforementioned literature [177]. In a 10 %, 1000 μL hydrogel 
there would be 100 mg of GelMA, and hence 4.11 mg of lysine. This corresponded 
to 2.811·10-5 M lysine, which when multiplied by the percentage of functionalised 
lysine, gave 2.642·10-5 M for GelMA-H, and 6.562·10-6 M for GelMA-L. Multiplying 
by Avogadro’s number then gave a total number of functional groups as 1.591·1019 
for GelMA-H and 3.952·1018 for GelMA-L. 
For GGMA, the molecular weight of one repeating unit was manually 
calculated using atomic weights and determined to be 728.74 Da assuming full 
hydrogen saturation. In a 1 %, 1000 μL hydrogel (10 mg GG), this proved to be 
1.372·10-5 M, or 8.264·1018 repeating units. As in each repeating unit there are 10 
modifiable hydroxyl groups, the molarity was multiplied by 10, then multiplied by 
the degree of functionalisation, giving 7.821·10-6 M of functionalised OH groups. 
Multiplying this result by Avogadro’s number gave the final number of 4.710·1018 
functional groups. 
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Number of molecules of Irgacure 2959 were calculated using the molecular 
weight of the molecule, and assuming concentrations of 0.05 % in 1000 μL. This 
gave a total of 2.229·10-6 M of IC, or 1.342·1018 actual molecules. 
Calculating IC/RG for the three different gels, GelMA-L, GelMA-H and 
GGMA for 0.05 % IC at the given concentrations above gave GelMA-H: 0.084; 
GelMA-L: 0.340; and GGMA: 0.285, which when normalised to GelMA-H, gave the 
ratios presented in Chapter 4 of GelMA-H: 1; GelMA-L: 4.026; GGMA: 3.377. 
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Appendix 4 
Chapter 5: Mechanical Testing Detailed Methods and Analysis 
The mechanical testing presented in Chapter 5 required a considerable amount 
of procedural and analytical optimisation in order to produce simple, coherent and 
accurate outputs. This appendix details the methods used in the development of the 
systems used in Chapter 5. 
Firstly, the Instron MicroTester had to be tested without any samples in order 
to assess the inertial forces that were present with the gel plunger and load cell 
attachments. This was done by using a full frequency sweep from 0.01 – 10.24 Hz 
with dummy constructs of 1.50, 1.75, 2.00 and 2.25 mm height. Dummy constructs 
here refer to the fact that the strain amplitude of the sinusoidal displacement was 
varied to correspond to normal samples of the heights listed above. This allowed for 
the development of a displacement function based on plunger extension, which was 
used to correct sample displacement in subsequent testing. This correction was 
required because the Instron does not reach the set displacements at higher 
frequencies, and either under- or over-shoots the required values. The correction 
factors were entered into an excel spreadsheet which was used for calculating the 
specific strain range number of each individual sample after initial height 
measurement. 
A blank amplitude test was then run at 1.28 – 2.56 Hz and 5.12 – 10.24 Hz, 
which consisted of the same frequencies tested at a number of amplitudes 
(amplitudes as above). Hydrogel and explant samples were tested using the corrected 
extension values and all raw data for the force correction blank samples and the 
experimental samples was collected. An Excel macro was written and used to move 
each frequency into a separate sheet, then label the sheets from 1 to 12. For the blank 
explants, the “New_Blank_Sweep” macro was used, for normal gels the 
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“Gel_Sorter” macro was used and in the case of explants the 
“Explant_Sorter_Sweep” macro was used. The macros are presented below. 
Sub New_Blank_Sweep() 
'
' New_Blank_Sweep Macro 
' Gel Sorting Macro 
'
' Keyboard Shortcut: Ctrl+Shift+U 
'
    ActiveSheet.Name = "Home" 
    Range("B2:G2").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.AutoFilter 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=4, 
Criteria1:=Array( _ 
        "2", "3", "4", "5", "6", "7", "8", "9", "10", "11", "12", 
"13", "14", "15", "16", "17", "18", "19", "20", "21"), 
Operator:=xlFilterValues
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="2"
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet1").Select 
    Sheets("Sheet1").Name = "1" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet2").Select 
    Sheets("Sheet2").Name = "2" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet3").Select 
    Sheets("Sheet3").Name = "3" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet4").Select 
    Sheets("Sheet4").Name = "4" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet5").Select 
    Sheets("Sheet5").Name = "5" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet6").Select 
    Sheets("Sheet6").Name = "6" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet7").Name = "7" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet8").Select 
    Sheets("Sheet8").Name = "8" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet9").Select 
    Sheets("Sheet9").Name = "9" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet10").Select 
    Sheets("Sheet10").Name = "10" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet11").Select 
    Sheets("Sheet11").Name = "11" 
    Sheets("Home").Select 
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.Copy 
    Sheets("1").Select 
    ActiveSheet.Paste 
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    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="3"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("2").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="4"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("3").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="5"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("4").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="6"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("5").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="7"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("6").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="8"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("7").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="9"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
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    Sheets("8").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="10"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("9").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="11"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("10").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    ActiveSheet.Range("$B$2:$G$593792").AutoFilter Field:=3, 
Criteria1:="12"
    Range("F3:G3").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("11").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Application.DisplayAlerts = False 
    Sheets("Home").Delete 
    Application.DisplayAlerts = True 
End Sub 
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Sub Gel_Sorter() 
'
' Gel_Sorter Macro 
' Gel Sorting Macro 
'
' Keyboard Shortcut: Ctrl+Shift+U 
'
    ActiveSheet.Name = "Home" 
    Range("B2:G2").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.AutoFilter 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=4, 
Criteria1:=Array( _ 
        "10", "100", "101", "102", "103", "104", "105", "106", 
"107", "108", "109", "11", "110", _ 
        "111", "112", "113", "114", "115", "116", "117", "118", 
"119", "12", "120", "121", "122", _ 
        "123", "124", "125", "126", "127", "128", "129", "13", 
"130", "131", "132", "133", "134", _ 
        "135", "136", "137", "138", "139", "14", "140", "141", 
"142", "143", "144", "145", "146", _ 
        "147", "148", "149", "15", "150", "151", "152", "153", 
"154", "155", "156", "157", "158", _ 
        "159", "16", "160", "161", "162", "163", "164", "165", 
"166", "167", "168", "169", "17", _ 
        "170", "171", "172", "173", "174", "175", "176", "177", 
"178", "179", "18", "180", "181", _ 
        "182", "183", "184", "185", "186", "187", "188", "189", 
"19", "190", "191", "192", "193", _ 
        "194", "195", "196", "197", "198", "199", "20", "200", "21", 
"22", "23", "24", "25", "26", _ 
        "27", "28", "29", "3", "30", "31", "32", "33", "34", "35", 
"36", "37", "38", "39", "4", "40", _ 
        "41", "42", "43", "44", "45", "46", "47", "48", "49", "5", 
"50", "51", "52", "53", "54", "55", _ 
        "56", "57", "58", "59", "6", "60", "61", "62", "63", "64", 
"65", "66", "67", "68", "69", "7", _ 
        "70", "71", "72", "73", "74", "75", "76", "77", "78", "79", 
"8", "80", "81", "82", "83", "84", _ 
        "85", "86", "87", "88", "89", "9", "90", "91", "92", "93", 
"94", "95", "96", "97", "98", "99") _ 
        , Operator:=xlFilterValues 
    ActiveWindow.SmallScroll Down:=93 
    Range("D165988").Select 
    ActiveWindow.SmallScroll Down:=-153 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="7"
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet1").Select 
    Sheets("Sheet1").Name = "1" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet2").Select 
    Sheets("Sheet2").Name = "2" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet3").Select 
    Sheets("Sheet3").Name = "3" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet4").Select 
    Sheets("Sheet4").Name = "4" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet5").Select 
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    Sheets("Sheet5").Name = "5" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet6").Select 
    Sheets("Sheet6").Name = "6" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet7").Name = "7" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet8").Select 
    Sheets("Sheet8").Name = "8" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet9").Select 
    Sheets("Sheet9").Name = "9" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet10").Select 
    Sheets("Sheet10").Name = "10" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet11").Select 
    Sheets("Sheet11").Name = "11" 
    Sheets("Home").Select 
    Range("F165915:G165915").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.Copy 
    Sheets("1").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D170749").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="8"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("2").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E178070").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="9"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("3").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E187857").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="10"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("4").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("C197609").Select 
    Selection.End(xlUp).Select 
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    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="11"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("5").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D207394").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="12"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("6").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D226928").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="13"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("7").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E242537").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="14"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("8").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E258174").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="15"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("9").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E289425").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="16"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
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    Sheets("10").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E326930").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="17"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("11").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Application.DisplayAlerts = False 
    Sheets("Home").Delete 
    Application.DisplayAlerts = True 
End Sub 
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Sub Explant_Sorter_Sweep() 
'
' Explant_Sorter_Sweep Macro 
' Gel Sorting Macro 
'
' Keyboard Shortcut: Ctrl+Shift+U 
'
    ActiveSheet.Name = "Home" 
    Range("B2:G2").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.AutoFilter 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=4, 
Criteria1:=Array( _ 
        "10", "100", "101", "102", "103", "104", "105", "106", 
"107", "108", "109", "11", "110", _ 
        "111", "112", "113", "114", "115", "116", "117", "118", 
"119", "12", "120", "121", "122", _ 
        "123", "124", "125", "126", "127", "128", "129", "13", 
"130", "131", "132", "133", "134", _ 
        "135", "136", "137", "138", "139", "14", "140", "141", 
"142", "143", "144", "145", "146", _ 
        "147", "148", "149", "15", "150", "151", "152", "153", 
"154", "155", "156", "157", "158", _ 
        "159", "16", "160", "161", "162", "163", "164", "165", 
"166", "167", "168", "169", "17", _ 
        "170", "171", "172", "173", "174", "175", "176", "177", 
"178", "179", "18", "180", "181", _ 
        "182", "183", "184", "185", "186", "187", "188", "189", 
"19", "190", "191", "192", "193", _ 
        "194", "195", "196", "197", "198", "199", "20", "200", "21", 
"22", "23", "24", "25", "26", _ 
        "27", "28", "29", "3", "30", "31", "32", "33", "34", "35", 
"36", "37", "38", "39", "4", "40", _ 
        "41", "42", "43", "44", "45", "46", "47", "48", "49", "5", 
"50", "51", "52", "53", "54", "55", _ 
        "56", "57", "58", "59", "6", "60", "61", "62", "63", "64", 
"65", "66", "67", "68", "69", "7", _ 
        "70", "71", "72", "73", "74", "75", "76", "77", "78", "79", 
"8", "80", "81", "82", "83", "84", _ 
        "85", "86", "87", "88", "89", "9", "90", "91", "92", "93", 
"94", "95", "96", "97", "98", "99") _ 
        , Operator:=xlFilterValues 
    ActiveWindow.SmallScroll Down:=93 
    Range("D165988").Select 
    ActiveWindow.SmallScroll Down:=-153 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="6"
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet1").Select 
    Sheets("Sheet1").Name = "1" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet2").Select 
    Sheets("Sheet2").Name = "2" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet3").Select 
    Sheets("Sheet3").Name = "3" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet4").Select 
    Sheets("Sheet4").Name = "4" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet5").Select 
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    Sheets("Sheet5").Name = "5" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet6").Select 
    Sheets("Sheet6").Name = "6" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet7").Name = "7" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet8").Select 
    Sheets("Sheet8").Name = "8" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet9").Select 
    Sheets("Sheet9").Name = "9" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet10").Select 
    Sheets("Sheet10").Name = "10" 
    Sheets.Add After:=ActiveSheet 
    Sheets("Sheet11").Select 
    Sheets("Sheet11").Name = "11" 
    Sheets("Home").Select 
    Range("F165915:G165915").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Selection.Copy 
    Sheets("1").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D170749").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="7"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("2").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E178070").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="8"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("3").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E187857").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="9"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("4").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("C197609").Select 
    Selection.End(xlUp).Select 
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    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="10"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("5").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D207394").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="11"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("6").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("D226928").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="12"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("7").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E242537").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="13"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("8").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E258174").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="14"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("9").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E289425").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="15"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
 Appendices 223 
    Sheets("10").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Range("E326930").Select 
    Selection.End(xlUp).Select 
    ActiveSheet.Range("$B$2:$G$558195").AutoFilter Field:=3, 
Criteria1:="16"
    Range("F5:G5").Select 
    Range(Selection, Selection.End(xlDown)).Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("11").Select 
    ActiveSheet.Paste 
    Sheets("Home").Select 
    Application.DisplayAlerts = False 
    Sheets("Home").Delete 
    Application.DisplayAlerts = True 
End Sub 
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Aside from macro processing, all output data was manually sorted to retrieve 
values for elastic modulus (block 3), and the two force points for equilibrium 
modulus (end of block 16 and block 19). These data were processed using the elastic 
modulus Excel spreadsheet, which used the height and weight of gels to calculate 
cross sectional area (assuming density of the hydrogels was very similar to water), 
and subsequently elastic and equilibrium moduli. The frequency sweep data were 
processed using Matlab scripts, depending on whether the low frequencies were 
tested first (blank samples) or the high frequencies were tested first (remainder of the 
samples). The discrepancy here was a result of evolution in testing protocol. It was 
decided that doing low frequencies prior to the fast would misrepresent the response 
as at very low frequencies some stress-relaxation would occur. This difference was 
not introduced into the blank specimen files and hence the two scripts were required. 
Matlab was used to fit sine-wave functions to the data, determining an amplitude and 
phase angle for each frequency. This was attempted using two different methods – 
constructing a custom Matlab function fit in the form of a sine wave with specific 
boundary conditions on amplitude and frequency; and using the standard Matlab 
‘sin1’ function fit. It was found that occasionally Matlab would fail to correctly 
identify either the frequency of the sine wave (hence the custom function) or the 
phase angle and amplitude (hence use of the ‘sin1’ function). The scripts presented 
below thus have both aspects included, with one or the other commented-out 
depending on the last successful use. The ascending sweep is presented first, as 
FitTest_Full_Blanks.m: 
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% Data is in the following format:
% One frequency per sheet, column A has extension, column B has 
force - 
% please do not include cycles 1-2 (only 3+) to avoid skewing the 
vertical
% zeroing achieved by subtracting the mean from the data
%
clear all
disp('Sine wave fitting tool')
% Ask the user to select an Excel file containing the data
[baseFileName, folder] = uigetfile('*.xl*', 'Please select your 
input data file');
fullFileName = fullfile(folder, baseFileName);
% Load the extension and force vector from the data matrix
fullData = cell(1,11);
for x = 0:10















































% Calculate mean force for area integral calculation (in Excel)
mf1024 = [-mean(for1024), 0];
mf512 = [-mean(for512), 0];
mf256 = [-mean(for256), 0];
mf128 = [-mean(for128), 0];
mf064 = [-mean(for064), 0];
mf032 = [-mean(for032), 0];
mf016 = [-mean(for016), 0];
mf008 = [-mean(for008), 0];
mf004 = [-mean(for004), 0];
mf002 = [-mean(for002), 0];
mf001 = [-mean(for001), 0];
% Subtract mean from each column to centre data about the x axis
ext1024 = ext1024 - mean(ext1024);
ext512 = ext512 - mean(ext512);
ext256 = ext256 - mean(ext256);
ext128 = ext128 - mean(ext128);
ext064 = ext064 - mean(ext064);
ext032 = ext032 - mean(ext032);
ext016 = ext016 - mean(ext016);
ext008 = ext008 - mean(ext008);
ext004 = ext004 - mean(ext004);
ext002 = ext002 - mean(ext002);
ext001 = ext001 - mean(ext001);
for1024 = for1024 - mean(for1024);
for512 = for512 - mean(for512);
for256 = for256 - mean(for256);
for128 = for128 - mean(for128);
for064 = for064 - mean(for064);
for032 = for032 - mean(for032);
for016 = for016 - mean(for016);
for008 = for008 - mean(for008);
for004 = for004 - mean(for004);
for002 = for002 - mean(for002);
for001 = for001 - mean(for001);














% Define fitting functions
FO1024 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -15], 'Upper', [0.1, 3], 'StartPoint', [0.04, -2]);
FT1024 = fittype('A*sin(64.3398*x - d)', 'options', FO1024);
FO512 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT512 = fittype('A*sin(32.1699*x - d)', 'options', FO512);
FO256 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT256 = fittype('A*sin(16.085*x - d)', 'options', FO256);
FO128 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT128 = fittype('A*sin(8.0425*x - d)', 'options', FO128);
FO064 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT064 = fittype('A*sin(4.0212*x - d)', 'options', FO064);
FO032 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT032 = fittype('A*sin(2.0106*x - d)', 'options', FO032);
FO016 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT016 = fittype('A*sin(1.0053*x - d)', 'options', FO016);
FO008 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT008 = fittype('A*sin(0.5027*x - d)', 'options', FO008);
FO004 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT004 = fittype('A*sin(0.2513*x - d)', 'options', FO004);
FO002 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT002 = fittype('A*sin(0.1257*x - d)', 'options', FO002);
FO001 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);

















































% Output to Excel spreadsheet
topDisp = {'Extension', 'Force', 'Mean Force'};
[Output] = [10.24 0 0; coeffvalues(E1024)' coeffvalues(F1024)' 
mf1024';5.12 0 0; coeffvalues(E512)' coeffvalues(F512)' mf512'; ...
    2.56 0 0; coeffvalues(E256)' coeffvalues(F256)' mf256';1.28 0 0; 
coeffvalues(E128)' coeffvalues(F128)' mf128'; ...
    0.64 0 0; coeffvalues(E064)' coeffvalues(F064)' mf064';0.32 0 0; 
coeffvalues(E032)' coeffvalues(F032)' mf032'; ...
    0.16 0 0; coeffvalues(E016)' coeffvalues(F016)' mf016';0.08 0 0; 
coeffvalues(E008)' coeffvalues(F008)' mf008'; ...
    0.04 0 0; coeffvalues(E004)' coeffvalues(F004)' mf004';0.02 0 0; 
coeffvalues(E002)' coeffvalues(F002)' mf002'; ...
    0.01 0 0; coeffvalues(E001)' coeffvalues(F001)' mf001'];







 Appendices 229 
The second Matlab script, FitTest_Full_v2.m, is shown below: 




% Data is in the following format:
% One frequency per sheet, column A has extension, column B has 
force - 
% please do not include cycles 1-2 (only 3+) to avoid skewing the 
vertical
% zeroing achieved by subtracting the mean from the data
%
clear all
disp('Sine wave fitting tool')
% Ask the user to select an Excel file containing the data
[baseFileName, folder] = uigetfile('*.xl*', 'Please select your 
input data file');
fullFileName = fullfile(folder, baseFileName);
% Load the extension and force vector from the data matrix
fullData = cell(1,11);
for x = 0:10















































% Calculate mean force for area integral calculation (in Excel)
mf1024 = [-mean(for1024), 0, 0];
mf512 = [-mean(for512), 0, 0];
mf256 = [-mean(for256), 0, 0];
mf128 = [-mean(for128), 0, 0];
mf064 = [-mean(for064), 0, 0];
mf032 = [-mean(for032), 0, 0];
mf016 = [-mean(for016), 0, 0];
mf008 = [-mean(for008), 0, 0];
mf004 = [-mean(for004), 0, 0];
mf002 = [-mean(for002), 0, 0];
mf001 = [-mean(for001), 0, 0];
% Subtract mean from each column to centre data about the x axis
ext1024 = ext1024 - mean(ext1024);
ext512 = ext512 - mean(ext512);
ext256 = ext256 - mean(ext256);
ext128 = ext128 - mean(ext128);
ext064 = ext064 - mean(ext064);
ext032 = ext032 - mean(ext032);
ext016 = ext016 - mean(ext016);
ext008 = ext008 - mean(ext008);
ext004 = ext004 - mean(ext004);
ext002 = ext002 - mean(ext002);
ext001 = ext001 - mean(ext001);
for1024 = for1024 - mean(for1024);
for512 = for512 - mean(for512);
for256 = for256 - mean(for256);
for128 = for128 - mean(for128);
for064 = for064 - mean(for064);
for032 = for032 - mean(for032);
for016 = for016 - mean(for016);
for008 = for008 - mean(for008);
for004 = for004 - mean(for004);
for002 = for002 - mean(for002);
for001 = for001 - mean(for001);














% Define fitting functions
%{
FO1024 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -15], 'Upper', [0.1, 3], 'StartPoint', [0.04, -2]);
FT1024 = fittype('A*sin(64.3398*x - d)', 'options', FO1024);
FO512 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT512 = fittype('A*sin(32.1699*x - d)', 'options', FO512);
FO256 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT256 = fittype('A*sin(16.085*x - d)', 'options', FO256);
FO128 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT128 = fittype('A*sin(8.0425*x - d)', 'options', FO128);
FO064 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT064 = fittype('A*sin(4.0212*x - d)', 'options', FO064);
FO032 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT032 = fittype('A*sin(2.0106*x - d)', 'options', FO032);
FO016 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT016 = fittype('A*sin(1.0053*x - d)', 'options', FO016);
FO008 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT008 = fittype('A*sin(0.5027*x - d)', 'options', FO008);
FO004 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT004 = fittype('A*sin(0.2513*x - d)', 'options', FO004);
FO002 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);
FT002 = fittype('A*sin(0.1257*x - d)', 'options', FO002);
FO001 = fitoptions('Method', 'NonlinearLeastSquares', 'Lower', [-
0.1, -3], 'Upper', [0.1, 3], 'StartPoint', [0.04, 0]);


















































% Output to Excel spreadsheet
topDisp = {'Extension', 'Force', 'Mean Force'};
[Output] = [10.24 0 0; coeffvalues(E1024)' coeffvalues(F1024)' 
mf1024';5.12 0 0; coeffvalues(E512)' coeffvalues(F512)' mf512'; ...
    2.56 0 0; coeffvalues(E256)' coeffvalues(F256)' mf256';1.28 0 0; 
coeffvalues(E128)' coeffvalues(F128)' mf128'; ...
    0.64 0 0; coeffvalues(E064)' coeffvalues(F064)' mf064';0.32 0 0; 
coeffvalues(E032)' coeffvalues(F032)' mf032'; ...
    0.16 0 0; coeffvalues(E016)' coeffvalues(F016)' mf016';0.08 0 0; 
coeffvalues(E008)' coeffvalues(F008)' mf008'; ...
    0.04 0 0; coeffvalues(E004)' coeffvalues(F004)' mf004';0.02 0 0; 
coeffvalues(E002)' coeffvalues(F002)' mf002'; ...
    0.01 0 0; coeffvalues(E001)' coeffvalues(F001)' mf001'];
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The output data from these (in the form of frequency, amplitude and phase 
angle) was then processed – first the blank data were assessed against each other, 
with a plot of extension versus force used to determine the slope of the trend line 
between data points. This slope was then used as a correction factor when the sample 
data were considered. Values for corrected force, /, blank correction factor 0 1
	and raw force 2, were used, with phase angles for corrected force, /, blank, 0 
and raw force, 2 also implemented. As we have an increase in displacement, we 
have an increase in inertial force, with 0 being the slope of the trend line fitted to 
the blank data. The corrected force therefore was calculated using the law of cosines 
to be: 
34 $ 4 5 64 7 86 () 9  
3 $ :4 5 64 7 86 () 9  
/ $ 	;24 5 
0 1  7 82
0 1  ()
< 7 0  
Whilst the corrected phase angle was calculated simply using the arctangent of 
the relationship: 
/ $ =>+ ?@AB  
/ $ =>+ ?2 *+ 2 7 
0 1  *+ 0 2 () 2 7 
0 1  () 0C B  
The values for /, /, 2 and  (extension and extension phase angle) were 
used to calculate storage and loss moduli using the amplitude and phase angle (in this 
case difference between phase angles of force and displacement), as shown 
previously in Chapter 5 (Equation 5.1.a and Equation 5.1.b). 
 
